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Summary 
 
The  increasing  resistance  of  almost  all  pathogenic  bacteria  to  antibiotics  (multidrug 
resistance)  causes  a  severe  threat  to  public  health.  The  mechanisms  underlying 
multidrug  resistance  include  the  induced  over  expression  of  multidrug  transporters 
which  extrude  a  variety  of  lipophilic  and  toxic  substrates  in  an  energy  dependent 
fashion through the membrane out of the cell. These proteins are found in all transporter 
families.  
The work described in this thesis is dedicated to drug-proton antiporters from the small 
multidrug resistance (SMR) family. These efflux pumps with just four transmembrane 
helices per monomer are so far the smallest transporters discovered. Their oligomeric 
state, topology, three dimensional structure, catalytic cycle and transport mechanism are 
still rather controversial. Therefore, the aim of this thesis was to directly address these 
questions for the small multidrug resistance proteins Halobacterium salinarium Hsmr 
and Escherichia coli (E. coli) EmrE using a number of biophysical methods such as 
NMR, transport assays, mass spectrometry and analytical ultracentrifugation. Especially 
the work on Hsmr has been challenging due to the halophilic nature of this protein. 
 
In  Chapter  1,  key  questions  and  the  most  important  biophysical  techniques  are 
introduced followed by Material and Methods in Chapter 2.  
 
Depending on experimental requirements, cell free or ‘classical’ in vivo expression has 
been used for this thesis.  
 
Cell free expression as an option for the production of small multidrug transporters has 
been explored in Chapter 3. It has been possible to produce the SMR family members 
Hsmr, EmrE, TBsmr and YdgF in vitro. The expression of Hsmr was investigated in 
more  detail  under  different  experimental  conditions.  Hsmr  was  either  refolded  from 
precipitate  or  maintained  in  a  soluble  form  during  expression  in  the  presence  of 
detergents and liposomes. Furthermore, amino acids for which no auxotrophic strains 
were available could be labelled successfully. This expression system has been also 
used for preparing labelled samples of EmrE as described in Chapter 9. 
 
In  vivo  in  E.  coli  expression  of  Hsmr,  as  described  in  Chapter  4,  provided  large 
amounts of proteins if fermenter production was used. Uniform labelling and selective 
unlabelling with stable isotopes (
13C, 
15N) for NMR spectroscopy was achieved in vivo 
in a more efficient and cost effective manner than using the cell free approach for this 
protein. Hsmr could be purified successfully from both in vitro and in vivo expression 
media. Hsmr is expressed in vivo and in vitro with N-terminal formylation. The N-
terminal formylation is unstable and Hsmr in the presence of low salt concentrations 
was amenable to N-terminal degradation. It was found that Hsmr shows longest stability 
in Fos-ß-choline
® 12 and sodium dodecyl sulphate, but best reconstitution conditions 
were  found,  when  dodecyl  maltoside  is  used  and  exchanged  with  Escherichia  coli 
lipids. A molar protein lipid ratio of 1 to 100, amenable to solid state nuclear magnetic 
resonance,  has  been  achieved.  Sample  homogeneity  was  shown  by  freeze  fracture 
electron microscopy. 
 
The oligomeric state of Hsmr in detergent has been assessed by SDS PAGE, blue native 
PAGE, size exclusion chromatography, analytical ultracentrifugation and laser induced 
liquid bead ion desorption mass spectrometry (LILBID) as described in Chapter 5. A Summary 
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concentration and detergent dependent monomer-oligomer equilibrium has been found 
by all methods.  
 
The activity of Hsmr under the sample preparation conditions used here was shown 
using radioactive and fluorescence binding as well as fluorescence and electrochemical 
transport assays (Chapter 6). For transport studies, a stable pH gradient was generated 
by  co-reconstitution  of  Hsmr  with  bacteriorhodopsin  and  subsequent  sample 
illumination. 
 
Based on the observed long term stability of Hsmr in Fos-ß-choline
® 12 and sodium 
dodecyl sulphate, liquid state NMR experiments were attempted in order to assess the 
correct folding of Hsmr in detergent micelles (Chapter 7). 1D proton and 2D HSQC 
spectra of U-
15N Hsmr revealed a poor spectral dispersion, low resolution and only a 
small number of peaks. These are at least partly due to long rotational correlation times 
of the large protein detergent complex. 
 
This problem has been overcome by applying solid-state NMR to Hsmr reconstituted 
into E. coli lipids (Chapter 8). Uniform 
13C labelled samples were prepared and two 
dimensional  proton-driven  spin  diffusion  and  double  quantum-single  quantum 
correlation spectra were acquired successfully.  Unfortunately, the spectral resolution 
was  not  yet  sufficient  for  further  structural  studies.  Reasons  for  the  observed 
linebroadening could be structural heterogeneity or molecular motions which interfere 
with the NMR timescale. Therefore, the protein mobility has been probed using static 
2H  solid  state  NMR  on  Ala-d3-Hsmr.  It  could  be  shown,  that  parts  of  Hsmr  are 
remarkably  mobile  in  the  membrane  and  that  this  mobility  can  be  limited  by  the 
addition  of  the  substrate  ethidium  bromide.  Ethidium  bromide  as  well  as 
tetraphenylphosphonium  (TPP
+)  is  typical  multidrug  transporter  substrates.  The 
membrane interaction of TPP
+ in DMPC membranes has been resolved by 
1H MAS 
NMR. It was found that it penetrates into the interface region of the lipid bilayers and 
therefore behaves like many other transporter substrates adding to the hypothesis that 
the membrane could act as a pre-sorting filter.  
 
Finally,  Chapter  9  is  dedicated  to  the  characterisation  of  the  essential  and  highly 
conserved  residue  Glu-14  in  EmrE  by  solid-state  NMR.  In  order  to  avoid  spectral 
overlap, the single Glu EmrE E25A mutant was chosen instead of the wildtype. The 
protein has been produced in vitro to take advantage of reduced isotope scrambling in 
the cell free expression system as verified by analytical NMR spectroscopy. Correct 
labelling of EmrE was tested by MALDI-TOF and solid-state NMR. The dimeric state 
of  DDM  solubilised  EmrE  has  been  probed  by  LILBID.  The  labelled  protein  was 
reconstituted into E. coli lipids to ensure a native membrane environment. Activity was 
determined by measuring ethidium bromide transport. Freeze fracture EM revealed very 
homogeneous protein incorporation even after many days of MAS NMR experiments. 
2D 
13C double quantum filtered experiments were used to obtain chemical shift and 
lineshape information of Glu-14 in EmrE. Two distinct populations were found with 
backbone chemical shift differences of 4 - 6 ppm which change upon substrate binding. 
These findings indicate a structural asymmetry at the assumed dimerisation interface 
and are discussed in the context of a model for shared substrate/proton binding. These 
studies  represent  the  first  successful  use  of  cell  free  expression  to  prepare  labelled 
membrane proteins for solid-state NMR and allow for the first time an NMR insight 
into the binding pocket of a multidrug efflux pump.   Zusammenfassung 
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Zusammenfassung 
 
Die  zu  beobachtende  Antibiotikaresistenz  nahezu  aller  pathogener  Bakterien 
(Multidrugresistenz)  stellt  ein  ernstes  medizinisches  Problem  dar.  Einer  der 
molekularen  Mechanismen  basiert  auf  der  induzierten  Überexpression  von 
Multidrugtransportern, welche eine Vielfalt lipophiler und toxischer Substanzen unter 
Energieverbrauch durch die Membran aus der Zelle pumpen. Derartige Proteine lassen 
sich in fast allen Transporterfamilien finden. 
Diese  Dissertation  widmet  sich  Substrat-Protonen-Antiportern  der  Small  Multidrug 
Resistance (SMR) Familie, welche mit nur 4 transmembranen Helices zu den kleinsten 
bisher bekannten Transportern gehören. Ihr Oligomerisierungsgrad, 3D Struktur und die 
molekularen Details des Transportzyklus sind trotz intensiver Studien stark umstritten. 
Das Ziel dieser Dissertation war es daher zu versuchen, diese Fragen für die Proteine 
Hsmr, aus Haslobacterium salinarium, und EmrE, aus Escherichia coli (E. coli), mittels 
biophysikalischer  Techniken  wie  Fluoreszenzspektroskopie,  Massenspektrometrie, 
NMR und analytischer Ultrazentrifugation zu beantworten. Neben den allgemeinen zu 
erwartenden Problemen bei der Präparation von Membranproteinen stellte der halophile 
Charakter von Hsmr eine besondere Herausforderung dar. 
 
In Kapitel 1 werden die behandelten Proteine, die zu lösenden Fragstellungen und die 
wichtigsten  Methoden  eingeführt.  Die  benutzten  Materialien  und  Methoden  sind  im 
Detail in Kapitel 2 beschreiben. Je nach experimentellen Erfordernissen wurde zellfreie 
Synthese oder „klassische“ in vivo Expression in E. coli für die in dieser Dissertation 
beschriebenen Arbeiten benutzt. Die Möglichkeiten der zellfreien Synthese als Option 
für die Herstellung von SMR Proteinen werden in Kapitel 3 untersucht. Es war möglich 
Hsmr, EmrE, TBsmr und YdgF in vitro in nachweisbaren Mengen zu produzieren. Die 
Expression  von  Hsmr  wurde  im  Detail  unter  verschiedenen  experimentellen 
Bedingungen studiert. Hsmr wurde entweder aus prezipitierter Form rückgefaltet oder 
direkt  in  der  Gegenwart  von  Detergenzmizellen  oder  Liposomen  exprimiert.  Ein 
besonderer  Vorteil  zellfreien  Synthese  besteht  gerade  in  der  Möglichkeit  bestimmte 
Aminosäuren mit stabilen Isotopen zu markieren für die keine auxotrophen Stämme für 
die in vivo Expression zur Verfügung stehen. Dieser Ansatz wurde für die Herstellung 
selektiv markierter EmrE Proben verfolgt, wie in Kapitel 9 beschreiben. 
 
Durch in vivo Expression von Hsmr in E. coli (Kapitel 4) konnten unter Verwendung 
eines Fermenters größere Proteinmengen bereitgestellt werden. Verschiedene U-
13C und 
15N Markierungsschemata konnten in vivo auf eine effizientere und kostengünstigere 
Art als mit der zellfreien Synthese verwirklicht werden. Hsmr konnte sowohl nach in 
vitro und in vivo Expression erfolgreich aufgereinigt werden. Hsmr wurde in beiden 
Fällen  mit  einer  N-terminalen  Formylierung  exprimiert.  Diese  N-terminale 
Formylierung  ist  instabil.  Bei  niedriger  Salzkonzentration  war  eine  N-terminale 
Degradation  des  Proteins  zu  beobachten.  Die  Detergenzien  die  die  größte 
Langzeitstabilität von Hsmr ermöglichen sind Fos-ß-choline
® 12 und SDS. Die für die 
Rekonstituierung besten Bedingungen wurden aber für Dodecylmaltosid und  E. coli 
Lipide gefunden. Es war so ein molares Lipid-Proteinverhältnis von 100:1 möglich, was 
weitergehende  Festkörper-NMR  Experimente  erlaubt.  Eine  hohe  Probenhomogenität 
wurde mittels Gefrierbruchelekronenmikroskopie nachgewiesen. 
Der Oligomerisierungsgrad von Hsmr in Detergenzmizellen wurde mittels SDS PAGE, 
blau-nativer PAGE, Gelfiltration, analytischer Ultrazentrifugation und Laser induzierter 
Tröpfchen-Desorptions-Massenspektrometrie (LILBID), wie in Kapitel 5 beschrieben, Zusammenfassung 
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untersucht. Es konnte gezeigt werden, dass das Gleichgewicht zwischen Monomeren 
und Oligomeren von der Proteinkonzentration, Salz und Detergenz abhängt.  
 
Die Aktivität von Hsmr für die hier etablierten Präparationsbedingungen wurde über 
Substratbindung  (Fluoreszenz,  radioaktiv)  und  mittels  Substrattransportmessungen 
(elektrochemisch, Fluoreszenz) nachgewiesen (Kapitel 6). Das für den transmembranen 
Transport notwendige, zeitlich stabile elektrochemische Potential konnte dabei durch 
Ko-Rekonstituierung von Hsmr mit Bakteriorhodopsin über Probenbeleuchtung erzeugt 
werden.  Da  Hsmr  in  Fos-ß-choline
®  12  und  SDS  längere  Zeit  stabil  war,  wurden 
Lösungs-NMR  Experiment  an 
15N markierten  Proben  durchgeführt,  um  die  korrekte 
Faltung des Proteins in Mizellen zu verifizieren (Kapitel 7). Leider konnten aber in 
1H-
15N HSQC Spektren nur wenige Resonanzen aufgelöst werden, was vermutlich zum 
Teil  auf  die  lange  Rotationskorrelationszeit  dieses  Proteindetergenzkomplexes 
zurückzuführen ist.  
 
Dieses Problem konnte jedoch teilweise durch die Anwendung von Festkörper-NMR 
auf Hsmr in E. coli Lipiden gelöst werden (Chapter 8). Es wurden eine Reihe von 
zweidimensionalen  protonengetriebenen  Spindiffusionsexperimenten  sowie  Doppel-
Einzelquanten-Korrelationspektren an vollständig 
13C markierten Proben aufgenommen. 
Leider war die spektrale Auflösung für weiterführende Studien nicht gut genug. Gründe 
für die zu beobachtende Linienverbreiterung könnten strukturelle Heterogenität oder mit 
der  NMR  Zeitskala  interferierende  molekulare  Bewegungen  sein.  Daher  wurde  die 
Proteinbeweglichkeit  qualitativ  mit  statischer 
2H  NMR  an  Ala-d3-Hsmr  studiert.  Es 
wurde  dabei  tatsächlich  eine  hohe  molekular  Beweglichkeit  in  Teilen  des  Proteins 
beobachtet, die jedoch nach Zugabe des Substrats Ethidiumbromid stark eingeschränkt 
wurde. Die Lokalisierung des Substrats TPP
+ in einer DMPC Membran wurde mittels 
1H MAS NMR untersucht. Wie viele andere Substrate auch, lagert sich TPP
+ in der 
Membran  oberhalb  der  hydrophoben  Kettenregion  ein,  was  die  Hypothese  einer 
membranunterstützten Bindung an das Protein unterstützt. 
 
Kapitel  9  widmet  sich  der  Festkörper-NMR  Charakterisierung  des  in  der  gesamten 
SMR Familie hochkonservierten Restes Glu14 in Helix 1 am Beispiel von EmrE. Zur 
Vereinfachung der Spektren wurde die Glu-Mutante EmrE E25A statt  des Wildtyps 
ausgewählt. Um den metabolischen Abbau von U-
13C-Glu zu verhindern, wurde das 
Protein in vitro hergestellt. Markierungseffizienz und korrekter Einbau wurde mittels 
MALDI-TOF und NMR verifiziert. Um eine möglichst native Situation zu emulieren, 
wurde das markierte Protein in E.coli Lipide rekonstituiert. Proteinaktivität wurde über 
Ethidiumbromidtransport  nachgewiesen.  Mittels  Gefrierbruchelektronenmikroskopie 
konnte ein sehr homogener Einbau des Proteins sogar nach mehreren Tagen MAS NMR 
Experimenten  gesehen  werden. 
13C  chemische  Verschiebungen  für  Glu14  wurden 
mittels  Doppel-Einzelquanten-Korrelationspektren  bestimmt.  Es  konnten  zwei 
Populationen unterschieden werden, die für den Bereich des Proteinrückgrats chemische 
Verschiebungsdifferenzen von 4–6ppm aufweisen. Nahezu alle Resonanzen ändern sich 
nach Zugabe von Ethidiumbromid. Diese Beobachtungen weisen auf eine strukturelle 
Asymmetrie im Bereich des vermuteten Dimerisierungsinterfaces hin und werden im 
Kontext eines Modells für eine gemeinsame Substrat/Protonenbindungsstelle diskutiert. 
Diese Studie repräsentiert die erfolgreiche Anwendung der zellfreien Expression zur 
Herstellung markierter  Membranproteine  für die Festkörper-NMR. Diese Messungen 
ermöglichen erstmals einen Einblick in die Bindungstasche einen Multidrugtransporters. 
 Chapter 1 - Introduction 
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Chapter 1 - Introduction 
 
1.1 Biological Introduction 
1. 1 Protein class introduction 
1. 1. 1. 1 Membrane Proteins  
Living cells are surrounded and compartmentalised by membranes. These lipid bilayers 
are a generally composed of nearly 50 % proteinaceous material which can be either 
integral,  membrane  spanning  proteins,  or  peripheral,  membrane  associated,  proteins. 
The role of these proteins is diverse including: energy conversion, transport of ions and 
molecules,  sensing  and  transmitting  stimuli.  The  abundance  of  different  membrane 
proteins is highlighted by recently sequenced bacterial genomes which revealed that 3-
10 % (3 % in Mycobacterium tuberculosis and 10 % in Salmonella typhimurium) of 
open reading frames are predicted to encode membrane transport proteins. Despite their 
abundance  the  difficulties  associated  with  working  on  membrane  proteins  is  for 
example  reflected  in  the  number  of  x-ray  crystallographic  structures  that  have  been 
solved. Currently only 144 unique membrane protein structures are known [1]. For the 
important class of transport proteins the situation is even worse and at the end of 2003 
only eight different 3D structures were known [1].  
 
1. 1. 1. 2 Transport proteins 
Transport of substances across a membrane may be passive or active and depends on 
the Gibbs free energy  G: 
 
V ZF
c
c
RT G e D + = D
1
2 log                  (1) 
 
 G  =  Gibbs  free  energy,  R  =  gas  constant,  T  =  temperature,  c2  =  concentration,  c1  = 
concentration, Z = electrical charge, F = Faraday constant,  V = potential across the membrane 
 
Channel proteins facilitate the downhill flux of a selection of specific molecules when 
opened.  G is negative for passive transport. In contrast active transport is defined as 
the uphill transport of a substance against the concentration gradient by coupling to an 
energy generating step.  G is positive for active transport. The net flux of molecules is 
thus determined by the thermodynamic gradient. In particular for charged molecules it 
is  important  to  keep  in  mind  that  not  only  the  concentration  gradient  but  also  the 
electrochemical gradient need to be overcome.  
 
Often only proteins involved in active energy requiring transport of molecules are called 
transporter [2]. This nomenclature is also adopted in this thesis.  
A  further  subclassification  of  transporter  into  primary  and  secondary  transporter  is 
based on their energy generating mechanism. Primary transporter, also called adenosine 
triphosphate  binding  cassette  (ABC)  transporter,  utilise  the  energy  provided  by  the 
hydrolysis of adenosine triphosphate (ATP) to adenosine diphosphate (ADP) for active 
transport  while  secondary  transporter  utilise  an  ion  gradient,  usually  H
+  or  Na
+,  as 
driving force for  active substrate transport. The secondary transport proteins can be 
further subdivided by the direction of substrate and driving ion transport. A transporter 
using  unidirectional  transport  of  ions  and  substrate  is  termed  symporter  while  a 
transport in opposite directions leads to the classification as an antiporter. For secondary 
transporter a multitude of different translocation mechanisms and so far four different 
folds have been described [3]. This suggests the possibility of the occurrence of further 
subclasses.  However  in  order  to  fulfil  their  function,  all  transport  proteins  must Chapter 1 - Introduction 
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negotiate a cycle which includes steps associated with substrate recognition, binding, 
translocation  and  release.  It  is  expected  that  transporter  show  a  high  specificity  for 
binding and transport of one or very few highly related substances and this is true for 
the majority of transporters. However, a subclass of proteins has been shown to exhibit 
a surprisingly broad substrate specificity which allows them to play important roles in 
multidrug  resistance,  cell  volume  regulation  and  peptide  selection  for  translocation 
across membranes.  
 
1. 1. 1. 3 Multidrug transporter   
Multidrug  drug  resistance,  particularly  bacterial  resistance  to  clinical  antibiotics  and 
neoplastic resistance to chemotherapeutic agents, are a widely known phenomenon. The 
World  Health  Organization  recognised  this  as  severe  threat  to  global  health  and 
launched  in  2001  a  global  strategy  to  combat  this  problem  [4].  Basic  defence 
mechanisms  of  bacteria  include  permeability  barriers,  inactivation  of  antimicrobials, 
modification of antibiotic targets and active drug efflux and these have been found to 
act synergistically [5, 6], see figure 1. The active efflux of toxic substances is mediated 
by so called multidrug transporter. These proteins can be primary and secondary active 
transport proteins and the latter are found in almost all transporter families [7]. To date 
six transport families which include multidrug transporter have been recognised [8], 
namely  the  ABC  superfamily,  and  the  secondary  transporter  families  resistance 
nodulation  cell  division  (RND)  superfamily,  major    facilitator  superfamily  (MFS), 
drug/metabolite  transporter  (DMT)  superfamily,  multidrug  and  toxic  compound 
extrusion (MATE) superfamily and multidrug endosomal transporter (MET) family. All 
secondary  multidrug  transporters  so  far  discovered  are  antiporter.  The  unifying 
characteristic  of  all  multidrug  transport  proteins  however  is  the  ability  of  a  single 
protein to recognise a diverse array of substrates.   
 
 
Figure 1. Bacterial defence mechanisms. A) Inactivation of the drug, B) alteration of drug 
target, C) prevention of drug uptake, D) active extrusion of drugs. Reproduced from [5]. Chapter 1 - Introduction 
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The molecular mechanism of the broad substrate specificity of multidrug efflux pumps 
is not yet fully understood. For biophysical studies much sample is needed which is 
difficult  to  obtain  due  to  the  inherent  difficulties  in  membrane  protein  sample 
preparations.  Therefore  alternative  approaches  have  been  pursued.  Soluble  proteins 
involved in transcriptional regulation of multidrug transporter such as BmrR and QacR 
have been investigated regarding their structure and mode of substrate binding [9-13]. It 
emerges  that  different  ligands  bind  in  the  hydrophobic  pocket  at  different  but 
overlapping  positions.  The  specificity  is  achieved  exclusively  by  electrostatic  and 
hydrophobic  interactions.  A  charged  amino  acid  in  an  otherwise  hydrophobic 
environment, flexibility of the binding site and the lack of hydrogen bonds are further 
reoccurring molecular patterns [14]. 
 
Now, several 3D structures of multidrug transporter are known, including: the ABC-
type transporter Sav1866 [15] and MsbA [16] and the secondary transporter AcrB from 
the  RND  superfamily  [17,  18]  and  EmrE  from  the  DMT  superfamily  and  small 
multidrug resistance (SMR) protein family [19]. None of these answer the question of 
the route of drug entry into the transporter unequivocally. For ABC transporter three 
substrate uptake and efflux mechanisms have been discussed namely: a classical pump, 
an hydrophobic vacuum cleaner [20] and a flippase [21], see figure 2.  
 
 
Figure 2. Schematic representation of the efflux mechanisms described for ABC multidrug 
transporter. A) classical pump, B) hydrophobic vacuum cleaner and C) flippase mechanism. 
 
A classical pump takes up substrates from the aqueous phase and translocates them into 
the extracellular space. A flippase requires the substrates to enter the membranes inner 
leaflet, where they bind to the protein and are subsequently flipped to the outer leaflet. 
From  the  outer  leaflet  the  substrates  can  diffuse  into  the  extracellular  space.  The 
vacuum cleaner model suggests that drugs diffuse into the lipid phase from which they 
enter the protein which expels them into the extracellular aqueous phase.  
Each 3D structure corresponds only to a snapshot of the protein during its transport 
cycle. Therefore, additional approaches are needed to elucidate the transport kinetics, 
substrate-protein  interactions,  oligomeric  state  or  conformational  changes  during 
substrate translocation. 
 
1. 1. 1. 4 SMR proteins 
The  topic  of  this  thesis  are  investigations  of  multidrug  transporters  from  the  SMR 
family, a subclass of the DMT superfamily. The SMR family (TC#2.A.7.1 [22]) [23, 
24] encompasses now more than 250 members from the bacterial and archeae kingdoms 
[25]. In general SMR proteins are small with only 100 to 140 amino acids, a molecular 
weight of roughly 12 kDa and have a four transmembrane helix topology, several highly 
conserved  residues  and  transport  a  diverse  array  of  aromatic,  positively  charged Chapter 1 - Introduction 
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substrates in antiport exchange for protons [26]. SMR proteins have overlapping but 
significantly different substrate specificities with measured affinities in the nM to mM 
range  [27,  28].  Recently,  SMR  proteins  have  been  subdivided  into  the  multidrug 
transport  protein  subclasses  small  multidrug  pumps  (SMP),  paired  small  multidrug 
resistance  (PSMR)  and  suppressor  of  groEL  mutations  protein  (SUG).  The 
subclassification  is  based  on  phylogenetic  analysis,  different  loci  on  the  bacterial 
genome, homo- or heterooligomerisation and range of substrate specificity [25]. Table 1 
gives a short overview of the characteristics of each subclass.  
 
name of 
subclass 
oligomerisation type  substrate specificity  typical member (organism) 
SMP  homo  broad  EmrE (E. coli) 
SUG  homo  narrow  SugE (E. coli) 
PSMR  hetero  broad  YdgE/F (E. coli) 
Table 1. Overview of SMR protein subclasses. 
 
A sequence alignment of proteins from each SMR protein subclass is shown in figure 3 
and the conserved residues as well as residues for which only conservative substitutions 
have been found are highlighted here.  
 
 
Figure 3. Sequence alignment of selected SMR proteins using ClustalW [29]. Three SMP 
proteins including the here investigated Hsmr and EmrE are aligned with 2 PSMR protein pairs 
and 2 SUG proteins. In red conserved residues are highlighted, while yellow indicates that only 
conservative substitutions are found. 
 
1. 1. 1. 5 EmrE - the SMP subclass model protein 
Most  investigations  have  been  conducted  on  EmrE,  the  model  protein  of  the  SMR 
protein family. EmrE has attracted significant interest for the class of SMR proteins due Chapter 1 - Introduction 
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to the controversies surrounding its: topological organization [30-34], oligomerisation 
state [35-38], transport cycle steps  [27, 31, 39-41] and initial 3D structures [42, 43] 
which were later retracted. More precisely, the oligomeric organisation of EmrE has 
been  investigated  in  detergent  a  solubilised  state  and  incorporated  into  a  lipid 
membrane.  Different  techniques  have  yielded  different  results,  see  table  2,  but  the 
accumulated  evidence  now  strongly  suggests  that  EmrE  in  a  detergent  or  lipid 
environment is a functional and structural dimer.  
 
oligomeric state  experimental methodology  reference 
monomer  isothermal calorimetry 
 
[37] 
dimer  EPR (electron paramagnetic resonance) 
spectroscopy 
EM (electron microscopy) structure 
x-ray crystallography structure with substrate 
x-ray crystallographic structure with substrate 
cysteine crosslinking 
whole cell growth assay 
analytical ultracentrifugation and 
size exclusion chromatography 
functional complementation of antiparallel 
proteins 
in vitro functional complementation 
 
[44] 
 
[45] and [46] 
[43] retracted 
[19] 
[47] 
[48] 
[35]  
 
[33] 
 
[36] 
trimer  in vivo and in vitro negative dominance   
radioactive ligand binding 
 
[38] 
[27]  
 
Tetramer  functional complementation of in vitro produced 
protein 
x-ray crystallography structure 
[36] 
 
[49] retracted 
Table 2. Summary of experimental evidence for the EmrE oligomeric state. 
 
Furthermore, the topological organisation of EmrE, with regards to the localisation of 
the  N-terminus  and  C-terminus,  has  been  investigated  using  several  different 
techniques; see table 3. Controversial result have been obtained. Data obtained mainly 
in Professor Schuldiner’s laboratory suggests a cytosolic location for the N-terminus 
and C-terminus and thus parallel dimers are formed. This organisation is expected as 
membrane proteins are inserted in a unique defined orientation into the membrane using 
an insertion machinery, which is for E. coli cytoplasmic membrane proteins usually the 
Sec  translocase  [50].  This  machinery  is  guided  by  signal  sequences  and  the  charge 
distribution in the loops of membrane proteins [51].  
Data obtained in many other laboratories suggest however that EmrE, which has low 
charge  bias  in  its  loops,  is  inserted  in  both  orientations.  The  thus  obtained  EmrE 
molecules with Nin-Cin or Nout-Cout topology have been found to form dimers consisting 
of two oppositely oriented EmrE protomers. The observation of functional antiparallel 
EmrE dimers has led to the postulation that EmrE is a so called dual topology protein. 
The idea of dual topology proteins is highly attractive as it would provide a missing link 
in  protein  evolution  [52].  Most  membrane  transport  proteins  have  more  than  4 
transmembrane helices and show an internal symmetry which could be explained by 
gene duplication, gene fusion and charge drift. The discovery that the heterooligomeric 
PSMR proteins are only functional if the protomers are located in the membrane with Chapter 1 - Introduction 
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opposite  topology  [53],  that  PSMR  proteins  show  a  strong  charge  bias  imposing  a 
defined orientation in the membrane [54] and the observation that the essential E14 
residues  in  both  protomers  are  not  functionally  equivalent  [55]  further  support  the 
hypothesis that SMR proteins are indeed dual topology proteins. 
 
topology  Method  reference 
parallel dimer  genetically fused dimer  [56] 
parallel dimer  antibodies + sulfhydryl reagents  [30] 
parallel dimer  EPR  [57] 
antiparallel dimer  computer modelling + EM  [58] 
antiparallel dimer  charge bias  [33] 
antiparallel dimer  x-ray crystallography  [19] 
antiparallel dimer  reporter proteins  [59] 
antiparallel dimer  mutations shift charge bias  [32] 
antiparallel  
Dimer 
cross linking  [60] 
Table  3.  Experimental  evidence  for  EmrE  functional  oligomerisation  as  parallel  or 
antiparallel dimer. 
 
Similarly  disputed  is  the  3D  structure  of  EmrE,  table  4,  summarises  the  published 
attempts. So far only backbone computer model based on EM data of EmrE with TPP
+ 
(tetraphenyl phosphonium) bound in DMPC (dimyristoylglycero-rac-3-phosphocholin) 
2D crystals and a backbone x-ray crystallographic structure of EmrE with TPP
+ bound 
in the detergent NG (N-nonyl-β-D-glucoside) are known. 
 
technique  comment  reference / PDB code 
solution NMR (nuclear 
magnetic resonance) 
resonance assignment and 
secondary structure in 
solvents 
[61] 
solution NMR  partial resonance assignment 
and secondary structure of 
fragments 
[62] 
EM  7 Å  [45] 
EM  with substrate TPP
+, 7 Å  [46] 
computer modelling + EM  helix assignment and 
backbone only 
[58] 
x-ray crystallography  3.8 Å  [42] retracted /1s7b 
x-ray crystallography  with substrate TPP
+, 3.7 Å   [43] retracted / 2f2m 
x-ray crystallography  3.8 Å, backbone only  [19] 3b61 
x-ray crystallography  with substrate TPP
+, 3.8 Å, 
backbone only 
[19] 3b5d 
Table 4. Structural investigations of EmrE.  
 
The latest and thus far uncontested transport mechanism for EmrE is based partly on the 
3D structure model of EmrE in DMPC and measured by electron microscopy. This 
model suggests that EmrE uses an alternate access mechanism [58]. See figure 4 for a 
schematic representation.  
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Figure  4.  Schematic  drawing  of  proposed  alternate  access  mechanism  for  substrate 
transport as proposed by Fleishman et al. and modified according to recent findings by 
Basting et al. [58, 63]. 
 
The alternate access mechanism is characterised by a high affinity for substrates, a low 
affinity for protons on the cytoplasmic side and a low affinity for substrates and high 
affinity for protons on the periplasmic side. Binding of substrate on the cytoplasmic side 
to the two E14 residues in the dimer induces structural changes which lead to protein 
reorientation. The transport includes at least one occluded state as first detected in this 
laboratory [63].  The protein then faces the periplasm and the low substrate but high 
proton affinity leads to an exchange of substrate for 2 protons at the glutamates. The 
protonated E14s again cause structural rearrangements which lead to EmrE reorienting 
toward the cytoplasmic side. This last step couples the uphill substrate transport to the 
downhill proton transport. In the absence of  ψ and  pH gradients the protein is in the 
equilibrium exchange mode. Substrate can be exchanged non-productively and at a slow 
rate in both directions [64]. 
   
Several aspects regarding SMR proteins are generally undisputed including: E14 in TM 
helix 1 is an essential residue and directly involved in drug and proton binding [65-67], 
EmrE has a very broad substrate specificity, see table 5, substrate transport occurs via at 
least one occluded transport cycle intermediate [63] and the transport of monovalent 
and divalent substrates has the same stoichiometry, see table 6.   This means that the 
transport  of  singly  charged  substrates  is  electrogenic  while  the  transport  of  doubly 
charged substrates to is electro neutral [39].  
 
substrate class  substrate 
   
Dye  ethidium bromide 
Dye  acriflavine 
Dye  crystal violet 
Dye  rhodamine 6G 
   
quaternary ammonium compound  benzalkonium 
quaternary ammonium compound  TPP
+ 
quaternary ammonium compound  methylviologen 
   
antibiotic or bacteriostatic  trimethoprim 
antibiotic or bacteriostatic  erythromycin 
antibiotic or bacteriostatic  tetracycline 
antibiotic or bacteriostatic  chloramphenicol 
antibiotic or bacteriostatic  Vancomycin 
Table 5. Known substrates of the SMP model protein EmrE [25]. 
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substrate  stoichio-
metry with 
monovalent 
substrate 
H
+:substrate 
electro-
genic 
transport 
with 
mono-
valent 
substrate 
substrate  stoichio-
metry with 
divalent 
substrate 
H
+:substrate 
electro-
genic 
transport 
with 
divalent 
substrate 
reference 
TPP
+  1:2  Yes  MV
2+  1:2  no  [39] 
TPP
+, 
ethidium 
bromide 
1:2  Yes  -  -  -  [65] 
Table 6. Stoichiometry of EmrE substrate transport.  
 
1. 1. 1. 6 Hsmr and EmrE 
Here work is focussed mainly on the E. coli SMR protein EmrE and the archeal SMR 
protein Hsmr from the halopilic organism Halobacterium salinarium. Both proteins are 
members of the SMP subclass. See figure 5 for a schematic SMR protein topology 
diagrams.  
 
 
Figure 5. Schematic EmrE and Hsmr topology diagrams. Key residues E14 and W63 are 
highlighted in red and yellow respectively. A) EmrE and B) Hsmr. The program TMRPres2D 
was  used  to  generate  these  diagrams.  The  TM  region  as  displayed  here  were  predicted 
previously [25, 28] and were visualised using TMPres2D [68].  
 
In the topology diagram the essential amino acids E14 and W63 are highlighted. It can 
be seen that EmrE and Hsmr at non-conserved sites differ vastly in their amino acid 
sequences.  Hsmr  has  a  preponderance  of  alanine  and  valine  residues  as  well  as  an 
increased number of negatively charged amino acids when compared to EmrE. Further 
key features of EmrE and Hsmr are tabulated in table 7. 
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protein  residue 
number 
molecular 
weight 
(Da) 
pI  %  
A + V 
amino 
acids 
% + charged 
amino acids 
% - charged 
amino acids 
substrate 
specificity 
Hsmr  112  11293.1 
 
4.2  39.3  0.9  7.2  TPP
+, 
etbr, bz, 
ac 
EmrE  110  11958.3 
 
7.7
2 
12.7  3.6  2.7  TPP
+, 
etbr, Bz, 
MV
2+, ac, 
crystal 
violet, 
R6G, 
SDS, tri, 
ery, tet, 
chl, van 
Table 7. Main properties of the here investigated SMP proteins. Calculations of properties 
used  the  program  ProtParam  [69].  Etbr  (ethidium  bromide),  bz  (benzalkonium),  ac 
(acriflavine), MV
2+ methyl viologen, R6G (rhodamine 6G), SDS, (sodium dodecyl sulphate), 
chl  (chloramphenicol),  tri  (trimethoprim),  ery  (erythromycin),  tet  (tetracycline)  and  van 
(vancomycin). 
 
Noteworthy  are  the  low  isoelectric  point  (pI),  large  content  of  alanine  and  valine 
residues as well as the large number of negatively charged residues of Hsmr. These 
features are typical of halophilic proteins. Besides these differences it can be seen that 
EmrE  and  Hsmr  have  overlapping  substrate  specificity  and  a  selection  of  these 
lipophilic substrates, typical for SMR proteins, is shown in figure 6. 
 
 
Figure  6.  Selection  of  substrates  of  SMR  proteins.  Methylviologen,  TPP
+,  ethidium  and 
benzalkonium.  These  substrates  are  commonly  used  in  SMR  protein  activity  assays.  TPP
+, 
ethidium and benzalkonium are substrates of Hsmr and all four substances are substrates of 
EmrE.  
 Chapter 1 - Introduction 
 
  10 
In  contrast  to  EmrE,  Hsmr  is  poorly  investigated.  As  a  halophilic  protein  Hsmr  is 
inherently difficult to study due to its requirement for high salt concentrations. The first 
publication describing Hsmr thus merely investigated the activity of unpurified protein 
and  established  a  salt  dependency  of  activity  [28].  A  later  study  circumvented  this 
problem by using synthetic Hsmr transmembrane helix peptides in different detergent 
solutions and postulated a mechanism for dimeric and tetrameric oligomerisation using 
two  helical  faces  of  TM  helix  4  [70].  The  special  features  and  challenges  of  the 
halophilic proteins are  described later. The reduction of amino acid diversity in the 
transmembrane regions strongly suggests which side of each helix is facing the lipid 
membrane.  This  was  utilised  during  the  computer  modelling  of  EmrE  into  the  EM 
electron density to verify the final model [58]. A thorough investigation of Hsmr or any 
SMP protein other than EmrE has thus far not been conducted. 
 
1. 1. 2 Introduction to halophilicity 
1. 1. 2. 1 Introduction to halophiles 
Organisms  living  under  inhospitable  conditions  with  respect  to,  for  example,  pH, 
temperature, pressure or salt are called extremophiles and often belong to the archaea 
domain.  Organisms  growing  at  salt  concentrations  approaching  saturation  are  called 
halophiles and may be found among eukarya, bacteria and archaea [71]. Halobacterium 
salinarium, an archaea isolated from the Dead Sea, is an aerobic, mesophilic organism, 
but  requires  NaCl  concentrations  of  3.5  to  5 M  salt  for  survival  [72],  which  is  the 
highest known salt tolerance today. H. salinarium does not require any further extreme 
conditions for growth, making it the ideal organism for studying the requirements for 
adaptation of organisms to high salt conditions.  
 
Extremophiles  are  of  great  interest  to  the  biotechnology  industry.  Thermophilic 
organisms have been studied in detail, and their proteins have been used in industrial 
processes in the food, chemical, pharmaceutical and paper sectors [73]. However, the 
industrial  interest  for  halophiles  has  lagged  behind,  due  to  the  lack  of  business 
opportunities,  and  academic  interests  have  been  blunted  by  the  many  difficulties 
associated with biochemical investigations in the presence of high salt concentrations. 
However, understanding halophilicity is becoming an increasingly attractive subject of 
study, as the biochemical nature of other extremophiles is elucidated and the general 
salinisation of the soil increases. 
 
1. 1. 2. 2 Characteristics of halophilic proteins and membranes 
Survival under high salt concentration requires the halophile to balance the osmotic 
pressure. This is generally achieved using a combination of compatible solutes such as 
sugars and amino acid derivatives, as well as high internal salt concentrations [74]. H. 
salinarium  matches  the outside  osmotic  pressure  generated  by  3.5  to  5  M  NaCl  by 
accumulating  isotonic  concentrations  of  NaCl  and  KCl  in  the  cytoplasm  [75]. 
Accordingly, both membrane and soluble proteins of halophiles need to be adapted to 
high salt concentrations.  It has been observed that most halophilic proteins have an 
acidic  pI,  low  lysine  and  aliphatic  residue  content  but  an  increased  occurrence  of 
alanine, glycine and valine [76] [77].  
In general, the presence of salts increases the solubility of a folded protein, but decrease 
its  stability.  Halophilic  proteins  overcome  this  problem  by  binding  salt  and  thus 
screening the extensive network of negatively charged residues which then drives the 
folding process. The protein then has a salt and a solvation shell [78]. This is known as 
the solvation-stabilization hypothesis of halophilicity. Furthermore, salting out effects 
of salts such as NaCl strengthen the hydrophobic interactions which are thought to be Chapter 1 - Introduction 
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the major determinant of halophilic protein stability [75]. Indeed, salt concentrations 
larger than 1 M are required for the stability and activity of a protein, with in some 
cases instantaneous deactivation upon salt removal [75]. Whilst in some cases the salt 
requirements are salt type specific [78] usually the high salt concentrations are only 
required for the proteins activity and stability, whereas its structure is also conserved at 
low  salt  concentrations  [79,  80].  This  feature  paved  the  way  for  the  structure 
determination of several halophilic proteins by x-ray crystallography and NMR. Most 
notable  are  the  solution  NMR  structures  of  HsFdx  at  0.45  M  NaCl  [81]  and  of 
hvDHFR1 in the presence of 3.5 M NaCl [80].  
 
Only  few  halophilic  membrane  proteins  have  been  investigated  directly,  with  most 
efforts focussed on genome sequencing or proteomics approaches. Notable exceptions 
include successful structural investigations of the rhodopsin family (bacteriorhodopsin 
[82], holorhodopsin [83] and sensory rhodopsin [84]) and non-structural work on an 
aspartate transport system that could be studied in vivo [85], and a CorA homologue 
involved  in  Mg
2+  uptake  [86].  Interestingly,  ABC  transporters  seem  to  be  the  most 
prevalent type of transporter in halophiles, and all secondary transporters studied use 
Na
+  instead  of  H
+  as  the  coupling  ion  [87].  The  use  of  sodium  motif  force  (SMF) 
instead of the proton motif force (PMF) arises from the higher H
+ than Na
+ permeability 
of  membranes  at  high  salt  concentrations  [87].  In  fact,  typical  bacterial  membranes 
composed of phospholipids are neither able to support a PMF nor SMF at high salt 
concentrations and the lipids aggregate. Archaeal membranes are therefore composed of 
different  lipids.  The  basic  types  of  lipids  in  archaea  are:  C20  glycolipids  or 
phospholipids composed of a glycerol or nonitol backbone with ether linked phytanyl 
chains  which  form  a  bilayer  and  C40  membrane-spanning  tetraetherlipids  [72,  88]. 
Figure 7 shows a typical C20 and C40 lipid of H. salinarium. The ether linkage between 
the  phytanyl  chain  and  the  glycerol  backbone  make  these  lipids  less  prone  to 
aggregation at high salt concentrations and the bulky core is responsible for low proton 
and Na
+ permeability [89]. 
 
 
Figure 7  Archaeal lipids. A) C20 lipids sn-2,3-diphytanylglycerol also called archaeol and B) 
C40 lipids dibiphytanyldiglycerol  tetraether  also called caldarchaeol. [88] 
 
1. 1. 3 Introduction to cell free expression 
1. 1. 3. 1 History of cell free expression 
To effectively study membrane proteins using biophysical techniques such as NMR new 
protein expression techniques such as cell free expression need to be used. Cell free Chapter 1 - Introduction 
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expression  was  first  described  in  the  1960s  [90].  Since  then,  many  prokaryotic  and 
eukaryotic  expression  systems  have  been  developed,  including:  E.  coli,  Thermus 
thermophilus, rabbit reticulocyte, wheat germ, cancer cell and human placental extracts. 
Crude  cell  extracts  supply  the  necessary  enzymes,  ribosomes  and  cofactors  for 
expression [91] [92]. First attempts to use a cell free protein synthesis system composed 
solely of purified components  were reported in the 1970s [93], and only recently have 
Shimizu et al. succeeded in making an E. coli cell free expression system entirely from 
purified proteins, cofactors and substrates. [94]  
Cell  free  expression  can  be  constituted  of  either  translation  or  coupled 
transcription/translation systems, for eukaryotic and prokaryotic systems respectively. 
Currently, E. coli based coupled transcription/translation expression systems are most 
common. Early cell free expression systems utilized batch mode but the yields were 
very low due to extract deactivation and exhaustion of substrates [95]. Development of 
continuous-flow reactors allowed dramatically prolonged production times of up to 40 
hours, but the yield only increased marginally due to loss of translation components 
[96]. Approaches using semi-continuous cell free expression were more successful, and 
yields up to 6mg/mL have been reported for soluble proteins. [95] [97] 
 
1. 1. 3. 2 E. coli based cell free protein synthesis 
Using  E.  coli  based  coupled  transcription/translation  systems,  integral  membrane 
proteins have been expressed and yields of 1 mg/mL for G-protein coupled receptors 
(GPCRs), [98] 1.3 mg/mL for MscL [99] and 3 mg/mL for EmrE have been achieved 
[36].  These  proteins  can  be  expressed  either  as  precipitate  or  in  the  presence  of 
detergents and lipids in a soluble form. However, yields in the presence of detergents 
are  reduced  in  a  detergent  dependent  fashion,  correlating  with  the  detergent  cmc. 
Bacteriorhodopsin for example has been expressed as aggregate in quantities sufficient 
for  biophysical  studies  such  as  Fourier  transform  infrared  (FTIR)  spectroscopy  and 
could be shown to refold correctly into its native and active conformation using SDS 
and halobacterial lipids. [100] Furthermore, small multidrug resistance SMR proteins, 
GPCRs and ion channels have been expressed successfully in the presence of detergents 
and lipids. These proteins, were shown to be active, and were reconstituted successfully 
into artificial membranes [36] [99] [98]. However, to obtain typical eukaryotic post-
translational modifications, a eukaryotic cell free expression system is necessary. 
In conclusion, in vitro expression is a viable alternative to in vivo expression under 
many circumstances. A high yield of protein per mass of labeled amino acid used and 
low detergent and lipid requirements make cell free expression of membrane proteins 
economically viable despite its inherent high reagent costs [101]. 
 
1. 1. 3. 3. Advantages of cell free protein synthesis 
A cell free expression system  gives the  experimenter a high degree of control over 
experimental  parameters  such  as  pH,  redox  potential  or  buffer  system  [102]. 
Furthermore, the direct manipulation of reaction conditions enables the use of cofactors 
and unnatural amino acids as well as their addition at any point of time. 
For protein NMR studies, cell free synthesis offers the choice of virtually any selective 
amino acid labeling scheme, due to the absence of a cellular metabolism and greatly 
minimized amino acid scrambling [103, 104]. This is particularly attractive for amino 
acid labeling schemes for which no auxotrophic strains are available. Substantial time-
savings compared to in vivo protein synthesis are achieved. Examples of time-savings 
are: PCR products can be used as DNA templates, shorter expression times, automation, 
shorter purification protocol and solution state NMR experiments on unpurified cell free Chapter 1 - Introduction 
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expression mixture [101, 103, 104]. Finally, even the production of toxic proteins and 
viruses is possible in vitro  [102] [105]. 
 
1. 1. 3. 4 Advantages for cell free expression of membrane proteins 
Especially for membrane proteins, cell free protein synthesis at a preparative scale is 
appealing,  as  comparatively  high  yields,  e.  g.  3  mg/mL  for  EmrE,  are  achievable. 
Additionally, production of proteins with the E. coli based cell free expression system 
has been reported for proteins that could not be synthesized in vivo in E. coli [49] [98]. 
This means that cell free expression systems can be used to obviate the use of elaborate 
eukaryotic cell culture in some cases. Particularly successful were cell free expression 
systems for the notoriously difficult to handle class of GPCRs [98, 106, 107]. 
 
1. 2 Introduction to NMR 
1. 2. 1 Why NMR spectroscopy? 
NMR spectroscopy has provided next to x-ray crystallography the largest amount of 
protein 3D structures. A total of 6924 out of 47407 protein structures in the protein 
databank are NMR derived (access date 29.11.2007). The vast majority of these were 
determined by solution state NMR. The quality of NMR structures was evaluated to 
correspond  to  a  2.0  Å  resolution  by  x-ray  crystallography  [108].  As  for  x-ray 
crystallography the ease with which a structure can be determined depends mainly on 
protein  stability  and  homogeneity.  Additionally,  both  structural  techniques  are 
challenged by membrane proteins and their requirement for a membrane mimicking 
environment.  
Unlike x-ray crystallography NMR offers not only the possibility to investigate protein 
structure but also protein dynamics. Particular to solution state NMR however is the 
limitation to small proteins. Initially, structures were obtained only of proteins with a 
maximum molecular weight of 12 kDa, isolated from natural sources using 
1H NMR of 
proteins.  The  use  of  coherent  magnetization  transfer  by  correlation  spectroscopy 
(COSY)  spectra  was  used  for  spin  group  assignment  and  incoherent  magnetization 
transfer by nuclear overhauser enhancement spectroscopy (NOESY) spectra was used to 
obtain sequential residue assignment, secondary structure information and long-range 
constraints for structure calculations [109].  
The size limitation has currently been stretched to above 100 kDa [110]. This is possible 
using 
13C and 
15N isotope labelled proteins in multidimensional NMR spectra, higher 
magnetic fields and the TROSY technique [111] to solve the problems of resonance 
overlap. Protein size is critical as it largely determines the rotational correlation time 
and therefore spectral resolution. A particular challenge for membrane proteins lies in 
the fact that the membrane mimetics used to provide integral membrane proteins with a 
native-like environment add to the molecular weight of the protein [112]. The protein 
detergent complex (PDC) thus determines the rotational correlation time. The largest 
membrane protein structure solved thus far by solution state NMR is OmpG in Fos-ß-
choline
® 12 (DPC) micelles with a protein only molecular weight of 33 kDa [113]. 
In contrast, solid state NMR is not inherently limited by the size of the molecule under 
investigation and thus is ideally suited for the investigation of membrane proteins in 
lipid  environments.  Apart  from  the  greater  sample  preparation  flexibility  solid  state 
NMR offers the possibility to measure internuclear distances, anisotropy, torsion angles, 
molecular dynamics and many more parameter with great accuracy. Solid state NMR is 
an established method in membrane biophysics but only recently is used as a tool for 
structural biology [114].  
 Chapter 1 - Introduction 
 
  14 
1. 2. 2 Brief introduction to NMR 
The observed chemical shifts of nuclei are magnetic field strength dependent and for 
comparison between experiments reported as parts per million (ppm). More precisely 
the  NMR  interactions  can  be  described  by  quantum  mechanics  using  Hamiltonian 
operator. The general Hamiltonian takes the form: 
 
Int Ext H H H + =                    (2) 
 
where  0 H H H RF Ext + =                  (3) 
 
and  Q D J CS Int H H H H H + + + =               (4) 
 
H  =  Hamiltoninan,  HExt  =  external  Hamiltonian,  HInt  =  internal  Hamiltonian,  HRF  = 
radiofrequency  Hamiltonian,  H0  =  static  magnetic  field  Hamiltonian,  HCS  =  chemical  shift 
Hamiltonian, HJ = scalar/J coupling Hamiltonian, HD = dipolar coupling Hamiltonian, HQ = 
quadrupolar coupling Hamiltonian 
 
which includes all possible NMR interactions. In general solid state NMR is dominated 
by strong dipolar couplings and quadrupolar couplings and the term HJ can often be 
neglected. 
 
For spin ½ nuclei such as 
1H, 
13C and 
15N the Hamiltonian simplifies to: 
 
D CS H H H + =                   (5) 
 
For integers spins such as 
2H the Hamiltonian simplifies to: 
 
Q D CS H H H H + + =                  (6) 
 
In  a  typical  solid  state  NMR  experiment  a  multitude  of  NMR  interactions  are 
simultaneously present and except for the J-coupling these interactions are anisotropic. 
The higher information content including orientational information however comes at 
the expense of a more complex spectrum. The design of solid state NMR experiments 
therefore selectively removes all but the wanted nuclear interactions, leading to easily 
interpretable spectra with the desired information content. See figure 8 for the effect of 
the commonly used technique magic angle spinning (MAS) on the lineshape of a 
13C 
glycine  spectrum.  The  fast  rotation  at  the  magic  angle  of  54.7  °  mimics  the  fast 
Brownian motion of small molecules in solution and thus removes the anisotropy. 
 
 
Figure 8. Glycine 
13C spectra simulated at different MAS speeds. A) Static spectrum of 
glycine, B) spectrum of glycine with 3000 Hz MAS and C) spectrum of glycine at 10000 Hz 
MAS. MAS is a rotation of the sample containing rotor at an angle of 54.7 ° with respect to the 
external magnetic field B0. The fast rotation at the magic angle removes anisotropic interactions 
such as chemical shift anisotropy. Chapter 1 - Introduction 
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In solid state NMR experiments generally low gyromagnetic ratio nuclei are detected, 
leading to an intrinsically low signal to noise (S/N) ratio. This ratio can be improved by 
transferring  magnetization  from  protons  to  low  gyromagnetic  ratio  nuclei  via  cross 
polarisation (CP). During CP dipolar couplings are used to share magnetization between 
heteronuclei for signal enhancement. CP is the solid state NMR equivalent of a solution 
state NMR INEPT transfer which uses J-couplings for magnetization transfer between 
heteronuclei. Both techniques offer an identical theoretical signal enhancement for the 
low abundant, low gyromagnetic ratio nucleus X. The theoretical limitation of signal 
enhancement is given by: 
 
X
H
g
g
                      (7) 
         
γH = gyromagnetic ratio of nucleus type H (usually protons) and γX = gyromagnetic ratio of 
nucleus type X  
 
For cross polarisation the so called Hartmann-Hahn match needs to be achieved: 
 
X H w w =                     (8)   
 
ωH = Larmor frequency of nucleus type H and ωX = Larmor frequency of nucleus type X 
               
which means that the applied radiofrequency B1 and B2 need to be adjusted since the 
gyromagnetic ratios γ are nuclei type dependent. 
 
) ( ) ( 2 1 X B H B x H g g =                  (9) 
 
γ = gyromagnetic ratio, B1 = magnetic field of radiofrequency pulse, B2 = magnetic field of 
radiofrequency pulse, H = arbitrary nucleus (usually protons), X = different arbitrary nucleus 
(usually 
13C or 
15N) 
 
To study specific interactions decoupling and recoupling experiments have to be carried 
out. Details of the experiments used in this thesis are given were relevant in Chapters 2, 
8 and 9. 
 
1. 2. 3 Solid State NMR for the Study of Membrane Proteins 
Solid state NMR has been widely used in membrane biophysics, to study membrane 
bound peptides and increasingly for investigations of larger integral membrane proteins. 
Areas  of  application  cover  protein  structure  and  dynamics,  lipid-protein,  substrate-
protein,  and  substrate-membrane  interactions.  Static  solid  state  NMR  applied  to 
macroscopically  ordered  membrane  samples  has  been  used  to  elucidate  secondary 
structure and topological organisation of membrane bound peptides [115]. However, for 
polytopic membrane proteins such as SMR proteins static solid state NMR techniques 
are of limited use. Instead MAS seems more promising as it imposes fewer restrictions 
with respect to sample preparations. The number of membrane proteins available for 
biophysical  studies  has  been  dramatically  increased  by  the  advent  of  microbial 
expression  systems  (e.g.  E.  coli,  yeast  and  baculovirus)  optimized  for  membrane 
proteins, the availability of detergent screens and advanced purification technologies in 
addition to the sequencing of a number of prokaryotic and eukaryotic genomes. Solid 
state NMR is increasingly applied to isotope labelled membrane proteins in order to 
derive data about protein structure and dynamics. The possibility of a complete de novo Chapter 1 - Introduction 
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structure determination purely based on MAS NMR recoupling techniques was first 
demonstrated for small insoluble peptides [116, 117] and has been extended to soluble 
proteins studied in the solid state [118, 119]. Similar studies with membrane proteins 
have started to become possible. A number of studies have reported promising MAS 
NMR spectra of membrane proteins prepared as 2D crystals [120], 3D crystals [121] 
and  also  in  proteoliposomes  [122].  The  first  successful  report  of  membrane  protein 
assignment  by  solid  state  NMR  was  a  81  %  sequence  specific  assignment  of  the 
residues of the α and β subunits of the photosynthetic light-harvesting 2 complex from 
Rhodopseudomonas  acidophila  [123].  Since  then  signal  assignment  and  secondary 
structure  determination of H
+ ATP synthase subunit c [124] and 144 kDa complex 
cytochrome bo3 oxidase [125] have been reported. Clearly, the preparation of choice are 
liposomes as they are closest to the proteins native environment. Lipid reconstituted 
samples also offer the option of investigating the dynamics of the protein as it binds 
ligands [126], goes through its reaction cycle [127] or responds to changes in the lipid 
environment [128]. However, the currently very limited knowledge base does not yet 
allows us to derive general rules about how to prepare membrane proteins for solid state 
NMR and so screens have to be performed for each individual protein.  
The  potential  role  of  solid  state  NMR  in  the  process  of  drug  discovery  has  been 
highlighted  in  a  recent  review  [129].  The  structures  of  ligands  and  drugs  can  be 
determined at their site of action by solid state NMR. This aids in defining the ligand 
binding  site.  In  addition  drug  partitioning,  drug-lipid  interactions  and  drug 
polymorphism can be assessed by solid state NMR. It has also recently been shown to 
be a method capable of determining the backbone structure of a peptide ligand bound to 
its native GPCR [130]. Indeed these investigations are starting to become routine with 
structures of bradykinin, neurotensin and histamine being reported recently [130-132]. 
In this thesis in vitro expressed transport proteins are studied with respect to dynamics 
and ligand binding interactions using solid state NMR. 
 
1. 2. 4 Solid State NMR Studies on Transporters 
So far, only a limited number of solid state NMR studies on transporters have been 
reported  [126,  133-142].  Applications  cover  in  principle  three  areas:  interactions  of 
substrates  with  the  membrane,  detection  of  substrates  bound  to  transporters, 
investigations of individual amino acids and methodological studies describing how to 
prepare isotope labelled transporters. 
The first solid state NMR applications to transporters were presented by the labs of 
Watts and Henderson who demonstrated the detection of substrate bound to the sugar 
transporter GalP [137, 140]. This has triggered a number of further studies aimed at 
obtaining structural information concerning  the position of the binding site [139], as 
well  as  the  ligand/protein  association  constant  [126].  Later  it  could  be  shown  that 
isotope  labelled  transporters  can  be  prepared  at  a  quantity  and  purity  suitable  for 
ssNMR [143]. Recently, uniformLy 
13C
15N labelled EmrE in 2D DMPC crystals has 
been investigated. The chemical shift of E14 could be assigned using a mutant [136]. 
During this thesis structural studies on Hsmr, single amino acid investigations on EmrE, 
protein dynamic studies on Hsmr and drug-membrane interactions were made. 
 
1. 3 Outline of thesis 
The  aim  of  this  thesis  is  the  investigation  of  SMR  proteins  of  the  SMP  subfamily 
regarding structure, dynamics, oligomerisation state and functionality.  
Reported structural investigations of the model protein EmrE have not yet led to a high 
resolution structure and controversies particularly regarding the topology require further 
investigations. In fact, most investigations were conducted under non-native conditions Chapter 1 - Introduction 
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and it is not certain that EmrE is indeed a typical representative of the SMP subfamily 
These aspects were addressed during this thesis.  
Substrate binding to the essential glutamic acid in the proposed EmrE binding pocket 
was  investigated  by  solid  state  NMR.  And  an  additional  SMP  protein,  the  scarcely 
studied halopilic protein Hsmr from H. salinarium was investigated thoroughly using a 
variety  of  biochemical  and  biophysical  techniques,  mainly  under  native  high  salt 
conditions. Structural investigations of Hsmr and EmrE utilised among other techniques 
cell free expression for the production of selectively isotope labelled proteins and non-
invasive solid state NMR in native-like lipid membranes. See figure 9 for an overview 
of all conducted experiments.  
 
 
Figure 9. Overview of protein states investigated and methods used. 
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Chapter 2 - Materials and Methods 
 
2. 1 Materials 
2. 1. 1 General materials 
Chemicals  were  purchased  from  Sigma  (München)  unless  otherwise  indicated.  The 
following  plasmids  were  purchased:  pT7-7  from  USB  (Ohio,  USA),  pET21a+  from 
Merck  KgA (Darmstadt, Germany), pIVEX2.1  from Roche  Diagnostics  (Mannheim, 
Germany) and the following E. coli cells: E. coli strain A19 from CGSC (New Haven, 
USA),  T7  Express,  BL21(DE3),  XL-1  Blue,  CT19  and  TA15  from  NewEngland 
Biolabs  (Frankfurt  am  Main,  Germany).  Molecular  biology  enzymes  were  obtained 
from NewEngland Biolabs (Frankfurt, Germany). Complete protease inhibitors, tRNA 
500  were  purchased  from  Roche  Diagnostics  (Mannheim,  Germany).  The  protein 
calibration mixture for mass spectrometry (MS) was from Applied Biosystems (Foster 
City, USA). Radioactive [
3H] TPP
+ (30 Ci/mmol) was purchased from GE Healthcare 
(München,  Germany).  1-myristoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-
glycerol)]  (LMPG),  1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] 
(LPPG),  1,2-diheptanoyl-sn-glycero-3-phosphocholine  (DHPC)  and  lipids  were 
obtained  from  Avanti  Polar  Lipids  (Alabaster,  USA).  Nondetergent  sulfobetaine 
(NSDB) substances were purchased from Merck KgA (Darmstadt, Germany). Fos-ß-
choline
® 12 (DPC) was obtained from Anatrace (Maumeen, USA). n-Dodecyl- ß-D-
maltoside (DDM) was purchased from Applichem GmbH (Darmstadt, Germany). n-ß-
octyl-D-glucopyranoside (OG) was obtained from Glycon Biochemicals (Luckenwalde, 
Germany). SM-2 Biobeads were obtained from BioRAD (München, Germany). The E. 
coli cell free extract was kindly provided by Birgit Schneider, Sina Reckel and Daniel 
Schwarz from the group of Prof. Dötsch (Frankfurt, Germany). Vectors coding for SMR 
proteins were provided by Prof. S. Schuldiner (Jerusalem, Israel) with the exception of 
pET21a+ EmrE E25A which was supplied by Theofanis Manolikas. 
 
2. 1. 2 Gel and western blot materials 
Protein standard for gels were obtained from Applichem (Darmstadt, Germany). 4 - 12 
% NativePAGE™ Novex® System gels were ordered from Invitrogen (Carlsbad, USA). 
The primary antibody mouse anti-c-myc IgG clone 9E10 was purchased from Acris 
(Hiddenhausen, Germany) and the secondary antibody goat anti-mouse IgG horseradish 
peroxidase  (HRP)  conjugate  order  number  sc-2005  was  ordered  from  Santa  Cruz 
Biotechnology (Santa Cruz, USA). 
 
2. 1. 3 Chromatography and dialysis materials 
The  nickel-nitrilotriacetic  acid  (Ni-NTA)  resin  was  obtained  from  Qiagen  (Hilden, 
Germany). Chromatography columns: HiTrap desalting column, DEAE Sepharose fast 
flow  IEX  column,  Superose  12  medium  were  from  GE  Healthcare  (München, 
Germany). The Äkta Economy basic fast protein liquid chromatography (FPLC) system 
and  gel  filtration  calibration  kit  were  also  obtained  from  GE  Healthcare  (München, 
Germany). Dialysis products: 12-14 kDa tubing, microdialyser and dispodialyser were 
obtained from Spectrum Laboratories Inc. (Breda, Netherlands).  
  
2. 1. 4 Equipment 
Western  blots  were  imaged  using  the  Lumi-Imager  F1™    from  Roche  Diagnostics 
(Mannheim, Germany). The 10 L fermenter used was a Biostat C from Sartorius Stedem 
(Melsungen, Germany). For ultraviolet (UV) and visible spectrophotometry a Jasco V-
550  spectrophotometer  (Jasco,  Gross-Umstadt,  Germany)  was  used.  Fluorescence Chapter 2 – Materials and Methods 
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measurements were made on a Jasco FP-6500 Fluorescence spectrometer (Jasco, Gross-
Umstadt, Germany). 
Freeze fracturing was performed using a BAF 060 freeze-fracturing unit from Bal-Tec 
Inc. (Principality of  Lichtenstein). A XL-A analytical ultracentrifuge from Beckman 
Coulter (Fullerton, USA) with an AN-50 TI rotor from Beckman Coulter (Fullerton, 
USA) was used for analytical ultracentrifugation. For preparative ultracentrifugation an 
Optima™ LE-80K ultracentrifuge from Beckman Coulter (Fullerton, USA) was used 
with rotors TI70, SW28 and SW50.1 all from Beckman Coulter (Fullerton, USA). TPP+ 
measurements used the calcium specific electrode (MI-600) and a reference electrode 
(MI-402)  from  Microelectrodes  Inc.  (Bedford,  USA).  Bruker  style  4  mm  zirconium 
rotor, KEL-F caps and bottom inserts were obtained from RototecSpintec (Biebesheim, 
Germany). The Ultraflex time of flight (TOF)/TOF mass spectrometer was from Bruker 
Daltonics  (Bremen,  Germany).  The  Voyager  DE-Pro  mass  spectrometer  was  from 
Applied Biosystems (Foster City, USA). Avance and Avance II NMR spectrometer as 
well as the probeheads were obtained from Bruker Biospin (Rheinstetten, Germany). 
 
2. 1. 5 Software 
Numerical data analysis was carried out using algorithms supplied and programmed into 
OriginPro  7.5  by  OriginLAB  (Northampton,  USA).  A  python  script  for  visualising 
typical amino acid double quantum single quantum (DQSQ) spectra was written by Dr. 
J. Lopez. For the full matrix analysis of NOESY peak volumes python scripts written by 
Dr. J. Lopez were used. Potential measurements of the TPP
+ assay were recorded and 
analyzed  with  MetraHit  and  MetraWin10  were  from  Gossen  Metrawatt  (Nürnberg, 
Germany).  Acquisition  and  analysis  software  used  for  NMR  includes  Topspin  1.3, 
Topspin  2.0  and  XWIN-NMR  Version  3.5  all  from  Bruker  Biospin  (Rheinstetten, 
Germany), Sparky 3 from Goddard and Kneller at the University of California (San 
Francisco, USA) and CARA 1.8.4 [144]. Reference spectra and typical chemical shifts 
of amino acids were obtained from the Biological Magnetic Resonance Bank (BMRB). 
The MS spectra were processed with Data Explorer Software from Applied Biosystems 
(Foster City, USA) or Flex Analysis v2.2 from Bruker Daltonics (Bremen, Germany). 
Topology models were generated using TMPres2D [68].  
 
2. 2 Methods 
2. 2. 1 Cloning procedures 
For this study, YdgF was cloned into a pT7-7 vector with myc-his tag, see figure 10 for 
pT7-7 vector map. YdgF was amplified from genomic E. coli DNA kindly provided by 
Dr. F. Bernhard using a forward primer (cag gag aag gca tat gta tat tta ttg g) and a 
reverse primer (gtg aac cga att caa ctg cgc). The amplified fragments and Hsmr pT7-7 
vector  were  digested  with  NdeI  and  EcoRI.  The  YdgF  fragments  were 
dephosphorylated and ligated into the vector using T4 DNA ligase.  
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Figure 10. pT7-7 vector as originally designed. Most SMR proteins were expressed from this 
vector in vitro and in vivo with a myc-his tag, using NdeI and EcoRI as restriction enzymes. 
multiple cloning site (mcs), ribosomal binding site (rbs), beta lactamase (bla), origin (ori) 
 
2. 2. 2 Protein production  
2. 2. 2. 1 In vitro expression of SMR proteins 
Bacterial cell-free extracts also called S30 extract were prepared from the E. coli strain 
A19 in a procedure modified after Zubay [145]. The cells were washed in buffer (10 
mM Tris-acetate, pH 8.2, 14 mM Mg(OAc)2), with 6 mM 2-mercaptoethanol and 0.6 
mM  KCl.  The  lysis  buffer  was  the  washing  buffer  supplemented  with  1  mM 
dithiothreitol and 0.1 mM phenylmethanesulfonylfluoride.  
The extract was dialyzed in washing buffer supplemented with 0.5 mM dithiothreitol 
and  0.6  mM  KOAc.  Endogenous  mRNA  was  removed  from  the  ribosomes  by 
incubation of the extract with 400 mM NaCl at 42 °C for 45 min. Aliquots of the cell-
free extract were frozen in liquid nitrogen and stored at -80 °C. The cell-free expression 
was performed in the continuous exchange mode using a membrane with a cutoff of 25 
kDa for GFP and 15 kDa for all other proteins, to separate the reaction mixture (RM) 
containing ribosomes and all enzymes, from the feeding mixture (FM) providing the 
low molecular mass precursors. The ratio of RM/FM was 1:17 (v/v). This expression 
mode yields membrane proteins as precipitates. Reactions in the analytical scale of 70 
µL  were  performed  in  microdialysers,  and  larger  dispodialysers  were  used  for 
preparative scale reactions with RM volumes of 500 µl to 1 mL. The reactions were 
incubated at 30 °C in a suitable shaker for 20 h. 
The  protocol  for  the  cell-free  reaction  mixtures  is  given  in  table  8.  Amino  acid 
concentrations  were  adjusted  with  regard  to  the  amino  acid  composition  of  the 
overproduced proteins. The least abundant amino acids (present at less than 3 % in the 
protein) were added at 1.25 mM, medium abundant (between 3 % and 8 %) at 1.8 mM 
and  highly  abundant  (more  than  8  %)  at  2.5  mM  final  concentration.  Amino  acid 
specific  labeling  was  achieved  by  replacing  the  corresponding  amino  acids  by  their 
isotopically labeled derivatives. For the soluble expression, mode detergents need to be 
added to the RM and FM at concentrations above their cmc. Chapter 2 – Materials and Methods 
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component  final concentration in RM  final concentration in FM 
S30-extract  35 %  - 
Tris-acetate, pH 8.2  3.5 mM  3.5 mM 
plasmid DNA  15 µg/mL  - 
RNAsin  0.3 U/µL  - 
T7 RNA polymerase  3 U/µL  - 
E. coli tRNA 500  500 µg/mL  - 
pyruvate kinase  40 µg/mL  - 
acetyl phosphate  20 mM  20 mM 
phosphoenol pyruvate  20 mM  20 mM 
ATP  
 
1.2 mM  
 
1.2 mM 
 
CTP   0.8 mM   0.8 mM 
GTP   0.8 mM   0.8 mM 
UTP  0.8 mM  0.8 mM 
1.4-dithiothreitol   2 mM  2 mM 
folinic acid  0.2 mM  0.2 mM 
complete protease inhibitor  1 tablet per 10 mL  1 tablet per 10 mL 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic 
acid (HEPES)-KOH pH 8.0 
100 mM   100 mM 
ethylenediaminetetraacetic 
acid (EDTA) 
2.8 mM  2.8 mM 
magnesium acetate  13 mM  13 mM 
Potassium acetate  290 mM  290 mM 
polyethylenglycol 8000  2 %  2 % 
sodium azide  0.05 %  0.05 % 
Table 8. Protocol for cell-free protein expression. Amino acids were adjusted according to 
the composition of the expressed protein.  
 
2. 2. 2. 2 In vivo shake flask expression of Hsmr and EmrE 
Overexpression  and  purification  of  SMR  proteins  were  adapted  from  protocols 
described [41, 146]. E.coli cells were grown at 30 °C (TA15) or 37 °C (all other cells) 
in Luria Bertani (LB) media. See table 9 for E. coli strains and plasmids used. 750 mL 
LB  or  other  medium,  see  table  9  for  media  compositions,  containing  100  µg/mL 
ampicillin in a 2 L flask was inoculated with 15 mL of overnight culture. 
Expression of SMR proteins was induced with 0.5 mM IPTG (all cells except TA15) or 
a temperature shift to 42 °C for 20 min (TA15 cells only), at a cell density of A600=1. 
Two hours later the cells were harvested by centrifugation (3800 g for 10 min at 4 ºC), 
washed  with  (100  mM  NaCl,  10  mM  Tris,  1  mM  EDTA,  pH  8)  and  pelleted  by 
centrifugation (3800 g for 10 min at 4 ºC).  Chapter 2 – Materials and Methods 
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strains and plasmids  relevant genotype  reference 
XL1-Blue   recA1 lac[F’Tn10 (Tet ) lacI lacZM15]   [147] 
A19  
 
rna19 gdhA2 his95 relA1 spoT1 metB1  [148] 
CT19  BL21(DE3) + aspC, ilvE, trpB, tyrB, avtA  [149] 
BL21(DE3)  F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
[150] 
T7 Express  BL21(DE3)  +  fhuA2  lacZ::T7  gene1  [lon] 
ompT  gal  sulA11  R(mcr-73::miniTn10--
Tet
S)2 [dcm] R(zgb-210::Tn10--Tet
S) endA1 
 (mcrC-mrr)114::IS10 
[151] 
TA15  melBLid nhaA1 nhaB1 lacZY  [152] 
GFP  in pIVEX 2.1  Roche 
Hsmr  hsmr NdeI-EcoRI in pT7-7 with myc-his tag  [28] 
EmrE   emrE NdeI-EcoRI in pT7-7 myc-his tag  [27] 
EmrE E25A  emrE  NdeI-HindIII  in  pET21a(+)  with  his 
tag 
[153] 
EmrE CAMY  emrE NdeI-EcoRI in pT7-7 myc-his tag  [154] 
TBsmr  tBsmr NdeI-EcoRI in pT7-7 myc-his tag  [155] 
YdgF  ydgF NdeI-EcoRI in pT7-7 myc-his tag  this study 
Table 9. Bacterial strains and plasmids used. pT7-7 vector map in figure 10 and pET21a+ 
vector map in figure 11. 
 
Figure 11. pET21a(+) vector map. EmrE E25A with his tag was cloned into this vector with 
NdeI and HindIII and expressed in the cell free expression system from this vector. 
 
2. 2. 2. 3 Fermenter expression of Hsmr and EmrE 
Expression of SMR proteins in a 10 L Biostat C fermenter was essentially as described 
for Erlenmeyer flask cultures. The aeration rate was 5 L/min and the broth was stirred at 
300 rpm. The fermenter was inoculated with 100 mL preculture in minimal medium. 
Fermenter expressions were always induced by heat shock and either minimal or high 
cell density minimal medium, see table 10, was used. 
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name of medium  type of medium  Composition 
LB  rich  25 g/L LB 
2xyeast 
tryptophan  (YT) 
[156] 
rich  16  g/L  tryptone,  5  g/L  NaCl,  10  g/L  yeast 
extract 
minimal  media 
[157] 
synthetic  60  mM  K2HPO4,  33  mM  KH2PO4,  7.5  mM 
NH4SO4, 0.83 mM MgSO4, 2.5 mM thiamine, 
22 mM glucose or 11 mM 
13C glucose 
minimal  media 
(high cell density) 
synthetic  60 mM K2HPO4, 33 mM KH2PO4, 12.5 mM 
NH4SO4, 0.83 mM MgSO4, 2.5 mM thiamine, 
222.4 mM glycerol 
defined  media 
[158] 
synthetic  5.56 mM L-alanine, 1.9 mM L-arginine, 3.01 
mM L-aspartic acid, 2.85 mM L-cysteine, 2.74 
mM  L-glutamine,  4.42  mM  L-glutamic  acid, 
7.33 mM L-glycine, 6.44 mM L-histidine, 1.75 
mM L-isoleucine, 1.75 mM L-leucine, 2.3 mM 
L-lysine, 1.68 mM L-methionine, 7.87 mM L-
phenylalanine, 8.69 mM L-proline, 19.98 mM 
L-serine,  1.93  mM  L-threonine,  0.94  mM  L-
tyrosine, 1.96 mM L-valine, 3.7 mM adenine, 
2.29 mM guanosine, 1.59 mM thymine, 4.46 
mM uracil, 1.8 mM cytosine, 18 mM sodium 
acetate,  12.7  mM  succinic  acid,  9.35  mM 
NH4Cl, 21.25 mM NaOH, 60.27 mM K2HPO4, 
0.01  mM  FeCl3,  4  mM  MgSO4,  110  mM 
D+glucose, 13.6 µM CaCl2, 6.96 µM ZnSO4, 
11.8 µM MnSO4, 0.24 mM L-tryptophan, 0.15 
mM  thiamine,  0.41  mM  niacin,  4.1  µM  D-
biotin 
Table 10. E. coli growth media. 
 
2. 2. 3 Protein purification 
Cells were resuspended in 5 mL lysis buffer/g wet cells (250 mM sucrose, 150 mM 
NaCl, 10 mM Tris-Cl pH 7.5, 2.5 mM MgSO4, DNase I) and broken three times in a 
cell disrupter at 1.5 kbar. Cell debris was removed by centrifugation at 4550 g for 10 
min. After centrifuging the supernatant at 223.000 g for 30 min, the membrane fraction 
was  washed  with  (100  mM  NaCl,  10  mM  Tris,  1  mM  EDTA,  pH  8)  for  45  min, 
centrifuged at 223.000 g for 30 min collected, frozen in liquid nitrogen and stored in 
fractions at -80 ºC until usage.  
In  vitro  (soluble  and  precipitate)  produced  SMR  proteins  and  in  vivo  produced 
membrane  pellets  were  diluted  into  25  mL  solubilising  buffer  (2  M  NaCl,  15  mM 
NaxHxPO4 pH 8.0, 10 mM imidazole, 1 % (w/v) DDM and complete protease inhibitor) 
for Hsmr or (100 mM NaCl, 50 mM Tris, pH 8.0, 1 mM DTT, 10 mM imidazole, 1 pill 
mini complete protease inhibitor and 1 % (w/v) DDM) for EmrE and incubated for 1 h 
at  room  temperature  (RT).    After  removal  of  the  unsolubilised  components  by 
centrifugation (184000 g, 50 min), the supernatant was mixed with Ni-NTA resin for 80 
min at 4 ºC in a beaker. The resin was washed with wash buffer (2 M NaCl, 15 mM 
NaxHxPO4, pH 8.0, 30 mM imidazole, 0.1 % (w/v) DDM) for Hsmr or (100 mM NaCl, 
50 mM Tris, pH 8.0, 1 mM DTT, 30 mM imidazole and 0.1 % (w/v) DDM) for EmrE 
until A280 was below 0.05. Chapter 2 – Materials and Methods 
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The protein was eluted with the same buffer containing 300 mM imidazole and the 
approximate protein concentration was determined at A280 using the elution buffer as a 
blank. 
 
2. 2. 4 Gel analysis 
2. 2. 4. 1 SDS-polyacrylamide gel electrophoresis (PAGE) 
Gels  for  SDS-PAGE  were  10  %  gels  and  run  in  a  two  buffer  system  [159].  The 
separation gel (25 % (v/v) 40 % acrylamide/bisacrylamide mixture, 43.6 % (v/v) gel 
buffer  (3  M  Tris  pH  8.45,  0.3  %  (w/v)  SDS),  31.4  %  (v/v)  H2O,  0.75  %  (v/v) 
ammonium persulfate (APS) and 0.075 % (v/v) tetramethylethylendiamin (TEMED)) 
was cast first at RT and sealed from air with H2O. After polymerization is completed, 
the stacking gel (10 % (v/v) 40 % acrylamide/bisacrylamide mixture, 20 % (v/v) gel 
buffer, 70 % (v/v) H2O, 0.8 % (v/v) 10 % APS solution, 0.08 % (v/v) TEMED) is cast 
and a comb with 10 or 15 teeth is inserted. Samples were diluted 2 fold in loading dye 
(4 % (w/v) SDS, 12 % (w/v) glycerol, 50 mM Tris, 2 % (v/v) mercaptoethanol, 0.01 % 
(w/v) Serva blue G, pH 6.8) and applied to the gel just prior to the run. Gels are run 
with cathode buffer (0.1 M Tris, 0.1 M tricine, 0.1 % (w/v) SDS, pH 8.3) and anode 
buffer (0.2 M Tris, pH 8.9) at RT for 30 min at 25 V and the remaining time at 150 V. 
 
2. 2. 4. 2 Blue native PAGE (BNPAGE) 
BNPAGE  utilized  either  home-made  gradient  gels  with  4-18  %  acrylamide 
concentration or 4-12 % NativePAGE™ Novex® System gels. The gradient gel recipe 
can be found in table 11. The 6x gel buffer contains 150 mM imidazole pH 7.0 and 54.6 
% (w/v) amino caproic acid. Precooled gradient mixer and gradient gel pouring device 
are assembled in the cold room. The stacking gel is cast first, followed immediately by 
the gradient gel. A plug solution (33 % (v/v) 6x gel buffer, 67 % (v/v) glycerol) was 
used to push the gel solution completely into the casting chamber. 
To achieve the best quality gels casting is performed as slow as possible in the cold 
room and the gels are left to polymerize overnight. Samples are applied in their own 
buffer with glycerol added to reach 10 % (v/v). The gels are run in the cold room with 
room temperature anode buffer (50 mM NaCl, 5 mM amino caproic acid, 1.25 mM 
EDTA, 50 mM imidazole pH 7.0) and cathode (50 mM tricine, 75 mM imidazole, 0.002 
% (w/v) coomassie brilliant blue G250) buffer. Initially the gels are run at 50 V for 20 
min, then for around 40 min at 250 V. As standards ferritin, catalase and bovine serum 
albumin (BSA) are used. 
Protein solutions analyzed contained 1-30 µg  Hsmr or standard proteins. Hsmr was 
generally dialyzed against 15 mM Tris, pH 8.0, 0 M NaCl before analysis. The gels are 
scanned directly after the run, fixed, stained, destained and scanned again. The recipes 
here are based on publications by Prof. Schägger [160, 161]. 
 
chemical  4 % gel mixture  18 % gel mixture 
water  9.77 mL  0.35 mL 
6x gel buffer  2.33 mL  2.0 mL 
30  % 
acrylamide/bis-
acrylamide mixture 
1.86 mL  7.2 mL 
80 % glycerol   -  2.4 mL 
TEMED  7.5 µl  5.0 µl 
10  %  ammonium 
persulfate 
75 µl  50 µl 
Table 11. Pipetting scheme one set of small for gradient gels. Chapter 2 – Materials and Methods 
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2. 2. 4. 3 Coomassie staining of PAGE 
The staining method is particularly suitable for small membrane proteins [159]. Gels are 
fixed (50 % methanol, 10 % acetic acid) for 30 min, stained (10 % acetic acid, 0.025 % 
(w/v) coomassie brilliant blue G250) for 2 h and destained (10 % acetic acid) until a 
crystal clear background is achieved. All steps at RT with 100 mL of each solution and 
gentle agitation.  
 
2. 2. 4. 4 Western blot 
Protein samples were separated using the standard SDS-PAGE procedure and 12 % 
acrylamide/bisacrylamide  gels.  A  prestained  protein  standard  was  used  to  allow 
assessment of the success of the blotting step. Sandwich of mats and wetted filter paper 
ensure tight contact between the gel and nitrocellulose membrane during the blotting 
step for 1 h at 4 °C at 350 mA in transfer buffer (0.3 % (w/v) Tris, 1.44 % (w/v) 
glycine). The membrane is blocked in 25 mL (0.242 % (w/v) Tris, 0.8 % (w/v) NaCl, 
0.1 % (v/v) Tween 20, pH 7.6) with 1.25 g milk powder for 1 h at RT, washed three 
times at RT with 25 mL (0.242 % (w/v) Tris, 0.8 % (w/v) NaCl, 0.1 % (v/v) Tween 20, 
pH 7.6) and incubated with the primary antibody mouse anti-c-myc IgG clone 9E10 at 
1:500 dilution in (0.242 % (w/v) Tris, 0.8 % (w/v) NaCl, 0.1 % (v/v) Tween 20, pH 7.6) 
for 1 h at RT. The membrane is washed three times at RT with 25 mL (0.242 % (w/v) 
Tris, 0.8 % (w/v) NaCl, 0.1 % (v/v) Tween 20, pH 7.6) and incubated 1 h at RT with the 
secondary antibody goat anti-mouse IgG horseradish peroxidase (HRP) conjugate at a 
1:10000 dilution in (0.242 % (w/v) Tris, 0.8 % (w/v) NaCl, 0.1 % (v/v) Tween 20, pH 
7.6). 
The membrane was washed three times at RT with (0.242 % (w/v) Tris, 0.8 % (w/v) 
NaCl, 0.1 % (v/v) Tween 20, pH 7.6) and equal volumes of the HRP assay solutions 
(2.5 mM luminol, 0.4 mM p-cumaric acid, 100 mM Tris, pH 8.5) and (0.02 % (v/v) 
H2O2, 100 mM Tris, pH 8.5) were added for 1 min prior to luminescence detection 
using the Lumi-Imager F1™. 
 
2. 2. 5 Protein concentration determination 
2. 2. 5. 1 Protein concentration measurement by absorption spectroscopy 
The concentration of purified proteins can be calculated from the absorption at 280 nm 
if  the  extinction  coefficient  (ε)  is  known.  The  Beer-Lambert  Law  is  used  for  this 
calculation: 
 
c l A * * e =                      (10) 
 
A=  absorbance  at  280  nm,  ε=  extinction  coefficient,  l=  path  length  of  the  cuvette,  c= 
concentration of the sample 
 
protein  vector  tag  ε (M
-1 cm
-1) 
Hsmr  pT7-7  myc-his  15930 
EmrE   pT7-7  myc-his  31065 
EmrE E25A  pET21a+  his  29575 
Table 12. Extinction coefficients of SMR proteins for concentration measurements by UV 
absorption spectroscopy. 
 
2. 2. 5. 2 Amido black assay 
The amido black total protein concentration determination is insensitive to detergents 
and  lipids  and  thus  used  for  the  measurement  of  total  protein  concentrations  in 
membrane patches [162].  Chapter 2 – Materials and Methods 
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Protein samples containing 2 - 24 µg protein were diluted with water to 2 mL. 0.2 mL 
10 % SDS was added and the sample vortexed. 0.3 mL Tris solution (1 M Tris, pH 7.5, 
1 % SDS (w/v)) was added and the sample vortexed. 0.6mL 100 % trichloroacetic acid 
(TCA) are added and the sample vortexed. The samples are incubated for more than 3 
min and the solutions spotted onto individual filter in a vacuum manifold. Vacuum is 
applied and each filtered washed with 6 % TCA. The filters are stained in 200 mL 
staining solution (45 % methanol, 10 % acetic acid) for 3 min under stirring. Rinse the 
filters  with  200  mL  water  and  wash  three  times  with  destaining  solution  (90  % 
methanol, 2 % acetic acid) under stirring for 1 min. The filters are washed once for 2 
min in water. The filters were dried and the blue spots cut out. The blue spots are added 
to a plastic tube with 0.7 mL solubilising solution (25 mM NaOH, 0.05 mM EDTA in 
ethanol) and incubated for 20 min with repeated vortexing. The absorbance at 630 nm 
was measured and the protein concentration calculated from a standard curve.  
 
2. 2. 6 Reconstitution protocols 
2. 2. 6. 1 Reconstitution of Hmsr and EmrE 
SMR proteins were reconstituted at various protein/lipid mol ratios during screens. For 
all reconstitution methods, 4 mg/mL lipid was used as stock solution. A protein/lipid 
mol  ratio  of  1:100  for  solid  state  NMR,  and  a  1:450  mol  ratio  for  fluorescence 
spectroscopy were best.  
The optimal conditions used DDM mediated destabilization of E. coli total liposomes 
with a 1:2 lipid:detergent mol ratio and with biobeads mediated detergent removal. In 
detail, protein and lipid/detergent solutions were mixed and incubated for 1 h at RT, 
followed by detergent removal using pre-washed and sonicated SM-2 Biobeads. In total 
3 times 30 mg biobeads/mg detergent were added and incubated for 1h at RT and once 
at 4 ºC overnight. Biobeads were removed and the liposomes pelleted by centrifugation. 
Detergent destabilization is achieved at Rsat, while liposome solubilisation is achieved at 
Rsol. Spectroscopically both points can be determined by light-scattering measurements 
at 540 nm. Rsat has the highest optical density and Rsol is reached at the lowest optical 
density following Rsat. Theoretically, Rsat and Rsol can be calculated using the following 
equation [163]: 
 
[ ] lipid R D D eff water total * + =                 (11) 
 
Dwater = detergent cmc in the presence of lipids in mM, Reff = effective detergent:lipid ratio in 
mixed lipid-detergent aggregates, [lipid] = concentration of lipids in mM  
 
Reconstitution without liposome presoftening was performed as described but omitting 
the destabilization step. Reconstitution by gel filtration as described by Kiefer [164] was 
performed in the absence of imidazole. The bound protein was washed slowly with 20 
column volumes (CV) of buffer with 4 mg/mL lipids. The thus reconstituted protein 
was  then  eluted  in  buffer  containing  300  mM  imidazole.  Reconstitution  by  rapid 
dilution  simply  mixes  the  protein/detergent  solution  quickly  with  a  sonicated  lipid 
solution  that  reduces  the  detergent  concentration  below  the  critical  micellar 
concentration (cmc) and thus forces the protein into liposomes [165]. Reconstitution 
using  organic  solvents  (chloroform:methanol  1:1  ratio)  first  dried  the  protein 
preparation under a stream of nitrogen and then the protein was solubilised in buffer (2 
M NaCl, 15 mM NaxHxPO4, pH 8.0) by sonication [166]. 
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2. 2. 6. 2 Preparation of EmrE E25A for NMR 
EmrE  E25A  on  a  pET21a+  vector  was  produced  as  described  above.  Substrate 
incubation was performed for 30 min at RT with 3 µM etbr in the buffer (100 mM 
NaCl, 50 mM Tris, pH 8.0 and 1 mM dithiothreitol (DTT)). The etbr concentration was 
chosen to theoretically provide greater than 99 % occupancy at the binding site. 
 
2. 2. 6. 3 Preparation of alanine-d3 labelled Hsmr 
Expression of Hsmr for the 
2H NMR study was conducted as described above but with 
the  following  exceptions.  In  vivo  labelling  with  alanine-d3  utilised  the  auxotrophic 
strain CT19. The cells were grown in unlabelled defined medium to a cell density of 
A600 = 1, pelleted at 25 °C for 5 min and resuspended in 1/4
th volume defined medium 
containing alanine-d3 [167]. After 10 min Hsmr expression was induced with 0.5 mM 
isopropyl  β-D-1-thiogalactopyranoside  (IPTG)  and  10  min  later  bacterial  DNA-
dependent RNA polymerase was inhibited with 1 mg rifampicin per L medium [168]. 
Prior to NMR measurements Hsmr reconstituted in E. coli total lipids was washed twice 
with  buffer  made  with  D2O  depleted  water.  After  the  NMR  measurements  without 
substrates were completed the sample was removed from the rotor and incubated in 400 
µL 2 M NaCl, 15 mM NaxHxPO4, pH 8.0 made with D2O depleted water and 50 mM 
etbr for 30 min at RT. The sample was collected by centrifugation and returned to the 
MAS rotor for further NMR measurements. 
 
2. 2. 6. 4 Freeze fracture analysis 
Proteoliposomes in sample holders were frozen in ethane cooled to -180 
oC by liquid 
nitrogen.  Fracturing  at  –120 
oC  and  replication  at  a  shadowing  angle  of  45 
o  with 
platinum/carbon was performed with a BAF 060 freeze-fracturing unit. Freeze fracture 
analysis  was  performed  by  Dr.  Winfried  Haase  at  the  Max  Planck  Institute  of 
Biophysics. 
 
2. 2. 7 Protein activity assay 
2. 2. 7. 1 Radioactive assay TPP
+ binding assay 
TPP
+ binding was assayed essentially as described in [27]. Briefly, Ni-NTA beads (20 
µL/assay) were washed once in distilled water and twice in standard high salt buffer (2 
M NaCl, 15 mM NaxHxPO4, pH 8.5, 1 % DDM). The purified protein was added to the 
washed beads and the detergent concentration increased to 1 % DDM. The protein/bead 
mixture was mixed at 4 °C for 1 h. The unbound material was discarded, and the His-
tagged protein bound to the beads was washed three times with 1 % DDM containing 
high salt buffer. Buffer containing 40 nM [
3H]TPP
+ was added, and the samples were 
incubated for 20 min at 4 °C.  In each experiment, the values obtained in a control 
reaction with 40 µM unlabeled TPP
+ were subtracted. Separating the beads from the 
supernatant by pulse centrifugation stopped the binding reaction. The bead fraction was 
then incubated for 10 min at room temperature with 450 µl of 1 % DDM containing 300 
mM imidazole in order to release the His-tagged protein from the beads. After spinning 
down  the  beads,  the  [
3H]TPP
+  associated  radioactivity  was  measured  by  liquid 
scintillation. All binding reactions were performed in triplicate.  
 
2. 2. 7. 2 Binding study using intrinsic tryptophan fluorescence 
Fluorescence was recorded with a Jasco FP 6500 Fluorescence spectrometer. Excitation 
at  295  nm  (bandwidth  2.5  nm)  was  used  to  selectively  excite  tryptophans  and  an 
emission wavelength at 330 nm (bandwidth 5 nm) was measured. All experiments were 
carried out in a 1x1 cm quartz cuvette in standard high salt buffer (2 M NaCl, 15 mM 
NaxHxPO4, pH 8.5, 0.1 % DDM) at 25 °C. Hsmr at a final concentration of 4 µM was Chapter 2 – Materials and Methods 
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used. TPP
+ or benzalkonium were added in sample buffer. The quenching of tryptophan 
fluorescence by substrate binding was analyzed using the binding equation as modified 
by Poget et al. [169].  
 
x P x m x P m m P y * 3 ) 5 . 0 ) * * 4 2 ) 2 ( * ) * 2 /( 1 + - + + =
Ù Ù         (12) 
 
P1  =   Fmax  (difference  between  maximal  fluorescence  intensity  of  protein  and  protein  + 
substrate), P2 = dissociation constant (Kd), P3 = fraction of non-specific TPP
+ binding, m = 
protein concentration  
 
2. 2. 7. 3 Ethidium bromide transport assay 
2. 2. 7. 3. 1 Bacteriorhodopsin 
Bacteriorhodopsin (bR) in purple membrane patches was prepared from Halobacterium 
salinarium  strain  JW5,  as  described  previously  [127].  Purple  membrane  was  used 
directly after density gradient purification with three additional washing steps to remove 
the sucrose [170]. 
 
2. 2. 7. 3. 2 Reconstitution of Hsmr 
10 mg of E. coli total lipids were solubilised in 1 mL of 150 mM KCl, 1 M NaCl, 5 mM 
K-EDTA, pH 7.3 and 20 mg/mL DDM. Different NaCl concentrations were initially 
tested. To 0.752 mL of the resulting suspension 0.1 mg of Hsmr, in elution buffer, was 
added. Elution buffer was used to produce a final sample volume of 2.4 mL. Excess 
detergent was removed with 250 mg of degassed biobeads in an overnight incubation at 
4 °C. The biobeads were then removed. 
 
2. 2. 7. 3. 3 Reconstitution of EmrE  
EmrE  was  reconstituted  at  a  protein/lipid  mol  ratio  of  1:450  for  fluorescence 
spectroscopy in buffer (150 mM KCl, 5 mM K
+-EDTA pH 7.3), using the following 
method: 4 mg/mL E. coli total lipid extract was solubilised with 1:2 mol ratio DDM for 
1  h  at  RT  with  sonication.  Protein  and  lipid/detergent  solutions  were  mixed  at  the 
required ratio and incubated for 1 h at RT, followed by detergent removal using pre-
washed and sonicated SM-2 Biobeads. In total, 3 times 30 mg biobeads/mg detergent 
were added and incubated for 1 h at RT and once at 4 ºC overnight. Biobeads were 
removed and the liposomes pelleted by centrifugation.  
 
2. 2. 7. 3. 4 Fusion of bR with Hsmr or EmrE containing liposomes 
Bacteriorhodopsin (0.41 mg) was added to 1 mL of the Hsmr-proteoliposomes or EmrE-
proteoliposomes. The mixture was freeze-thawed three times, which results in a 90 % 
inside-out orientation of bR in the vesicles [171]. If necessary, the sample was stored at 
–80 °C after the last freezing step. Proteoliposomes were centrifuged at 149,008 g, 30 
min, 4 °C, and the resulting pellet was resuspended in 1 mL of 150 mM KCl, 1 M NaCl, 
5 mM K-EDTA at pH 7.3 for Hsmr or 150 mM KCl, 5 mM K-EDTA at pH 7.3 for 
EmrE. The sample was sonicated in a water bath for 3 min to form unilamellar vesicles. 
The sample typically contained final concentrations of 1 µM Hsmr/EmrE, 15.4 µM bR, 
and 4.19 mM lipids. 
 
2. 2. 7. 3. 5 Fluorescence measurements 
All fluorescence measurements were carried out with a Jasco FP 6500 Fluorescence 
spectrometer. A 1x1 cm cuvette was kept at 25 °C by a thermostatic circulating water 
bath. Etbr measurements were carried out with excitation and emission wavelengths of 
545 and 610 nm, respectively. Emission slits were kept constant at 10 nm; excitation Chapter 2 – Materials and Methods 
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slits of 20 nm were used. In the cuvette, 220 µL of the bR/Hsmr proteoliposomes was 
diluted into 2 mL of 150 mM KCl, 1 M NaCl, 5 mM K-EDTA at pH 7.3, and 13.6 µM 
etbr. The sample was incubated in the dark for 5 min. Illumination at 545 nm excites 
etbr and enables bacteriorhodopsin to pump protons. The change in etbr fluorescence 
was  measured  over  200  s.  Illumination  was  switched  off  and  the  system  left  to 
equilibrate for 5 min.  pH and  ψ are collapsed at a final concentration of 43.5 µM c 
arbonyl cyanide 3-chlorophenylhydrazone (CCCP). 10 mM etbr stock solution and the 
various TPP
+ stock solutions were prepared in 150 mM KCl, 1 M NaCl, 5 mM K-
EDTA at pH 7.3. The uncoupler CCCP was prepared as a 10 mM stock solution in 
water.  
 
2. 2. 7. 3. 6 Data analysis 
Maximal etbr fluorescence after 200 s ( F), at each TPP
+ concentration, was plotted 
with OriginPro 7.5 and this data representing etbr transport inhibition by  TPP
+ was 
fitted using the dose response curve equation [172]: 
 
) * ) ) 50 ( 10 ((log ^ 10 1 / ) 1 2 ( 1 p x IC A A A y - + - + =          (13) 
 
A1  =  minimal    F ( F without TPP
+  addition  minus   F  with  least TPP
+  addition),  A2  = 
maximal    F  ( F  without  TPP
+  addition  minus   F  with  most  TPP
+  addition),  IC50  = 
concentration at which 50 % inhibition is observed, p = Hill coefficient 
 
The Hill coefficient p was set to 1 as it can be reasonably assumed that a functional 
Hsmr oligomer has a single binding site. 
 
2. 2. 7. 4 TPP
+ transport assay 
10 µL proteoliposomes prepared in 15 mM Tris, pH 7.0, 0 M KCl were diluted into 1 
mL outside buffer (15 mM Tris, pH 9.5, 0.15 M KCl and valinomycin (0.5 µg/mL)) 
with  initially  a  TPP
+  concentration  of  3  µM.  To  obtain  a  calibration  curve,  several 
aliquots of TPP
+ are added, each increasing the final TPP
+ concentration by 3 µM. Tests 
at higher salt concentration used proteoliposomes in 15 mM Tris, pH 7.0, 0 M KCl, 2 M 
NaCl and outside buffer (15 mM Tris, pH 9.5, 0.15 M KCl, 2 M NaCl and valinomycin 
(0.5 µg/mL)). The TPP
+ uptake by  proteoliposomes was determined  with a specific 
electrode  (MI-600)  and  a  reference  electrode  (MI-402)  from  Microelectrodes  Inc.. 
Potential  measurements  assay  were  recorded  and  analyzed  with  MetraHit  and 
MetraWin10 from Gossen Metrawatt. 
 
2. 2. 8 Centrifugation techniques 
2. 2. 8. 1 Density gradient centrifugation 
A discontinuous gradient from 0 to 40 % (w/v) sucrose was used to separate empty 
liposomes  from  proteoliposomes.  0.8  mL  of  each  solution,  starting  with  40  %,  was 
carefully layered into a 5mL centrifuge tube and left to equilibrate for 1 h. The 0.2 mL 
liposome or proteoliposome sample, at 4 mg/mL lipids, was carefully layered on top. 
Centrifugation at 101,843 g in a SW50.1 rotor and Beckman R class centrifuge was 
performed overnight at 4 °C. 
 
2. 2. 8. 2 Analytical ultracentrifugation (AUC) 
Analytical ultracentrifugation measurements were made in the Institut für Biophysik, 
Johann Wolfgang Goethe Universität in collaboration with Dr. Vitali Vogel, AK Prof. 
Mäntele. A Beckman XL-A Analytical Ultracentrifuge with an AN-50 TI rotor was 
used. The Hsmr molecular mass (Mp) and partial specific volume (υp) were estimated Chapter 2 – Materials and Methods 
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from the amino acid composition to be 14526 kDa and 0.7533 mL/g respectively, using 
Sednterp software version 1.09 (http://www.jphilo.mailway.com/download.htm). 
The  partial  specific  volumes  considered  for  the  detergents  were:  p u   =  0.824  mL/g 
DDM  [173]  and    p u   =  0.937  mL/g  DPC  [174].  For  analytical  ultracentrifugation 
analysis  imidazole  was  removed  and  Hsmr  exchanged  into  2  M  NaCl,  15  mM 
NaxHxPO4, pH 8.0, (ρ = 1.08055 mg/mL, η = 1.2269x10
-2) with 0.1 % DDM or 0.1 % 
DPC using HiTrap desalting columns. Data analysis was performed using the program 
“Sedfit”  version  94  [175] 
(http://www.analyticalultracentrifugation.com/sedphat/download.htm). 
 
2. 2. 8. 2. 1 Sedimentation velocity experiments with Hsmr 
Sedimentation velocity experiments were carried out at a rotor speed of 116444 g, at a 
sample concentration of 1.65 mg/mL for the DDM containing sample and 2 mg/mL for 
the DPC containing sample. 300  L of the protein samples were loaded into 2-channel 
1.2 cm path length centrepieces prior to velocity runs at 20 °C or 4 °C for DDM and 
DPC respectively. Absorbance scans were recorded every 5 min at 280 nm with 0.002 
cm  radial  step-size.  Sedimentation  velocity  profiles  were  analysed  using  size 
distribution analysis from the Sedfit programme providing a differential sedimentation 
coefficient  distribution,  c(s).  This  continuous  c(s)  distribution  of  the  sedimentation 
coefficient analysis was performed with a grid size of 500, estimated frictional ratio, 
f/f0, of 1.20 (corresponding to globular species) and sedimentation coefficients in the 
range  of  0.5  –  20  S  (in  DDM)  and  0.5  -  20  S  (in  DPC).  S  values  reported  are 
experimental and are S(20°C,buffer) or S(4°C,buffer) for DDM and DPC samples respectively. 
The  continuous  sedimentation  coefficient  analysis  c(s)  uses  the  following  equation 
[176]: 
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c = concentration, a = concentration profile, r = radial, t = time, L = Lamm coefficient, D = 
diffusion coefficient 
 
2. 2. 8. 2. 2 Sedimentation equilibrium experiments with Hsmr 
Sedimentation equilibrium experiments were performed at a rotor speed of 8064 g and 
18144 g, at a sample concentration of 0.56 mg/mL.  130  L were loaded into a 2-
channel centrepiece with 1.2 cm path length and the experiment was run at 20 °C. To 
obtain neutral buoyancy for the detergent DPC in the protein buffer, the salt content was 
reduced to 1 M NaCl and 25 % D2O are required (ρ = 1.04069 mg/mL, η = 1.1042x10
-
2). Four samples with 0 %, 10 %, 15 % and 25 % D2O were used for a global analysis of 
Hsmr molecular weight. Absorbance scans were recorded after 12 h, then every 2 h, at 
280  nm  with  0.03  cm  radial  step-size.  Sedimentation  equilibrium  profiles  were 
preliminarily  analysed  using  the  c(s)  size  distribution  analysis  from  the  Sedfit 
programme.  
 
2. 2. 9. Chromatographic techniques 
2. 2. 9. 1 Anionexchange chromatography 
A 1 mL DEAE Sepharose fast flow IEX column was used with a flow rate of 4 mL/min. 
The column was washed with (0 M NaCl, 50 mM Tris, pH 8.0, 0.1 % DDM) for 20 CV 
and the sample applied in this buffer in 2 CV and washed for 10 CV. The protein was 
eluted with a gradient to (0.5 M NaCl, 50 mM Tris, pH 8.0, 0.1 % DDM) in 15 CV. The Chapter 2 – Materials and Methods 
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entire purification was performed at 4 °C. Absorption at A280 and conductivity were 
measured. 
 
2. 2. 9. 2 Desalting column or dialysis for buffer exchange 
Efficient  buffer  exchange  was  achieved  using  12  kDa  cut-off  dialysis  membranes, 
stirred solutions of 1000 times the sample volume and three buffer changes within 24 h. 
Alternatively a 5 mL HiTrap Desalting column was washed with 25 mL target buffer, 
1.5 mL sample was loaded and two 1 mL fractions were eluted in target buffer.  
 
2. 2. 9. 3 Size exclusion chromatography 
A  home-made  preparative  gel  filtration  column  with  Superose  12  medium  with 
adequate resolution (9369 plates/m, close to the theoretical 10000 plates/m) was used. 
The column was calibrated with acetone, blue dextran 2000, ferritin, aldolase, catalase, 
equine myoglobin, chicken ovalbumin, bovine γ globulin, bovine serum albumin (BSA) 
in 50 mM NaxHxPO4, pH 7.0, 150 mM NaCl. The Stokes radii (Rs) of these proteins are 
known and the following equation is used obtain the partition coefficient KD [177]: 
 
) (
) (
o t
o e
D V V
V V
K
-
-
=                   (15) 
 
Ve= elution volume of the protein, Vo= void volume as determined by blue dextran, Vt= total 
volume as determined by acetone 
 
The calibration standard curve plots Rs versus KD or molecular weight (MW) versus KD. 
The gel filtration column was equilibrated with sample buffer before 1.5 mL sample are 
applied. The sample buffer composition depends on the experiment and is indicated in 
the figure legend. Unless otherwise indicated size exclusion chromatography (SEC) was 
conducted at 4 °C and with a 1 mL/min flow rate. Absorption at A280 and conductivity 
were measured. 
 
2. 2. 10 Mass spectrometry techniques 
2. 2. 10. 1 Matrix assisted laser desorption (MALDI) MS and MS/MS 
2. 2. 10. 1. 1 MALDI-TOF and MALDI TOF/TOF of tryptic digests 
Samples were digested with trypsin in Tris or ammonium bicarbonate buffers at pH 8-9. 
A trypsin:protein ratio of 1:50 (w/w) was used and the reaction incubated at 37 °C for 
12 h. The reaction was stopped by adding 10 % (v/v) formic acid. 1 µl sample and 1 µl 
alpha-cyano-4-hydroxy-cinnamic acid (3 mg/mL; 70 % (v/v) acetonitrile, 0.5 % (v/v) 
trifluoroacetic acid (TFA) were mixed and dried in the open air. Dried preparations 
were washed with 5 % (v/v) formic acid. All MS experiments were performed on an 
Ultraflex TOF/TOF from Bruker Daltonics in reflector mode. The low mass gate was 
set to 650 Da and the detection range to 700 – 5000 Da. Approximately 1200 shots were 
added for each MS spectrum. The resolution was approximately 15000 at m/z = 2000. 
All MS-spectra of tryptic digests were calibrated externally unless indicated otherwise. 
The external calibration ensures a mass accuracy of at least 50 ppm. The peptides of the 
referencing standard are listed in table 13A.  
 
MS/MS  experiments  were  performed  using  the  LIFT  methodology  [178].  The  mass 
accuracy of the precursor ion was 50 – 100 ppm, the mass accuracy of the fragment was 
0.5 – 1.0 Da. The isolation width of the precursor ion selector was manually adjusted 
(0.5 % - 1 % of the mass of the precursor ion). The fragmentation was laser induced. Chapter 2 – Materials and Methods 
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Depending on the intensity and the signal to noise ratio of the precursor ion 2000 – 
20000 shots were added up. 
Processing of MS spectra and MS/MS spectra used the program Flex Analysis v2.2 
from Bruker Daltonics. For all spectra the settings in table 13B and table 13C were 
used. Further analysis utilised the programme Biotools v2.2 from Bruker Daltonics. 
 
2. 2. 10. 1. 2 MALDI-TOF of proteins for total mass measurement 
For  MALDI  sample  preparation  matrix  (2,5-dihydroxy  benzoic  acid:2-hydroxy-5-
methoxy benzoic acid = 10:1 (DHBs) and (40 mg/mL; solvent, 33 % acetonitrile/0.1 % 
TFA)  was  used.  1  µl  sample  solution  was  mixed  with  1  µl  matrix  directly  on  the 
MALDI plate and dried in the open air. All MALDI measurements were conducted on a 
Voyager DE-Pro from Applied Biosystems in linear mode. The instrument settings of 
MALDI-TOF  were  selected  in  accordance  with  Bahr  et  al.  [179].  A  commercial 
calibration  mixture  from  Applied  Biosystems  was  used  for  internal  and  external 
calibrations, table 14. The MS spectra were processed with Data Explorer Software 
from Applied Biosystems including baseline correction, smoothing, calculation of mass 
lists and internal or external calibration.  
All MS MALDI spectra were acquired and preliminary processed by Apotheker Björn 
Meyer in the group of Prof. Karas. Chapter 2 – Materials and Methods 
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A 
peptide  monoisotopic mass [M+H] 
Des-Arg-bradykinin  904.4681 
angiotensin I  1296.6853 
Glu-fibrinopeptide B  1570.6774 
ACTH_clip (1-17)  2093.0867 
ACTH_clip (18-39)  2465.1989 
ACTH_clip (7-38)  3657.9294 
 
B 
parameter  setting 
peak detection algorithm  SNAP 
signal to noise threshold  3 
relative intensity threshold  0 % 
maximal number of peaks  200 
quality factor threshold  50 
building block  averagine 
smoothing algorithm (Savitzky Golay)  width = 0.2 m/z; 1 cycle 
baseline substraction (median)  flatness = 0.8 
 
C 
parameter  setting 
peak detection algorithm  SNAP 
signal to noise threshold  3 
relative intensity threshold  0 % 
maximal number of peaks  500 
quality factor threshold  0 
building block  averagine 
fragment peak width  0.75 m/z 
smoothing algorithm (Savitzky Golay)  width = 0.2 m/z; 1 cycle 
baseline substraction (median)  flatness = 0.8 
Table 13.  Data processing parameters. A) Peptides for external calibration of MS spectra 
(Applied Biosystems, SCIEX), B) parameters for the programme Flex Analysis v2.2 (Bruker 
Daltonics,  Bremen)  for  processing  of  MS  spectra,  C)  parameters  for  the  programme  Flex 
Analysis v2.2 (Bruker Daltonics, Bremen) for the processing of MS/MS spectra.  
 
Protein  electric charge n  (M+nH)
n+ (average) 
Insulin (bovine)  +1  5734.59 
  +2  2867.80 
thioredoxin (E. coli)  +1  11674.48 
  +2  5837.74 
apomyoglobin  +1  16952.56 
  +2  8476.78 
Table 14. Standards for MALDI-TOF mass spectrometry.  
 
2. 2. 10. 2 Laser induced liquid bead ion desorption (LILBID) 
LILBID is a novel mass spectrometry method first developed by the group of Professor 
Brutschy [180]. The analysis performed here was conducted as described previously for 
membrane protein complexes [181]. As for all MS techniques, the sample needs to have 
low salt and detergent concentrations. Chapter 2 – Materials and Methods 
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Hsmr  samples  were  eluted  in  the  desired  detergent  from  the  Ni-NTA  column  and 
dialyzed with a molecular weight cut-off of 14 kDa for 24 h with salt and detergent free 
buffer to ensure suitability for LILBID measurements. Accordingly, the exact salt and 
detergent concentration of the LILBID samples is unknown. Micro droplets of the salt 
and detergent reduced Hsmr sample (diameter 50  m) were produced at 10 Hz by a 
piezo-driven  droplet  generator  and  introduced  into  vacuum  via  differential  pumping 
stages. The droplets are irradiated by synchronized high-power mid-infrared (mid-IR) 
laser pulses of typically 5 ns pulse length. The wavelength is tuned to the absorption 
maximum of water at around 3  m corresponding to the excitation of its stretching 
vibrations. Above threshold intensity the radiation induces a rapid transition into the 
supercritical state which leads to the explosion of the droplets. The pre-formed ions in 
the  liquid  can  escape  into  the  gas  phase,  where  they  are  mass  analyzed  in  a  TOF 
reflectron mass spectrometer. At low laser intensity LILBID desorbs ions out of the 
liquid very gently (ultra soft mode) enabling detection of the non-covalently assembled 
membrane  protein  complexes.  Using  the  ultra  soft  mode,  generally,  ions  carry  an 
average of 10 % of the detergent molecules from their micelle. The semi-soft and harsh 
mode  enable  only  the  measurement  covalently  bound  molecules  in  a  detergent  free 
state. For these experiments only the ultra soft mode was used. The signals from the 
detector are recorded by a transient recorder. For data acquisition and analysis user-
written labview programs are used. The signal to noise ratio is improved by subtracting 
the unstructured background, caused by metastable loss of water and buffer molecules, 
from the original ion spectra. These difference spectra are smoothed by averaging the 
signal over a pre-set number of channels of the transient recorder, with the smoothing 
interval  always  lying  within  the  time  resolution  of  the  TOF  mass  spectrometer.  All 
LILBID measurements were carried out by Dipl.-Phys. Nina Morgner in the group of 
Prof. Brutschy. 
 
2. 2. 11 Sample preparation for 
1H NOESY spectroscopy 
25  mg  DMPC  and  3.13  mg  TPP
+  were  dissolved  separately  in  a  2  mL 
chloroform:methanol (1:1 (v/v)) mixture. The two solutions were mixed and the solvent 
was removed under a stream of nitrogen. The lipid:TPP
+ film was redissolved in 2 mL 
of  cyclohexane,  frozen  in  liquid  nitrogen,  and  lyophilized  under  vacuum  overnight. 
Unilamellar vesicles were prepared by hydrating the lyophilised sample with 20 µL 
D2O. The samples were homogenized by sonication. 
 
2. 2. 12 NMR techniques 
2. 2. 12. 1 Solution state and high resolution (HR) MAS NMR 
Solution state NMR spectra were collected at 14.1 T or 21.1 T with Avance 
Spectrometer from Bruker Biospin and TXI HCN probeheads. The spectra were 
processed with Topspin 2.0 and Sparky 3. An average resonance list was obtained from 
the BMRB and used in Sparky for tentative assignment resonances to amino acid types. 
Spectra were collected in collaboration with Dipl.-Biochem. Max Stadler and Dr. Karla 
Werner from the group of Prof. Schwalbe. A schematic diagram of the heteronuclear 
single quantum coherence (HSQC) [182] type spectrum used is given in figure 12.  
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Figure 12. Schematic diagram of a HSQC pulse sequence. The pulse sequence shown is 
Bruker-implemented on Avance Spectrometer as hspcetf3gpsi.av. Phase sensitive detection in 
the indirect dimension, coherence pathway selection and water suppression are achieved using 
gradients  [183].  For  water  suppression  additionally  a  trim  pulse  is  used.  Sensitivity 
enhancement  is  afforded  by  an  additional  INEPT  transfer  so  that  both  orthogonal  in-phase 
proton magnetization components are detected [184, 185].    
 
HR MAS NMR spectra were collected at 9.39 T with an Avance Spectrometer from 
Bruker Biospin and XWINNMR 3.5 as acquisition software or 9.39 T with an Avance II 
Spectrometer  from  Bruker  Biospin  and  Topspin  1.3  as  acquisition  software. 
Experimental  settings  are  specific  to  each  experiment  and  indicated  in  the  figure 
legends. All experiments were measured using 4 mm MAS DVT probeheads. 4 mm 
Bruker  style  zirconium  rotors  were  sealed  by  HR  MAS  inserts  and  KEL-F  bottom 
inserts were used. Spectra were processed with Topspin 2.0. CARA 1.8.4 [144] was 
used for peak assignment and integration. The NOESY pulse sequence is depicted in 
figure 13. 
 
 
Figure 13. Schematic diagram of NOESY experiment. The NOESY [186] is a solution state 
NMR experiment but can also be used for hydrated liquid crystalline membranes at high speed 
MAS. 
 
2. 2. 12. 2 NOESY analysis 
The full matrix analysis described previously [187] enables NOESY cross relaxation 
rates to be determined from experimentally measured peak volumes (diagonal and cross 
peak). A minimum of two spectra (one spectrum at zero mixing time and a spectrum 
with a longer mixing time) are required for the analysis. The peak volume matrix A(0) 
at zero mixing time was approximated by a measurement at 10 ms mixing time. 
The experimentally measured peak volumes are determined by the cross relaxation rates 
of the diagonal peaks as described by the following matrix equation: 
 
) 0 ( ) exp( ) ( A Rt t A m m - =                 (16) 
 
A(tm) = peak volume matrix of experimental data at mixing time (tm), R(tm) = relaxation rate 
matrix at mixing time tm, A(0) = experimentally determined peak volume matrix at mixing time 
zero (here approximated by a 10 ms mixing time) 
 
 
 
 
 Chapter 2 – Materials and Methods 
 
  36 
To calculate the relaxation rate matrix from this the following equation is used: 
 
m t
X D X
R
1 ) (ln
-
- =                   (17) 
 
R = relaxation rate matrix, X = matrix of eigenvectors, D = diagonal matrix of eigenvalues, tm = 
mixing time 
 
The  relaxation  rate  matrix  thus  gives  the  calculated  cross  relaxation  rate  for  each 
nucleus pair. This cross relaxation rate depends on the distance between the two nuclei 
and the time the two nuclei spend in each others vicinity. Thus the cross relaxation rate 
is a location probability for these two nuclei. Here the location probability of a substrate 
nucleus near all lipid nuclei is plotted. 
 
2. 2. 12. 3 Solid state NMR 
Solid state NMR spectra were collected at 9.39 T with an Avance Spectrometer from 
Bruker Biospin and XWINNMR 3.5 as acquisition software or 9.39 T with an Avance II 
Spectrometer from Bruker Biospin and Topspin 1.3 as acquisition software or 14.1 T 
with an Avance Spectrometer from Bruker Biospin and XWINNMR 3.5 as acquisition 
software. Experimental settings are specific to each experiment and indicated in the 
figure legends. All experiments were measured using 4 mm MAS DVT probeheads. 4 
mm  Bruker  style  zirconium  rotors  were  sealed  by  HR  MAS  inserts  and  if  space 
permitted KEL-F bottom inserts were used. Spectra were processed and line shapes 
fitted with Topspin 2.0. Professional display and tentative resonance assignment using a 
BMRB  average  resonance  list  was  performed  in  Sparky  3.  Figures  14  –  16  show 
schematic representations of the solid state NMR pulse sequences used in this thesis. 
 
 
Figure 14. Schematic diagram of proton driven spin diffusion (PDSD) experiment [188]. 
Signal  enhancement  is  achieved  using  variable  amplitude  CP.  During  the  mixing  step 
magnetization is  shared  between  carbons  using the strong  dipolar  couplings to  protons  and 
proton spin diffusion. 
 
 
 
Figure 15. Schematic diagram of DQSQ experiment. The DQSQ experiment used is similar 
to the previously described INADEQUATE experiment for large spectral widths [189] but uses 
the  R  type  sequence  SR22  [190]  for  excitation  and  reconversion  of  double  quantum 
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Figure 16. Schematic diagram of the quadruple echo experiment. The quadruple echo is 
used to enable static experiments with direct detection of fast relaxing quadruple nuclei with 
large spectral width [191]. 
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Chapter 3 – Cell free expression 
 
3. 1 Introduction  
Here, an E. coli based home-made cell free expression system that combines in vitro 
transcription and in vitro translation is used under semi-continuous exchange conditions 
[49]. Figure 17 depicts a schematic representation of this cell free expression system. 
The expression of several SMR proteins was attempted. Only SMR proteins of the SMP 
and PSMR subgroups were chosen, as the aim of this work is the investigation of a 
multidrug  transporter.  [25]  Initially,  SMR  proteins  EmrE,  TBsmr,  Hsmr,  YdgF  and 
mutants  of  EmrE  were  screened  for  successful  expression  in  the  cell  free  protein 
synthesis system.  
 
 
Figure  17.  Schematic  representation  of  the  semi-continuous  E.  coli  based  cell  free 
expression system with coupled transcripton and translation. 
 
EmrE is the archetypal SMR protein and best studied member of the SMP subfamily. 
TBsmr  was  chosen  based  on  its  occurrence  in  the  human  pathogen  Mycobacterium 
tuberculosis,  the  causative  agent  of  tuberculosis.  [155].  As  a  multidrug  transporter 
TBsmr is likely involved in the soaring drug resistance of tuberculosis [192]. Hsmr was 
the first SMR protein described in the archaea domain of life and offers the chance of 
investigating a multidrug transporter in the presence of high salt concentrations. The 
unusual amino acid sequence of Hsmr, comprised roughly of 40 % alanine and valines, 
highlights the amino acid residues conserved in SMP proteins, and opens up unique 
isotope labeling opportunities [28]. The E. coli PSMR proteins YdgE/F were chosen for 
investigation  as  a  representative  heterooligomeric  SMR  protein  pair  [193].  The 
available  expression  modes  and  purification  steps  that  were  used  are  shown  in  a 
schematic overview in figure 18. 
 Chapter 3 – Cell free expression 
 
  39 
 
Figure 18. Choices for in vitro SMR protein expression. The flow diagram gives an overview 
of  the  choices  regarding  expression  mode  and  protein  purification  when  using  cell  free 
expression for the production of SMR proteins. immobilized metal affinity chromatography 
(IMAC) 
 
3. 2 Expression of SMR proteins in an E. coli based cell free expression system 
All SMR proteins tested could be successfully expressed as a precipitate in the home-
made  cell  free  expression  system.  Western  blots  of  proteins  obtained  during  initial 
expression attempts can be seen in figure 19. The hydrophobic SMR proteins precipitate 
in the hydrophilic environment of the cell free expression directly after translation. The 
precipitate  contains  mainly  the  expressed  hydrophilic  SMR  protein  and  therefore 
provides a first crude purification from the multitude of proteins present in the cell free 
extract. The precipitate was collected by centrifugation and subjected to SDS-PAGE 
after solubilisation by SDS.  
Particularly noteworthy is the successful expression of Hsmr using the home-made cell 
free expression system, as Schuldiner et al. were unable to produce Hsmr in an identical 
construct using the commercially available cell free expression system RTS 100 E. coli 
HY by Roche Diagnostics [36]. Immediately obvious is the occurrence of oligomeric 
species on denaturing SDS-PAGE. This remarkable resistance to oligomer dissociation 
was  previously  observed  and  the  smearing  between  oligomerisation  states  indicates 
dynamic exchange between oligomerisation states [28, 36, 41, 146, 194]. This feature of 
SMR proteins is particularly visible using sensitive western blot analysis. The observed 
multimers  on  SDS-PAGE  further  foster  discussions  regarding  the  native  oligomeric 
state of SMR proteins. 
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Figure  19.  Screening  SMR  protein  production  by  cell  free  expression  in  precipitation 
mode. This compound figure shows the successful precipitate expression of A) Hsmr, B) EmrE 
on one western blot, C) TBsmr, D) YdgF and E) EmrE CAMY each on separate western blots. 
The precipitate was solubilised using SDS and subjected to SDS-PAGE. SMR proteins were 
visualized using an anti-myc antibody which detects the C-terminal myc tag. SMR proteins run 
on SDS PAGE as monomers and multimers. Smearing between oligomerisation states indicates 
dynamic exchange between them [28, 36, 41, 146, 194].  
 
3. 3 Choice of targets and improving purity 
After  initial  screening,  the  proteins  EmrE  and  Hsmr  were  chosen  for  further 
investigation, with first attempts concentrating only on Hsmr. Higher Hsmr purity than 
achievable by collecting the pelleted precipitate was desired and a further purification 
step was added. Some soluble proteins co-precipitate with the hydrophobic heterologous 
protein and it was tested whether pellet washes with detergents can selectively remove 
these  soluble,  contaminating  proteins.  The  ideal  detergent  would  extract  all  soluble 
proteins  of  the  cell  free  extract,  but  would  not  solubilise  or  harm  Hsmr.  Table  15 
summarizes the solubility of Hsmr in various wash buffers as detected by SDS-PAGE 
and western blot analysis. The buffers were maintained at pH 7 or 8 as at this pH Hsmr 
is functional and crossing of its isoelectric point is avoided [28]. The detergents chosen 
are  grouped  according  to  their  ionic  properties.  Non-detergent  substances  were  also 
used and are listed together. All detergent concentrations were chosen to be above the 
cmc. 
It can be concluded that pellet washes with minimal Hsmr loss are possible using the 
nonionic  detergent  Tween  (2  %  Tween  80),  the  zwitterionic  detergent  3-[(3-
Cholamidopropyl)dimethylammonio]propanesulfonic acid (CHAPS) (3 % CHAPS) or 
the nondetergent buffers containing DHPC (5 % or 10 % DHPC), tetrafluoroethylene 
(TFE), 3:1 chloroform/methanol or 0.5 M urea. However, improvements in Hsmr purity 
were small and a different purification strategy was sought. Chapter 3 – Cell free expression 
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type of substance  name of substance and concentration  solubility  
(-, +,++,+++) 
     
ionic     
     
  2 % SDS  + 
  4 % SDS  ++ 
     
zwitterionic     
     
  5 % DPC  +++ 
  3 % CHAPS  - 
     
nonionic     
     
  0.5 % DDM  ++ 
  2 % DDM  ++ 
  2 % Triton X 100  ++ 
  2 % Triton X 114  + 
  2 % Tween 20  ++ 
  2 % Tween 80  - 
  4 % OG  + 
  10 % OG  ++ 
     
nondetergent     
     
  TFE  - 
  5 % DHPC  - 
  10 % DHPC  - 
  NSDB-195  - 
  NSDB-201  ++ 
  NSDB-256  ++ 
  5 % LPPG  ++ 
  5 % LMPG  + 
  10 % LMPG  ++ 
  3:1 chloroform/methanol  - 
  0.5 M urea  - 
  1 M urea  + 
  2 M urea  + 
  3 M urea  + 
Table 15. Purification of SMR proteins using differential solubilisation of the precipitation 
pellet. Pellets of precipitated Hsmr were washed twice in 0.2 M sodium phosphate wash buffer, 
pH 7. Detergent solutions were prepared in 50mM potassium phosphate buffer pH 8.0, 2 mM 
DTT. The pre-washed Hsmr pellets were solubilised for 30 min at 30 ºC with detergents and 
non-detergent substances. Urea, TFE and chloroform/methanol extractions were kept at RT. 10 
µL of the wash solution were subjected to SDS-PAGE and western blot analysis. The amount of 
Hsmr solubilised was detected with an anti-myc tag antibody.  
 
3. 4 Immobilized metal affinity purification  
The used vectors include a hexahistag which is added to the C-terminal end of the SMR 
proteins. Hexahistags bind tightly to IMAC columns charged with nickel. A one step 
purification scheme for the target protein using affinity chromatography was devised. Chapter 3 – Cell free expression 
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Here, batch binding to the Ni-NTA beads was combined with wash and elution steps in 
plastic chromatography columns. Elution of the selectively immobilized target protein 
can be achieved using pH drop, competition with imidazole or ammonium hydroxide. 
Elution by lowering the pH to 4.6 should elute selectively monomers and dimers [195], 
whereas  ammonium  hydroxide  elution  [196]  would  be  beneficial  for  subsequent 
biochemical assays. The most efficient method for elution of Hsmr in DDM micelles 
was evaluated and the western blot can be seen in figure 20. Elution from the nickel 
affinity column was most efficient using imidazole. The other methods were therefore 
no longer pursued. 
 
 
Figure  20.  Affinity  purification  of  solubilised  Hsmr  and  evaluation  of  optimal  elution 
method. Hsmr was eluted using three different methods. a) 0.4 M ammonium hydroxide, b) low 
pH 4.6 sodium acetate, c) 250 mM imidazole. 
 
3. 5 Soluble expression 
The  expression  of  membrane  proteins  as  precipitate  requires  efficient  refolding 
protocols  and  the  verification  that  native  activity  is  regained.  Therefore,  soluble 
expression modes were sought for selected SMR proteins. Detergents and lipids provide 
a hydrophobic micellar environment for the nascent protein chain, which can prevent 
protein  precipitation  and  enable  correct  protein  folding.  Initially,  Hsmr  in  vitro 
expression, in the presence of various detergents above their cmc, was screened. The 
detergents  chosen  were  successful  in  solubilizing  Hsmr,  as  assessed  during  the 
differential solubilisation experiments, and are frequently successfully used detergents 
for  membrane  protein  investigations.  After  cell  free  expression,  a  sample  from  the 
expression mixture was analysed by SDS-PAGE and western blot analysis. Hsmr was 
expressed in the presence of DDM and DPC as can be seen in figure 21a.  
Expression in the presence of the zwitterionic detergent DPC was most efficient. A 
correlation  between  increasing  cmc  and  increasing  detergent  interference  with  the 
transcription/translation  machinery  has  been  noted  [197].  Accordingly,  it  is  not 
surprising that DPC was the most successful detergent for the soluble expression of 
Hsmr. Next, the general suitability of DPC for the soluble SMR protein expression was 
assessed.  Additionally,  the  effect  of  soluble  versus  precipitate  expression  on  the 
oligomeric  state  of  SMR  proteins  was  investigated.  The  results  can  be  seen  on  the 
Western blot figure 21b. Finally, the possibility of expressing Hsmr in the presence of 
liposomes  was  investigated  using  DOPC  in  the  cell  free  reaction  mixture,  at 
concentrations far above the estimated lipid cmc. Expression in the presence of lipids is 
possible as seen in figure 21c. 
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Figure 21. Soluble expression of SMR proteins in cell free expression systems. A) Screen of 
Hsmr expression using different detergents to provide a hydrophobic micellar environment for 
the nascent protein chain. Expression in a) 36.75 mM OG, b) 0.26 mM DDM and c) 2.25 mM 
DPC. B) Comparison of yields and oligomerisation state for EmrE a, e), TBsmr b, f), Hsmr c, g) 
and YdgF d, h) expressed as precipitate a-d) and soluble e-h) in 2.25mM DPC. +) as positive 
control  0.8  g Hsmr expressed in vivo was used. C) Soluble expression in the presence of a) 
8.5mM DOPC, +) Hsmr in vivo expressed as positive control and -) cell free extract as negative 
control are shown.  
 
3. 6 Conclusion 
In conclusion, the SMR proteins Hsmr, EmrE, TBsmr and YdgF can be obtained by cell 
free expression, as precipitates, and in the presence of detergents or lipids in a soluble 
form.  Protein  expression  as  precipitate  can  be  combined  with  differential  pellet 
solubilisation  or  IMAC.  Expression  in  a  soluble  form  is  best  achieved  with  the 
zwitterionic  detergent  DPC  proved  to  be  superior  and  protein  purification  utilises 
IMAC. The highest protein purity can be achieved using IMAC in combination with 
imidazole as the eluant.  Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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Chapter  4  -  Large  scale  in  vivo  Hsmr  preparation  and 
optimization of detergent and reconstitution conditions  
 
4. 1 Introduction 
Despite  the  abundance  of  membrane  proteins,  around  30  %  of  proteins  in  most 
proteomes [198], membrane proteins are less well studied than soluble proteins and 
grossly underrepresented in structural databases such as the Protein Data Bank [199]. 
The reluctance to study membrane proteins arises from their frequently low expression 
in  native  sources  and  heterologous  expression  systems  [200].  Additionally,  the 
preparation  of  membrane  proteins  is  cumbersome  due  to  the  necessity  to  imitate  a 
native-like hydrophobic environment in order to obtain functional and natively folded 
membrane  proteins.  Bearing  this  in  mind,  a  particular  effort  regarding  membrane 
protein expression, purification and optimization of handling procedures is required. 
Sought-after  parameters  are  protein  solubility,  monodispersity,  stability  and 
functionality. Here conditions for in vivo expression of Hsmr and EmrE are sought as an 
alternative to the costly cell free expression and as a means of obtaining uniformly 
isotope labeled protein. Furthermore, protein purification and reconstitution conditions 
are optimized which are transferable to in vitro produced proteins. 
 
4. 2 Overview of the optimization of Hsmr expression, purification and handling 
In this chapter, optimizations regarding Hsmr preparation for solution-state methods and 
solid-state NMR are shown. Figure 22 summarizes the individual stages in the process 
of protein expression and purification.  
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Figure 22. Overview of Hsmr sample preparation optimization performed.  
 
4. 3 In vivo Hsmr protein expression optimization 
Here, in vivo expression of Hsmr in E. coli cells was optimized regarding yield and 
possible isotope labeling schemes. In all cases the pT7-7 Hsmr myc-his tag construct 
described in the material and methods section was used. Transcription of Hsmr mRNA 
required the presence of T7 polymerase. In table 16, the utilized E. coli strains and their 
metabolic requirements are listed.  
Figure 23 shows the yields that were obtained using different E. coli strains and media.  Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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strain  genotype  auxotrophic  literature 
CT19  BL21(DE3)  + 
aspC, ilvE, trpB, 
tyrB, avtA 
Leu,  Val,  Ile, 
Tyr,  Trp,  Phe, 
Asp, Ala 
[149] 
BL21(DE3)  F
–  ompT  gal 
dcm  lon 
hsdSB(rB
-  mB
-) 
λ(DE3  [lacI 
lacUV5-T7 gene 
1  ind1  sam7 
nin5]) 
no  [150] 
 
T7 Express  BL21(D3)  + 
fhuA2  lacZ::T7 
gene1  [lon] 
ompT  gal 
sulA11  R(mcr-
73::miniTn10--
Tet
S)2  [dcm] 
R(zgb-
210::Tn10--
Tet
S)  endA1 
 (mcrC-
mrr)114::IS10 
no  [151] 
TA15  melBLid  nhaA1 
nhaB1 lacZY 
no  [152] 
Table 16. E. coli strains evaluated for use with Hsmr. Genotype and auxotrophy are listed to 
enable assessment of the usefulness of each strain with regards to isotope labeling experiments. 
 
 
Figure 23. Hsmr expression yield in mg protein / L culture medium. The effect of different 
E. coli strains and media on the production of Hsmr can be seen. The standard deviation, if 
applicable, is indicated as a bar. Below the diagram the number of replicate experiments (N=) is 
indicated. Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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Initially, for all Hsmr protein expressions, TA15 cells were used. The differences in 
protein yields per L of medium are striking. TA15 cells encode T7 polymerase on a 
separate vector pG1-2 under the control of a heat shock promoter. Poor control over 
heat shock parameters such as heating, cooling, temperature maintenance and mixing in 
shake flask cultures are the likely causes of the poor yield reproducibility. Expression in 
a fermenter offers a potential solution to low yields by easing up scaling and providing 
potentially higher reproducibility. To improve reproducibility and potentially also the 
yields, the use of CT19, BL21(DE3) and T7 Express cells was evaluated. These strains 
support chemical induction of T7 polymerase production with IPTG. T7 Express cells 
offer  the  advantage  of  resistance  against  T1  phages  whereas  the  auxotrophic  strain 
CT19 enables amino acid specific isotope labeling (see table 16). Overall, the Hsmr 
yield  was  not  only  more  reproducible  but  also  higher  when  IPTG  was  used  for 
induction. However, since IPTG mediated induction is very costly, Hsmr is expressed in 
TA15 cells when using a fermenter. In flask cultures, IPTG induction was preferentially 
carried out with T7 Express cells or, for amino acid specific labeling experiments, CT19 
cells.  
 
The highest  yields  were obtained with  rich media (LB and 2xYT) and much lower 
yields with synthetic media (defined and minimal). In general, faster growth and higher 
heterologous protein expression are expected for rich media and the synthetic 19 amino 
acid containing defined medium. In fact, proteorhodopsin expression yields are known 
to be much higher with such a synthetic defined medium than in a rich medium [201]. 
The  reasons  for  low  yields  with  the synthetic  defined  medium  remain  unknown.  In 
conclusion,  depending  on  the  strain,  expression  mode  (fermenter  versus  flask)  and 
isotope  labeling  scheme  used  different  media  were  employed.  See  table  17  for  an 
overview of combinations used. 
   
media  labeling possibilities  suitable for auxotrophs 
2xYT  no  yes 
LB  no  yes 
minimal media  uniform or pattern  No 
minimal  media 
(high cell density) 
uniform or pattern  No 
defined media  amino acid selective  Yes 
Table  17.  Overview  of  media  for  E.coli  based  SMR  protein  expression.  The  media 
compositions are detailed in the material and methods section.  
 
Expression levels of proteins under the control of a T7 promoter can be boosted by 
using  the  antibiotic  rifampicin  to  inhibit  native  E.  coli  polymerases  [202].  This  is 
inhibition  of  native  transcription  channels  all  metabolic  energy,  precursors  and 
ribosomes to the production of the heterologous protein. Here, the effect of a rifampicin 
mediated  yield  increase  was  investigated  for  TA15  cells  only  and  could  not  be 
reproduced. Nevertheless, the combination of the spin down methodology [203]  and 
rifampicin  was  used  for  isotope  labeling  experiments.  Briefly,  the  spin  down 
methodology enables pulse labeling by the use of unlabelled media for the growth phase 
and  switching  to  labeled  media  at  high  cell  density  for  the  heterologous  protein 
expression phase. Rifampicin ensures the efficient use of labeled compounds for the 
heterologous product, and reduces required nutrient amounts by suppressing the native 
metabolism. These techniques reduce the necessary amount of labeled media and the 
nutrient content of the media, leading to significant cost savings. 
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To  assess  the  success  of  the  described  expression  yield  optimization,  the  Hsmr 
overexpression,  as  %  of  total  membrane  protein,  was  measured.  Unfortunately,  a 
meager 1.6 % of the total membrane protein content consisted of Hsmr. Membrane 
protein overexpression of around 30 % have been described for various transporters 
[126, 134, 139, 204, 205]. However, several of these transporters are over expressed in 
their  native  host.  Further,  Hsmr  has  a  highly  biased  amino  acid  composition  and 
published  values  for  other  SMR  proteins  also  suggest  very  low  overexpression  [42, 
194]. 
 
4. 4 Optimization of Hsmr protein purification 
Protein purification is achieved as detailed in the material and methods section. Briefly, 
the plasma membrane is collected, Hsmr solubilised by detergent and bound to a nickel 
affinity chromatography column via its hexahistag. Solubilisation of Hsmr is generally 
achieved using 1 % DDM, as previously described for all SMR proteins. However, the 
buffer contains 2 M NaCl as Hsmr is a halophilic protein from the extreme halophile H. 
salinarium. This high salt concentration was chosen based on the general observation 
that halophilic proteins denature below 1 M salt, and more specifically that Hsmr can 
bind the substrate TPP
+ with maximal affinity at a minimum of 2 M NaCl [28, 206]. In 
vitro and in vivo produced Hsmr can be successfully purified under these conditions. 
Hsmr is eluted in 0.1 % DDM, a concentration roughly five times above the DDM cmc. 
However, multiple bands on SDS-PAGE and western blots, for examples see figure 
21B,  suggest  either  residual  protein  contaminants  or  SDS  resistant  inconsistent 
oligomerisation behavior. Additionally, time dependent aggregation is visible as a pellet 
after slow centrifugation. Therefore, optimization of Hsmr purification conditions with 
regard to protein purity and stability were sought.  
 
4. 4. 1 Ion exchange chromatography (IEX) 
Particularly before the advent of IMAC, IEX was widely used for protein purification 
and SEC as final purification step [207]. Unfortunately, ion exchange chromatography 
is  a  poor  choice  for  halophilic  proteins  since  it  requires  the  absence  of  salt  in  the 
beginning of the purification process and low salt concentrations during the majority of 
the  process.  However,  it  has  been  reported  that  many  halophilic  proteins,  including 
membrane  proteins,  can  maintain  their  native  fold  in  the  absence  of  salt  and  only 
activity and stability are compromised [79, 80]. Due to the acidic pI of Hsmr, an anion 
exchange column was used for Hsmr purification. In the absence of salt, the highly 
negatively charged Hsmr should bind tightly to the chosen anion exchanger together 
with  all  negatively  charged  contaminants.  Following  sample  loading  the  column  is 
washed with no salt buffer. Elution utilizes for differential elution a salt gradient. A 
typical chromatogram is seen in figure 24. 
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Figure  24.  Anion  exchange  chromatography  of  Hsmr  after  IMAC.  An  anion  exchange 
column was used to investigate the possibility of improving Hsmr purity after IMAC. Column 
loading was completed after less than 2 CV and washes with no salt buffer continued up to 10 
CV, as can be seen from the red conductivity trace. Protein elution was initiated with a gradient 
to  0.5  M  NaCl  over  15  CV.  During  column  loading,  an  increase  in  absorption  at  280  nm 
indicates that imidazole traces and potentially also net positively charged proteins are washed 
through. During the wash process, nonspecifically bound, net positively charged proteins are 
eluted. The gradient elutes the vast majority of protein in one broad peak with two shoulders.  
 
Not all material loaded binds to the anion exchange chromatography column. 6 % of the 
material contributing to the A280 absorption elute during binding and wash steps. This 
material includes imidazole and possibly contaminating proteins. However, since less 
than 6 % of contamination can be removed using  IEX, the protein aggregation and 
inactivation risks associated with low salt concentrations are not warranted.  
It  can  be  concluded  that  traces  of  other  proteins  are  present  in  Hsmr  samples  after 
IMAC. However, only a small amount (< 6 %) can be removed using ion exchange 
chromatography  and  thus  does  not  warrant  the  risk  of  protein  aggregation  and 
deactivation due to low salt concentrations. 
 
4. 4. 2 Size exclusion chromatography 
SEC  was  evaluated  as  possible  further  purification  method.  SEC  of  Hsmr  was 
performed in the presence of 2 M NaCl. The separation is based on the hydrodynamic 
radius  of  a  molecule,  the  so  called  Stokes  radius  [208].  For  globular  proteins  the 
separation is also approximately by molecular weight. A typical separation profile of 
Hsmr is shown in figure 25 A.  
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Figure 25. Gel filtration of Hsmr to improve sample homogeneity, assess molecular weight 
of Hsmr + micelle and test the effect of a low salt buffer. A) Hsmr in 0.1 % DDM and 
standard buffer (2 M NaCl, 15 mM NaxHxPO4, pH 8.0, 300 mM imidazole) B) Hmsr in 0.1 % 
DDM and low salt buffer (10 mM NaCl, 15 mM NaxHxPO4, pH 8.0). For the gel filtration run, 
standard buffer without imidazole and low salt buffer were used respectively. The gel filtration 
column was packed with Superose 12 medium. The calibration results are indicated below each 
trace. The void volume (VV) was determined using blue dextran 2000 and the total volume 
(TV) was measured using acetone. Peaks close to the total volume arise from imidazole and 
detergent molecules.  
 
SEC of membrane proteins enables a rough molecular weight estimation of the protein-
micelle complex, provided the column was calibrated with suitable standards [208]. The 
column used here was calibrated as described by Cohen et al. [177]. 
 
detergent  elution  volume 
in mL 
Rs in Å  MW  of  PDC  in 
Da 
       
DDM  39.30  4.57  136279.8 
low salt DDM  39.36  4.56  134913.3 
Table 18. Summary of the SEC data obtained for Hsmr. The corresponding gel filtration 
traces can be seen in figure 25. Stoke’s radii and molecular weights were calculated using a 
calibration curve.  
 
In figure 25A, the SEC chromatogram of Hsmr under high salt conditions reveals a peak 
in the VV which must arise from large aggregates (> 440 kDa), a peak centered roughly 
at  136  kDa  and  a  small  peak  close  to  the  total  volume  which  arises  from  DDM 
molecules and imidazole. Since a single broad peak is observed in the useful volume 
range, SEC does not separate Hsmr and possible contaminating proteins. The peak at 
136 kDa arises from the complex of Hsmr + DDM micelle. Expected molecular weights 
of this complex are listed in table 19. A molecular weight of 136 kDa suggests either 
that Hsmr can form multimers larger than tetramers, or that Hsmr + DDM micelles 
contain more than 50 kDa DDM, or does not obey the assumption of the behavior of an 
ideal globular protein. This highlights the shortcomings of SEC to estimate membrane 
protein molecular weights, and highlights the problem of Hsmr aggregation observed in 
standard high salt buffer with 0.1 % DDM.  Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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oligomeric state  calculated  Hsmr 
molecular 
weight (kDa) 
estimated  DDM 
micelle  size 
(kDa) 
estimated  total  molecular 
weight  of  Hsmr/micelle 
complex (kDa) 
monomer  14.526  50  65 
dimer  29.052  50  79 
trimer  43.578  50  94 
tetramer  58.104  50  108 
Table 19. Hypothetical molecular weights of Hsmr + micelle complexes for various Hsmr 
oligomeric states. Hsmr molecular weight as calculated from the sequence using ProtParm 
[209] and DDM micelle size was calculated from its tabulated aggregation number [210]. 
 
Since  some  halophilic  proteins  such  as  bacteriorhodopsin  from  Halobacterium 
salinarium are known to survive low salt conditions unharmed [211], this was assessed 
for  Hsmr  in  figure  25B.  The  ability  to  work  in  low  salt  buffers  would  be  highly 
beneficial for most biochemical and NMR investigations. Hsmr again eluted as a single 
broad peak indicating that low salt concentrations (10 mM NaCl) did not affect the 
oligomerisation  behavior  of  Hsmr.  However,  the  precise  molecular  weight  and 
oligomerisation state could not be determined. 
 
Hsmr in standard high salt buffer has a lower Hsmr + micelle molecular weight and a 
better separation of aggregates from soluble protein than Hsmr in low salt buffer. Hsmr 
in low salt buffer has a more favorable ratio between aggregate peak and soluble protein 
peak. However, this is likely due to the continuum of Hsmr aggregation. The estimated 
molecular weight of Hsmr at low salt concentrations is around 135 kDa. Neither buffer 
system offers satisfactory protein stability. Oligomerisation of Hsmr is not surprising as 
previously judged as stabilization feature in halophiles [78]. SDS resistant oligomers 
and even unspecific aggregation in the presence of SDS has previously been reported 
for several proteins [212-216] and more specifically has been reported for TBsmr [146] 
and Hsmr [28]. A problem highlighted by these investigations is the time dependent 
instability of Hsmr which is aggravated by freeze-thawing.  
 
4. 5 SDS-PAGE and MALDI-MS of Hsmr to assess protein purity 
Generally, SDS-PAGE in combination with Coomassie staining is used to assess the 
purity of a protein preparation. For SMR proteins, the occurrence of multiple bands due 
to SDS resistant oligomerisation and exchange between these has been reported [28, 
146]. Accordingly, the SDS-PAGE seen in figure 26, which exhibits several bands at 
multimer molecular weights but not at the monomer molecular weight, does not give a 
conclusive  answer  regarding  purity.  However,  the  band  pattern  was  reproducible 
between preparations and identical to the pattern seen for in vitro transcribed Hsmr. 
Furthermore, western blots of Hsmr produced in vitro showed an identical pattern and 
smearing between states, see figure 21, endorsing the idea that the pattern is due to 
native Hsmr.  
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Figure  26.  Hsmr  in  vivo  produced,  purified  by  IMAC  in  the  presence  of  DDM  and 
separated by SDS-PAGE. The gel exhibits distinct bands for Hsmr at a concentration of ~ 0.7 
mg/mL  at  dimer,  trimer,  tetramer  and  undefined  higher  molecular  weight,  as  indicated  by 
arrows. 
 
To further investigate the purity of the in vivo produced Hsmr, MALDI-TOF MS was 
employed. The sample was dialyzed to remove as much NaCl as possible and the total 
mass was determined, see figure 27. Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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Figure 27. MALDI-TOF MS of in vivo produced Hsmr. The sample contained ~ 0.7 mg/mL 
Hsmr and was dialysed in 10 mM NaCl, 15 mM NaxHxPO4, pH 8.0, 0.1 % DDM to reduce the 
salt concentration. A) The spectrum shows a pure protein preparation with a two major peaks 
around  the  expected  molecular  weight  of  14526  Da  and  at  the  molecular  weight  of 
Hsmr+formylation. The spectrum was not calibrated. B) Tryptic digest of Hsmr at ~ 0.2 mg/mL 
dialysed into 25 mM ammonium bicarbonate, pH 8.0, < 0.1 % DDM, measured with internal 
calibration. Eight fragments could be detected and assigned to Hsmr, see table 21. 
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The protein preparations examined by SDS-PAGE in figure 26 and MALDI-TOF MS in 
figures  27  are  identical.  SDS-PAGE  clearly  exhibits  several  high  molecular  weight 
bands, including one around 29 kDa. A protein of 29 kDa was not detected by MALDI-
TOF MS, nor multiplies charged peaks for hypothetical proteins of higher molecular 
weight. Generally, MALDI-TOF MS is thought to be a technique that should be able to 
detect  even  small  amounts  of  soluble  protein  contaminants.  From  this,  it  can  be 
concluded that in vivo produced Hsmr can be successfully purified with a single step 
IMAC purification protocol. 
 
MALDI-TOF MS and tryptic digestion followed by MALDI-TOF MS of a different 
Hsmr sample verified the initial conclusion that Hsmr produced in vivo is pure and also 
confirmed that Hsmr is present in its formylated and unformylated form. The second 
MS  investigation  of  Hsmr  also  used  internal  calibration  and  verified  the  predicted 
molecular weight of 14526 Da, see table 20.  
 
  M+H (m/z) 
   
measurement 1  14526.20 
measurement 2  14528.17 
measurement 3  14525.55 
average  14526.64 
Std  1.36 
calculated  14526.5 
Table 20. Hsmr total mass investigated by MALDI-TOF MS. Hsmr at ~ 0.2 mg/mL dialysed 
into 25 mM ammonium bicarbonate, pH 8.0, < 0.1 % DDM, measured with internal calibration. 
 
Tryptic digestion and MALDI-TOF MS identified a total of 8 different peptides, the 
specific cleavages and 5 unspecific cleavages arising from sample instability in low salt 
buffers, see table 21 and figure 27B . 
 
M+H (m/z)  sequence 
   
841.4037  HHHHHH 
1055.5104  VDHHHHHH 
1126.5497  AVDHHHHHH 
1213.5951  NSAVDHHHHHH 
1813.5951  EEDLNSAVDHHHHHH 
2127.0797  LISEEDLNSAVDHHHHHH 
2233.2869  MHPYAYLAAAIAAEVAGTTALK 
2261.2889  Formyl-
MHPYAYLAAAIAAEVAGTTALK 
Table 21. Hsmr tryptic digest investigated by MALDI-TOF MS. Highlighted are detected 
unspecific  breakages  (grey)  and  the  observed  specific  tryptic  fragments  (black).  Only  two 
trypsin sites are situated outside the predicted TMS and only these hydrophilic fragments are 
detected. 
 
In  conclusion,  IMAC  provides  pure  in  vivo  produced  Hsmr.  The  additional  bands 
observed  by  SDS-PAGE  and  western  blotting  of  Hsmr  arise  from  different  SDS 
resistant Hsmr oligomers and exchange between these oligomers. In a next step time 
stability of Hsmr needs to be improved and this is attempted below. 
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4. 6 Optimization of Hsmr time stability in detergent 
Long-term  stability  of  protein  in  detergent  solution  is  a  requirement  for  most 
biochemical methods. In particular, this is true for solution state NMR studies which 
require protein stability and monodispersity for several weeks at elevated temperatures. 
The  major  determinant  of  membrane  protein  stability  in  solution  is  the  choice  of 
detergent. Here, a selection of the detergents used in chapter 1 was assessed. The choice 
was narrowed to DDM, DPC, LPPG, OG and SDS. Nonionic detergents OG and DDM 
with 5 % glycerol, zwitterionic detergent DPC, ionic detergent SDS and single chain 
lipid  LPPG  were  selected  for  investigation.  All  of  these  detergents  have  been  used 
successfully for the extraction and reconstitution of several membrane proteins, as well 
as their analysis by NMR and x-ray crystallography [112, 217]. The additive glycerol 
has  been  shown  to  enhance  membrane  protein  solubility  in  numerous  cases  [218]. 
Additionally, DPC, LPPG and SDS proved to be suitable as detergents for Smr, the 
Staphylococcus  aureus  SMR  protein,  in  solution  state  NMR  experiments  [112]. 
Additionally, the use of glycerol as additive was examined. Glycerol is suggested to 
have salting out effects and therefore reduce the NaCl requirement of halophiles [78] 
and in general glycerol is thought to promote membrane protein stability [218, 219]. 
 
 
 
Figure  28.  Gel  filtration  of  Hsmr  to  assess  protein  stability  in  various  buffers.  After 
detergent exchange on the IMAC column, Hsmr was eluted in standard buffer (2 M NaCl, 15 
mM NaxHxPO4, pH 8.0, 300 mM imidazole) in the new detergent. For SDS samples, the SDS 
buffer (300 mM NaCl, 15 mM Tris, pH 8.0, 300 mM imidazole) was used. A) 0.1 % DDM + 5 
% glycerol, B) 0.1% DPC, C) 0.1% LPPG, D) 0.41 % SDS. Samples were stored at 4 °C and 
run on the gel filtration at 4 °C at day 2 (black trace) and day 10 (red trace). SDS incubations 
and gel filtration runs were conducted at RT. For gel filtration runs standard buffer (2 M NaCl, 
15 mM NaxHxPO4, pH 8.0) was used. For SDS experiments, an alternative buffer was used (300 
mM NaCl, 15 mM Tris, pH 8.0). The gel filtration column was home-made and packed with 
Superose  12  medium.  The  calibration  results  are  indicated  below  each  trace.  The  VV  was 
determined using blue dextran 2000 and the TV was measured using acetone.  Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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detergent  elution  volume 
in mL 
Rs in Å  MW  of  PDC  in 
Da 
       
DDM + glycerol  37.02  5.1  199870.2 
LPPG  38.18  4.83  164486.8 
OG  -  -  - 
DPC  39.49  4.53  131999.4 
SDS  39.50  4.53  131777.9 
Table 22. Summary of the SEC data obtained for Hsmr. The corresponding gel filtration 
traces can be seen in figure 28. Stoke’s radii and molecular weights were calculated using a 
calibration curve.  
 
Hsmr was purified using; 1 % DDM as solubilising detergent, standard high salt buffer, 
and purified on an IMAC column using standard wash buffer with 0.1 % DDM and 30 
mM imidazole. The detergent was exchanged on the IMAC column in the absence of 
imidazole to avoid protein elution. Hsmr, in the presence of OG, was eluted as visible 
aggregates  and  not  investigated  further.  In  all  other  cases,  Hsmr  was  evaluated 
regarding aggregation by SEC after 2 and 10 days. Protein samples were stored at 4 °C 
and in the case of SDS containing buffers at RT. Figure 28 shows the two time traces 
for each detergent. The largest difference in quantity of aggregation was observed for 
Hsmr  stored  in  the  presence  of  0.1  %  DDM  with  5  %  glycerol.  Therefore,  no 
improvement over the previously tested condition of 0.1 % DDM, see figure 25, could 
be achieved. Despite being a suitable detergent for the solubilisation of SMR proteins 
from the plasma membrane, DDM is not suitable for Hsmr storage. Changes between 
day 2 and day 10 are small for LPPG, DPC and SDS. In fact, the two time point traces 
for Hsmr in LPPG overlap perfectly. The different expected micelle sizes (50 kDa for 
DDM, 19 kDa for DPC, 18 kDa for SDS, unknown for LPPG [210, 220, 221]) may give 
rise to the differences in calculated molecular weights, see table 22, ranging from 132 to 
200 kDa. The detergents with the smallest micelle size give, as expected, the lowest 
molecular weight estimates. However, if the assumed micelle molecular weights are 
correct, the calculated PDC molecular weight cannot be explained by this alone.  In 
other words, the PDC of DDM and SDS have a molecular weight difference of around 
68 kDa. This cannot arise solely from the expected molecular weight difference of the 
micelles of only 32 kDa. 
Additionally,  there  are  substantial  differences  with  regard  to  the  extent  of  protein 
aggregation. The least aggregation is detected in buffers containing SDS, followed by 
DPC. Both detergents seem to be suitable for maintaining Hsmr stably in solution. SDS 
is known as a highly denaturing and α-helix inducing detergent and is generally used to 
unfold proteins, although SDS-PAGE of Hsmr showed that SDS is not able to unfold 
Hsmr  or  even  break  oligomerisation.  SDS  is  an  unconventional  detergent  for 
maintaining proteins in their native conformation. However, SDS has been used in a 
few cases for protein structure investigations by NMR and x-ray crystallography [222]. 
 
In  conclusion,  DDM,  DPC  and  SDS  are  evaluated  further  with  regards  to  their 
suitability for reconstitution and used for techniques that require Hsmr in the solution 
state. 
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4. 7 Reconstitution of Hsmr 
4. 7. 1 Introduction to reconstitution optimization 
Transport  proteins  like  SMR  proteins  can  only  be  fully  functional  in  a  vectorial 
environment. To assess the native structure and transport capability of SMR proteins, 
these need to be investigated when incorporated in a membrane. To obtain a highly 
controlled environment, in vivo expressed Hsmr is removed from the plasma membrane. 
Both in vivo and in vitro produced protein can then be reconstituted into an artificial 
membrane,  which  gives  complete  control  over  the  lipid  composition,  vesicle  size, 
proteins  present  and  buffering  of  each  compartment.  Reconstitution  of  membrane 
proteins is commonly achieved by one of three methods: mechanical means such as 
freeze-thawing  and  sonication,  dissolving  protein  and  lipid  in  organic  solvent  with 
subsequent removal of the solvent, or detergent mediated procedures.  
A  literature  review  regarding  the  most  commonly  used  and  promising  methods 
narrowed  the  choice  to  methods  using  solvents  or  detergents.  However,  transport 
proteins are mostly reconstituted using detergent based methods.  
Of importance for the reconstitution process are protein stability and activity as well as 
uniform  protein  incorporation  and  orientation.  Stability  and  activity  of  membrane 
proteins are mainly governed by the detergent choice and a homogeneous incorporation 
and  preferential  orientation  in  proteoliposomes.  Directional  protein  insertion  can  be 
achieved  by  direct  incorporation  of  the  protein  into  preformed  liposomes.  Thus, 
transporters  are  preferentially  reconstituted  using  preformed  liposomes,  rather  than 
solubilised  lipids.  Successful  reconstitution  can  be  monitored  using  discontinuous 
density gradient centrifugation to separate empty liposomes and proteoliposomes with 
different protein:lipid ratios [223]. Further characterization of proteoliposomes can be 
achieved  by  freeze  fracture  electron  microscopy.  This  method  allows  the  protein 
distribution to be assessed as well as monitoring of proteoliposome homogeneity and 
protein aggregation. 
 
Solvent-based reconstitution has been used successfully for example for diacylglycerol 
kinase and β–D-galactoside transport protein, using evaporation and dialysis as solvent 
removal methods [224]. However, the methodology has fallen out of favor as only few 
proteins are solvent resistant and show native fold and activity after this procedure.  
With detergent-based reconstitution, protein incorporation into liposomes is initiated by 
decreasing  the  detergent  concentration.  This  can  be  achieved  using  dialysis,  gel 
chromatography, dilution or hydrophobic absorption. The method of choice depends 
mainly on detergent properties such as CMC and hydrophobicity but also on the desired 
speed  of  reconstitution  and  completeness  of  detergent  removal.  The  most  rapid 
detergent removal is achieved using gel filtration. However, detergents with a low CMC 
can  only  be  removed  efficiently  by  hydrophobic  adsorption,  which  is  also  the  best 
method  for  almost  complete  detergent  removal.  The  speed  of  reconstitution  can  be 
effectively controlled using dialysis and hydrophobic adsorption. An excellent review 
on biobead based reconstitution was written by Rigaud et al. [225].  
 
Besides choosing an appropriate methodology for Hsmr reconstitution, the choice of 
lipids  and  detergents  is  of  prime  importance.  The  choice  of  detergents  was  already 
narrowed  down  during  the  experiments  investigating  Hsmr  solubility  and 
monodispersity (Chapter 3 and 4.6). On one hand the selection of lipids was guided by 
trying to create as native an environment for Hsmr as possible but, on the other hand to 
keep the lipid composition as simple as possible. The native lipid composition of H. 
salinarium  and  E.  coli  are  listed  in  table  23.  The  membrane  lipid  composition  of 
archeae,  like  H.  salinarium,  is  very  different  from  prokaryotic  and  eukaryotic Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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membranes. Archeal lipids are built from isoprenoid units and linked to the glycerol 
backbone with an ether linkage. Nevertheless, previous studies on Hsmr have shown 
that  it  exhibits  residual  functionality  when  heterologously  expressed  in  E.  coli  and 
therefore the E. coli lipid composition can serve as a guide for the selection of suitable 
liposome lipids [28]. 
 
Escherichia coli lipid composition [226] 
head group  %  chain  length  and 
unsaturation 
% 
PE  80.4  12:0   4.0  
PG  14.9  14:0   3.5  
CL  1.3  16:0   26.5  
PS  not specified   16:1   34.1 
LE  3.4   17   not specified  
    18:1  31.9 
       
       
Halobacterium salinarium lipid composition [88, 226, 227]  
head group  %  chain length   % 
non-polar  7  C20  not specified 
PG  12  C40  not specified 
PGP-Me  not specified     
PGS  not specified     
TGD-1  not specified     
S-TGD-1  not specified     
PA  not specified     
Table 23. Lipid composition of E. coli and H. salinarium. (PE , phosphatidylglycerol (PG), 
cardiolipin (CL), phosphatidylserine (PS), lysophosphatidylethanolamine (LE), 
phosphatidylglycerolmethylphosphate (PGP-Me), phosphatidylglycerosulfate (PGS), 
galactose1,6-mannose1,2-glucose1,1-sn-2,3-diphytanylglycerol (TGD-1), 3-HSO-galactose1,6-
mannose1,2-glucose1,1-sn-2,3-diphytanylglycerol (S-TGD-1), PA (phosphatidic acid)) 
 
4. 7. 2 Hsmr reconstitution screen  
Initially,  a  total  E.  coli  lipid  mixture  was  tested,  as  this  most  closely  mimics  the 
conditions found in the heterologous expression host. These first attempts utilized DDM 
to solubilise  total E. coli lipids, and biobeads to catalyze the fast and efficient detergent 
removal.  These  reconstitutions  at  moderate  protein  to  lipid  mol  ratios of  1:800  and 
1:100 were successful as judged by discontinuous density gradient centrifugation and 
freeze fracture electron microscopy, shown in figure 29.  
 
Figure 29. Hsmr in DDM reconstituted into E. coli total lipids. Initial Hsmr reconstitution 
utilized Hsmr solubilised in DDM and E. coli total lipid liposomes saturated with DDM as 
judged  by  A590  measurements.  As  successful  examples,  protein:lipid  mol:mol  reconstitution 
ratios 1:800 A) and 1:100 B) are shown.  Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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After these initial successes, the aim was not only to find a simpler, more reproducible 
lipid combination, but also to increase the protein:lipid mol ratio further. Reducing the 
lipid content of samples is important for solid-state NMR experiments as the sample 
volume is limited by the rotor. Only at protein:lipid mol ratios of 1:100 or higher are 
sufficient numbers of spins available for detection of a suitable NMR signal. To fulfill 
this dual pretence a large variety of lipids was tested, alone and in combination with 
other lipids. Lipid properties, such as chain length, were matched in lipid mixtures and 
only bilayer forming lipids were tested singly. An overview is given in table 24. Figure 
29  shows  examples  of  selected  positive  results  from  sucrose  density  gradient 
centrifugation. Only samples that indicated successful incorporation at this step were 
evaluated  further  by  freeze  fracture  electron  microscopy.  Unfortunately,  many  false 
positives due to protein aggregation were obtained, see figure 30. The success scoring in 
table 24 is based on the results of sucrose density gradient centrifugation and freeze 
fracture electron microscopy.  Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
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detergent  lipid  protein:lipid 
mol ratio 
reconstitution 
method 
success  method 
           
DDM  E.coli lipids  1:800  rapid dilution  -   
DDM  E.coli lipids  1:800  biobeads  ++   
DDM  E.coli lipids  1:250  biobeads  -  A 
DDM  DOPC  1:200  biobeads  +-   
DDM  E. coli lipids  1:200  biobeads  ++   
DDM  DMPC  1:100  biobeads  -   
DDM  DMPC  1:100  biobeads  -   
DDM  POPE/POPG/Cardiolipin 
(75/20/5) 
1:100  biobeads  -   
DDM  POPC/POPG 5/1  1:100  biobeads  -   
DDM  POPE/POPG 3/1  1:100  biobeads  -   
DDM  E. coli lipids  1:100  biobeads  +++   
DDM  DMPC  1:75  biobeads  -   
DDM  E. coli lipids  1:75  biobeads  +-   
DDM  PML  1:75  biobeads  -   
DDM  POPC/POPG (5/1)  1:50  biobeads  -   
DDM  DMPC  1:50  biobeads  -   
DDM  DOPC  1:50  rapid dilution  -  B 
DDM  DOPC  1:28  dialysis  -  C 
           
DPC  DOPC  1:500  dialysis  -   
DPC  DOPC  1:500  dialysis  -   
DPC  E.coli lipids  1:250  dialysis  -  A 
DPC  E.coli lipids  1:100  biobeads  -   
DPC  POPC/POPG (5/1)  1:50  biobeads  -   
DPC  DOPC  1:42  dialysis  -  C 
           
OG  E.coli lipids  1:250  biobeads  -  A 
OG  Archaeal lipid (16:0)  1:100  biobeads  -   
OG  DOPC  1:50  dialysis  -  C 
           
SDS  DMPC  1:75  biobeads  -   
SDS  DOPC  1:75  biobeads  -   
SDS  PML  1:75  biobeads  -   
SDS  Archaeal lipids  1:75  biobeads  -   
SDS  POPC/PG (5/1)  1:75  biobeads  -   
SDS  E.coli lipids  1:75  biobeads  -   
           
Triton X-100  DMPC  1:75  biobeads  +-   
Triton X-100  E.coli lipids  1:75  biobeads  +-   
Triton X-100  PML  1:75  biobeads  -   
           
Organic 
solvent 
E.coli lipids  1:800  -  -  D 
Table 24. Overview of attempted reconstitution conditions. Tested conditions are grouped 
according to the utilized detergent, with increasing detergent/lipid ratio. The success is rated 
from +++ for uniform incorporation at a density expected for the utilized ratio without protein 
aggregation  to  –  for  failure  to  incorporate  significant  amounts  of  protein  and  protein 
aggregation. If more than one band was observed during density gradient centrifugation, only 
the lowest was investigated further by freeze fracture electron microscopy. Conditions marked 
with A) used liposome solutions without detergent pre-softening. Conditions marked with B) 
were tested using the rapid dilution methodology [165]. Conditions marked with C) were tested 
on an IMAC column [164], attempting the reconstitution of immobilized protein. Conditions 
marked  with  D)  utilized  an  organic  solvent  based  reconstitution  method  [228].  (1,2-
Dimyristoyl-sn-phosphatidylcholine  (DMPC),  1,2-Dioleoyl-sn-phosphatidylcholine  (DOPC), 
purple membrane lipids (PML), 1-palmitoyl-2-Oleoyl-sn-phosphatidylethanolamine (POPE), 1-
palmitoyl-2-Oleoyl-sn-phosphatidylglycerol (POPG)). Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
reconstitution conditions 
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Figure 30. Examples of reconstitution trials – two step selection using density gradients 
and freeze fracture imaging to detect successful reconstitutions. A) Hsmr in 0.41 % SDS 
reconstituted into PML using SDS (1:75 mol:mol ratio) , B) Hsmr in SDS reconstituted into 
POPC/PG using SDS (1:75 mol:mol ratio), C) Hsmr in 0.1 % DDM reconstituted into PML 
using DDM (1:75 mol:mol ratio), D) Hsmr in 0.1 % DDM reconstituted into DMPC using 
DDM  (1:75  mol:mol  ratio).  Standard  buffer  was  used  for  all  reconstitution  trials  with  the 
exception of SDS containing samples. Chapter 4 – Large scale in vivo Hsmr preparation and optimization of detergent and 
reconstitution conditions 
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The result after this extensive screen was sobering as the starting conditions were best. 
The lowest protein:lipid mol ratio achievable was 1:100 and DDM with E. coli total 
lipids proved to be the best detergent/lipid combination. Additionally, hopes to obtain 
directional insertion of Hsmr could not be realized. Directed incorporation requires the 
use of saturated liposomes instead of solubilised lipids [229]. Saturated lipids, defined 
as Rsat, were obtained initially by experimental determination [143], later by utilizing 
the theory developed by Lichtenberg et al. [230]. However, the dilute Hsmr protein 
solutions  that  were  eluted  from  the  IMAC  column  contributed  sufficient  detergent 
molecules  to  push  protein-detergent-lipid  mixtures  from  the  Rsat  value  over  the  Rsol 
threshold, leading to solubilised lipids. 
 
In conclusion, Hsmr can be reconstituted successfully into E. coli total lipid liposomes. 
The  protein:lipid  mol  ratio  attainable,  1:100,  was  sufficient  for  solid  state  NMR 
experiments on Hsmr. 
 
4. 8 Conclusion 
Hsmr can be purified to a high degree using IMAC as a single step. Detergents suitable 
for maintaining Hsmr long-term stability are DPC and SDS. DDM is suitable for short-
term storage and reconstitution. Successful incorporation of Hsmr into liposomes could 
be  achieved  at  a  1:100  protein:lipid  mol  ratio  using  DDM,  E.  coli  total  lipids  and 
hydrophobic absorption based detergent removal. Hsmr can be successfully prepared 
both for solution-state methods and for solid-state NMR. 
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Chapter 5 - Hsmr oligomerisation state 
 
5.1 Introduction 
5. 1. 1 Introduction to oligomerisation 
Protein characterisation naturally involves the assessment of a proteins oligomeric state 
and functional stoichiometry. Particularly important is the knowledge of the strength of 
the oligomerisation as it may have a regulatory role. Furthermore, determination of the 
interaction  surface  as  either  isologous  or  heterologous  can  limit  the  type  of 
oligomerisation, as these are possible even within homooligomers. Interestingly, it has 
emerged in recent years that only around 1/5
th of all proteins are monomeric and that 
dimers are the most common quaternary structure. Additionally, it was observed that 79 
%  of  all  oligomers  are  homooligomers  and  these  are  almost  exclusively  symmetric 
[231]. Notable exceptions to this are membrane proteins, which are embedded in an 
asymmetric  membrane  environment  and  therefore  limited  with  respect  to  possible 
symmetry  axes.  Local  asymmetry,  associated  often  with  half-of-site  reactivity,  is 
commonly found as well as a reciprocating mechanism. An interesting example of local 
asymmetry and proposed  half-of-site reactivity is haemolysin B [232]. 
 AcrAB [18] and the F1F0 ATP synthase [233, 234] are prominent examples for the 
reciprocating  mechanism.  However,  the  reasons  for  the  prevalence  of  oligomeric 
proteins are still under investigation. Currently it is thought that the key benefits of 
oligomerisation are: faster and less error prone folding of smaller proteins, better error 
control of the final protein, possibility for regulation at the level of protein assembly, 
greater stability and capability for a variety of functions [231, 235].  
 
5. 1. 2 Introduction to Hsmr oligomerisation 
Despite extensive investigations of the SMP protein [25] EmrE, its oligomerisation state 
could not be determined unequivocally, although most evidence suggests that EmrE is a 
functional dimer [27, 35, 40]. The oligomeric state of full length Hsmr has not been 
evaluated.  Instead,  Rath  et  al.  used synthetic  peptides  of  TMS  1 to  4 to  assess  the 
oligomerisation behaviour of Hsmr. They concluded that Hsmr can form either dimers 
or tetramers using two distinct interaction surfaces [70]. SDS-PAGE and SEC in this 
study  suggest  that  Hsmr  in  detergent  micelles  is  in  a  dynamic  equilibrium  between 
dimeric, trimeric, tetrameric and higher oligomeric states, but neither method is ideally 
suited for the investigation of oligomeric species. During SDS-PAGE, ideally all non-
covalent  interactions  are  broken  and  polypeptides  migrate  solely  based  on  their 
molecular  weight.  However,  several  cases  of  SDS  resistant  multimers  have  been 
reported [236]. SEC separates molecular complexes based on their Stokes radius, which 
enables an estimate of the molecular weight only if the protein-detergent complex is 
approximately globular [177]. Additionally, the protein oligomeric state can only be 
derived if the amount of bound detergent is known [173]. To investigate the intriguing 
and  elusive  oligomeric  state  of  solubilised  full  length  Hsmr,  three  methods  were 
employed: Native PAGE and AUC are typically used to obtain information regarding 
protein oligomeric states and the Kds of these protein-protein interactions. In addition 
the new MS technique LILBID was used here.  
 
5. 2 Analytical ultracentrifugation 
One of the classical biochemistry techniques, the use of analytical ultracentrifugation to 
elucidate the mass, shape and stoichiometry of proteins, dates back to the 1930s [237]. 
More  recently,  methods  have  been  developed  that  enable  also  the  investigation  of 
membrane proteins [174, 238]. The key benefits of analytical ultracentrifugation are the 
possibility for real time observation of sedimentation, and that both hydrodynamic and Chapter 5 - Hsmr oligomerisation state 
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thermodynamic  data  can  be  collected  using  either  sedimentation  velocity  or 
sedimentation  equilibrium  experiments  respectively.  Sedimentation  velocity 
experiments  provide  combined  molecular  mass  and  shape  information,  yielding  the 
sedimentation coefficient S. During the experiment a strong centrifugal field is applied 
and a sedimentation boundary is formed which moves with time to the cell bottom. 
Absorption scans determine the rate of boundary movement and broadening. The thus 
determined  experimental  S  values  need  to  be  reported  as  S(temperature,buffer)  and  for 
comparison between experiments adjusted to S(20°C,water) [239]. In contrast sedimentation 
equilibrium data supplies solely molecular weight information and is performed at low 
centrifugal  fields.  This  enables  the  investigated  molecules  to  reach  an  equilibrium 
position where sedimentation and diffusion are balanced. The equilibrium concentration 
distribution is analysed to obtain the apparent molecular weight MWapp [239]. For the 
investigation of even weak protein-protein interactions of membrane proteins, analytical 
ultracentrifugation  is  proving  very  successful,  examples  include  the  multidrug 
transporter EmrE [35] and BmrA [173] as well as the receptor ErbB [240].  
 
5. 2. 1 Sedimentation velocity analysis of Hsmr 
Here, sedimentation velocity was used to aim at the identification of the number of 
discrete  Hsmr  species  and  the  Hsmr  oligomeric  state.  The  sedimentation  velocity 
experiments  can  answer  this  question  by  measuring  the  sedimentation  coefficients 
which are related to the molecular mass. However, if molecular weight information is 
sought, the frictional ratio of all species needs to be identical [176]. For Hsmr it is not 
known if this is true, and therefore only the experimental sedimentation coefficients 
S(temperature,  buffer)  and  the  number  of  discrete  species  are  calculated.  Sedimentation 
velocity  experiments  can  be  analysed  using  several  methods,  including  a  plot  of  ln 
radius  of  boundary  midpoint  against  time,  diffusion  corrected  analysis  (G(s)),  time 
derivative method (DCDT), fitting of the Lamm equation, equation 14 [239]. Here the 
model  dependent  continuous  sedimentation  coefficient  analysis,  c(s)  analysis,  which 
attempts to fit the experimental data to numeric solutions of the Lamm equation, was 
used. This analytical approach was chosen as it makes use of the whole sedimentation 
boundary and takes into account the effect of diffusion. It therefore provides a high-
resolution  determination  of  the  sample  homogeneity.  Furthermore,  even  if  the 
theoretical  assumption  of  ideal  sedimenting,  non-interacting  or  slow  interacting 
molecules (on the time-scale of the experiment) is not met; a valuable and valid average 
sedimentation coefficient can still be obtained. 
 
5. 2. 1. 1 Sedimentation velocity analysis of Hsmr in DDM 
As can be seen from figure 31A and more pronounced from the residuals analysis in 
figure 31B, the c(s)  analysis in the computer program Sedfit9.4 does not provide a 
satisfactory fit of the data. Possible reasons for this dissatisfactory result are the use of 
estimates for the frictional ratio and different frictional ratios for different oligomeric 
species. Buffer density, viscosity and Hsmr partial specific volume can be computed 
using the computer program Sednterp. The frictional ratio of the PDC and the partial 
specific volume of the PDC can only be estimated. Here a typical frictional ratio for 
globular  proteins  (f/fo  =  1.2)  and  the  calculated  Hsmr  partial  specific  volume  (υp  = 
0.7533  mL/g)  were  used  as  estimates  for  the  PDC.  Nevertheless,  in  figure  31C  the 
obtained sedimentation coefficient profile is depicted. The results should therefore be 
merely taken as a rough estimate of the sedimentation coefficient. A broad peak centred 
around 3.075 S, trailing to 16 S can be observed. The spike at 20 S is an analysis 
artefact.  The  sedimentation  coefficient  profile  suggests  that  the  sample  is  very 
inhomogeneous with a very broad size distribution around 15 S. The trace to higher Chapter 5 - Hsmr oligomerisation state 
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sedimentation coefficients probably arises from Hsmr aggregation in DDM, as already 
observed in chapter 4. From protein stability experiments, figure 25 and figure 28, it is 
known that DDM is not suitable for Hsmr long-term storage and aggregation occurs 
almost immediately. Below traces in figure 31A, the first 10-15 scans show a ladder-
like  or  two-steps  profile  which  indicates  a  fast  sedimenting  species  is  present.  It 
sediments quickly to the cell bottom, therefore a drop in the plateau after ~15 scans is 
detected. However, DPC at 4 °C is known to provide a more stable protein preparation 
with  little  aggregation.  In  order  to  further  investigate  the  native  oligomerisation 
behaviour  of  Hsmr  sedimentation  velocity,  experiments  in  DPC  at  4  °C  were  also 
conducted. 
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Figure 31. Sedimentation velocity of Hsmr in standard buffer and in the presence of 0.1 % 
DDM. A) Superimposed are experimental sedimentation profiles as individual data points and 
the fitted curves as lines from the c(s) analysis in Sedfit of Hsmr at 1.65 mg/mL in the presence 
of 0.1 % DDM. The last profile corresponds to 3 h 45 min sedimentation at 116444 g at 20 °C. 
B) Superimposed residuals between the experimental and fitted curves from A). C) c(s) analysis 
reveals one peak centred at 3.075 S with a large continuous trail to approximately 16 S. The 
spike at 20 S is a data analysis artefact. Chapter 5 - Hsmr oligomerisation state 
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5. 2. 1. 2 Sedimentation velocity analysis of Hsmr in DPC 
As can be seen from figure 32A and more pronounced from the residuals analysis in 
figure  32B  the  c(s)  analysis  in  the  computer  program  Sedfit9.4  of  Hsmr  in  DPC 
provides an acceptable fit of the data. The obtained sedimentation coefficient profile 
displayed in figure 32C, is shows a single peak centred at 1.5 S. A single peak centred 
at 1.5 S can be observed. The spike at 0.5 S is an analysis artefact. Here the absence of a 
two step profile indicates the absence of high molecular weight aggregates. The smaller 
S value for Hsmr in DPC indicates a lower oligomerisation state in DPC. Overall, the 
obtained sedimentation coefficient profile of Hsmr in DPC suggests that the sample is 
homogeneous  and  a  single  type  of  PDC  with  a  small  sedimentation  coefficient  is 
present.  
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Figure 32. Sedimentation velocity of Hsmr in standard buffer and in the presence of 0.1 % 
DPC. A) Superimposed are experimental sedimentation profiles as individual data points and 
the fitted curves as lines from the c(s) analysis in Sedfit of Hsmr at 2.0 mg/mL in the presence 
of 0.1 % DPC. The last profile corresponds to 8 h 15 min sedimentation at 116444 g at 4 °C. B) 
Superimposed differences between the experimental and fitted curves from A). C) c(s) analysis 
reveals one peak centred at 1.5 S. The spike at 0.5 S is a data analysis artefact. Chapter 5 - Hsmr oligomerisation state 
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5. 2. 2 Sedimentation equilibrium analysis of Hsmr 
In order to further investigate the native oligomerisation state of Hsmr and obtain the 
Hsmr  molecular  weight,  sedimentation  equilibrium  analysis  was  performed. 
Sedimentation  equilibrium  analysis  enables  the  measurement  of  the  PDC  molecular 
weight  [239].  The  contributions  of  the  detergent  micelle  to  the  measured  molecular 
weight  can  be  removed  using  several  approaches,  namely,  measurement  of  density 
increment, calculation of density increment by summation and density matching [241]. 
Currently, the most common approach, density matching, is also used here. Briefly, 
density matching requires the solvent to have the same density as the detergent. This 
renders  the  detergent  neutrally  buoyant  and  removes  its  contribution  to  the 
sedimentation behaviour of the PDC. However, the high salt content of the standard 
Hsmr buffer means that the buffer density (ρ=1.08055 g/mL) is already higher than the 
density of the detergent DPC (1/ υp = 1/0.937 mL/g = 1.067 g/mL) and thus cannot be 
density matched by adding D2O. Therefore, a buffer with a lower salt concentration 
needs to be used for sedimentation equilibrium experiments. The standard buffer with 
just 1 M NaCl has a density of ρ=1.04069 g/mL, which enables DPC to have neutral 
buoyancy at a concentration of 25 % D2O (ρ=1.067 g/mL). 
 
Figure 33. Initial analysis of Hsmr sedimentation equilibrium data using c(s) analysis. A 
single Hsmr sample in 1 M NaCl, 15 mM NaxHxPO4, pH 8.0 was diluted to a final concentration Chapter 5 - Hsmr oligomerisation state 
 
  70 
of 0.56 mg/mL with H2O and/or D2O. A) Hsmr in the presence of 15 % D2O, B) Hsmr in the 
presence of 25 % D2O was centrifuged at 18144 g.  
 
To  judge  the  data  quality,  sedimentation  equilibrium  data  is  first  analysed  by  c(s) 
analysis. A single Hsmr preparation was diluted to obtain 1 M NaCl, 15 mM NaxHxPO4, 
pH 8.0 with different H2O and/or D2O mixtures. A total of 4 samples with different D2O 
concentrations were analysed at two rotor speeds (8046 g, 18144 g) to attain 2 different 
equilibrium  positions  per  sample.  Unfortunately,  already  the  c(s)  analysis  revealed 
apparently inconsistent sample homogeneity, see figure 33. A possible reason for the 
different  apparent  number  of  sedimenting  species  and  differences  in  sample 
homogeneity lies in the effects of D2O and salt on halophilic proteins. In fact, it has 
been described that D2O has salting out effects like NaCl, and that both compounds can 
have  additive  effects  [78].  All  other  experimental  conditions  can  be  excluded  as  a 
source  for  inconsistencies  since  they  are  identical.  It  is  therefore  likely  that 
sedimentation  equilibrium  experiments  using  the  density  matching  approach  are  not 
feasible with Hsmr. 
 
5. 2. 3 Analytical ultracentrifugation summary 
Sedimentation velocity experiments revealed that Hsmr in DDM is unstable even at 
high salt concentrations and for short periods of time. Hsmr in DDM is found in a 
defined  but  broad  range  of  sedimentation  coefficients,  arising  from  a  continuum  of 
oligomerisation or aggregation states. In contrast, Hsmr is stable in DPC at high salt 
concentrations and a single highly populated species of Hsmr is detected. Under these 
conditions  Hsmr  is  predominantly  homogeneous.  The  sedimentation  equilibrium 
experiments performed in DPC at 1 M NaCl with different D2O concentrations. D2O 
and  NaCl  have  additive  effects  for  halophilic  proteins  and  thus  data  generated  at 
different D2O concentrations could not be compared. Therefore the Hsmr molecular 
weight and thus the oligomerisation state of Hsmr in DPC could not be determined. 
 
5. 3 BNPAGE 
BNPAGE is the native PAGE technique suitable for most membrane proteins. Unlike 
SDS-PAGE during native PAGE the investigated proteins are denatured neither during 
sample  preparation  nor  during  electrophoresis.  To  investigate  membrane  proteins  in 
their  native  state  in  solution  detergent  micelles  need  to  be  present.  The  blue  dye 
coomassie acts here as detergent, adds a molecular weight dependent charge shift, and 
reduces the risks of protein aggregation by providing a uniform charge. Unfortunately, 
BNPAGE also requires low salt concentrations to avoid protein stacking and sample 
heating [161]. Finally, to obtain a very accurate membrane protein molecular weight, 
the standard curve generated with soluble proteins needs to be modified according to the 
formula  described  by  Veenhoff  et  al.  [242].  In  the  past,  BNPAGE  has  been  used 
successfully for the determination of very weak protein-protein interactions mainly of 
mitochondrial membrane proteins.  
Here,  various  BNPAGE  recipes  [161]  [160],  NativePAGE™,  Novex®  System  from 
Invitrogen, various low salt concentrations and different detergents were tested. Figure 
34  depicts  a  typical  BNPAGE  of  Hsmr  and  soluble  proteins  as  molecular  weight 
standards.  
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Figure 34. BNPAGE of Hsmr. The soluble proteins A) BSA, B) ferritin and C) catalase were 
used as molecular weight marker. Hsmr was investigated in 15 mM Tris pH 8.0, > 0 M NaCl 
and D) 0.1 % DPC or E) 0.1 % DDM. This gradient gel was not successful in separating Hsmr. 
 
Despite avid testing, no conditions could be found for successfully electrophoresis of 
Hsmr.  It  has  been  reported  previously  that  not  all  proteins  can  be  investigated 
successfully by BNPAGE, even if the electrophoresis conditions are close to the native 
protein  environment.  Likely  reasons  for  the  failure  of  Hsmr  electrophoresis  by 
BNPAGE  are:  Hsmr  aggregation  due  to  extremely  low  salt  concentration  for  a 
halophillic  protein  and  potentially  poor  binding  of  the  anionic  dye  and  detergent 
coomassie to the highly acidic Hsmr. It was concluded that BNPAGE cannot be used to 
study the stoichiometry of solution-state Hsmr.  
 
5. 4 LILBID 
Laser induced liquid bead ion desorption is a novel MS technique which is capable of 
analysing ionic non-covalent macromolecular complexes. Briefly, solution droplets are 
injected  into  a  vacuum  chamber,  irradiated  at  the  frequency  of  water  stretching 
vibrations, and the ionic molecules which are released by the bursting droplets then 
analysed by MS. The technique has been established using a variety of biomolecules 
including DNA, soluble proteins and membrane proteins [181, 243]. With respect to this 
study,  the  relevant  LILBID  validation  used  F1F0-ATP  synthase  c-rings.  It  could  be 
shown that, using ultra soft ionization conditions, intact c-rings comprised of 11 to 15 
protomers can be observed with LILBID, though SDS-PAGE analysis denatured these 
oligomers [181]. For Hsmr, SDS resistant oligomers are well documented, with dimers 
being  the  smallest  oligomers  observed.  It  could  therefore  be  expected  that  LILBID 
enables  the  observation  of  the  native  Hsmr  oligomerisation  state.  Figure  35  shows 
LILBID spectra of Hsmr in three different detergents. Along the x – axis, molecules are 
separated according to their mass/charge ratio, and their abundance recorded along the y 
– axis.  
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Figure 35. LILBID measurement of Hsmr in different detergents. Hsmr was measured in 
the ultra soft ionisation mode after being dialysed into 15 mM Tris, pH 8.0 without detergent. 
The detergent concentrations given are therefore the upper limit. A) 5.6x10
-5 M Hsmr in < 0.1 
% DDM, B) 5.51x10
-5 M Hsmr in < 0.1 % DPC and C) 5.6x10
-5 M Hsmr in < 0.41 % SDS. 
 
It can be clearly seen that Hsmr in all detergents is present as monomer, dimer, trimer 
and tetramer. The fact that Hsmr at nearly 0 M NaCl could be detected by LILBID as 
discrete  multimers  suggests  that  Hsmr  is  not  yet  aggregated  and  probably  correctly 
folded. The observation of the halophilic Hsmr at 0 M NaCl supports the hypothesis that 
halophillic proteins retain a nearly native fold at low salt concentrations but experience 
a time-dependent decrease in stability [80]. In the following, the effect of detergents on 
Hsmr  oligomerisation  is  described.  Indeed,  the  oligomerisation  equilibrium  is  at  a 
different  position  for  each  detergent,  indicating  that  detergents  effect  Hsmr 
oligomerisation. In DDM, the detergent of choice for Hsmr functional investigations 
and reconstitution, Hsmr is mainly present as oligomer, see figure 35A. The dimeric 
Hsmr state is most populated. The origin of the peak at 38 kDa is unknown and not 
detected  for  the  same  Hsmr  sample  in  different  detergents.  Not  surprisingly,  harsh 
detergents like DPC and SDS dissociate Hsmr more efficiently than the milder DDM. In 
the zwitterionic DPC and anionic SDS, monomeric Hsmr is clearly the most abundant 
state, figure 35B and figure 35C. Pentameric Hsmr cannot be detected in the presence of 
DPC and may only be anticipated in the presence of SDS. However in several ways the 
result is surprising: Hsmr was expected to be a stable dimer and/or tetramer in solution 
[36, 70], resistant to SDS mediated oligomer dissociation as witnessed by SDS-PAGE 
and the Hsmr homo-oligomerisation was expected to be self-limiting [70, 244].  
In  light  of  these  LILBID  results,  the  presence  of  multimers  on  SDS  gels  is  not 
surprising, but the absence of monomers is. The fundamental difference in experimental 
parameters  between  LILBID  and  SDS  PAGE  was  the  salt  concentration.  LILBID Chapter 5 - Hsmr oligomerisation state 
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required low salt concentrations, while SDS PAGE could be performed with Hsmr in 
the  presence  of  2  M  NaCl.  Ionic  concentrations  are  well  known  to  effect 
oligomerisation behaviour in non-halophilic proteins [244] and for halophilic proteins 
oligomerisation is a suggested stabilizing mechanism [78]. The discrepancy between 
Hsmr  oligomerisation  behaviour  as  assessed  by  SDS-PAGE  and  LILBID  cannot  be 
elucidated  conclusively.  The  discrepancy  may  arise  from  the  ability  of  different 
methods to discriminate between molecular interactions, or may be due to the different 
salt concentrations. However, the lack of self-limiting oligomerisation as detected by 
SDS-PAGE and LILBID suggests that Hsmr in its native environment is present at low 
concentrations, thus avoiding its uncontrollable oligomerisation behaviour in vivo. 
  
To follow this up, the effect of the Hsmr concentration on its oligomerisation state was 
investigated. This is necessary since it is known that not only the dissociation constant 
(Kd) determines a protein’s oligomerisation state but that protein concentration can in 
some  cases  also  influence  the  oligomeric  state  of  a  protein  [244].  In  figure  36,  the 
degree of Hsmr oligomerisation at two different concentrations can be seen.  
 
 
 
 
 
Figure 36. LILBID of Hsmr in SDS at different concentrations. Hsmr in < 0.41 % SDS at A) 
5.6x10
-5 M and B) 7x10
-6 M. A concentration decrease of one order of magnitude leads to the 
disappearance of tetrameric Hsmr species and a reduced content of trimeric Hsmr. 
 
Here Hsmr at 7x10
-5 M = 1.0 mg/mL is investigated and present mainly as a monomer, 
but dimer, trimer and tetramer are also detected. After decreasing the concentration by 
only one order of magnitude, Hsmr tetramer can no longer be detected.  
From  this  it  is  clear  that  Hsmr  oligomerisation  is  concentration  dependant  and 
reversible. Such dynamic, reversible oligomerisation behaviour has been observed for 
many  proteins  and  often  has  regulatory  functions  [245]  [246]  [247].  It  can  be Chapter 5 - Hsmr oligomerisation state 
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hypothesised that Hsmr activity in its native host is also regulated via oligomerisation 
but oligomerisation in the membrane was not investigated here. 
 
Inferences from EmrE to the whole class of SMR proteins have to be treated cautiously. 
In  particular,  comparisons  of  Hsmr  and  TBsmr  with  EmrE  are  precarious,  as  H. 
salinarium and M. tuberculosis live under vastly different physiological conditions than 
E. coli. In fact, regarding the protein oligomerisation state, discrepancies within one 
protein family have been reported for organisms in different environmental conditions 
[244]. It is therefore likely that this is also the case here. 
 
Unfortunately,  the  obtained  data  is  not  able  to  answer  the  question  of  the  Hsmr 
oligomerisation state in vivo, as this would require assessment directly in the native 
Halobacterium  salinarium  plasma  membrane.  However,  functional  investigations 
suggest that SMR proteins are only functional as oligomers, which indicates that Hsmr 
is an obligate multimer. It can also be concluded that Hsmr is a transient oligomer in 
detergent  solutions.  In  such  a  system,  Hsmr  oligomerisation  behaviour  is  dynamic, 
reversible  and  can  be  manipulated  by  the  choice  of  detergent  and  probably  salt 
concentration.  
 
5. 5 Conclusions regarding the Hsmr oligomerisation 
The  result  that  Hsmr  is  in  dynamic  equilibrium  between  a  multitude  of  different 
oligomerisation  states  is  supported  by  LILBID  and  analytical  ultracentrifugation  of 
Hsmr  in  the  presence  of  DDM.  Discrepancies  between  LILBID  and  analytical 
ultracentrifugation were found for Hsmr in DPC at high salt concentrations may derive 
from differences of the  experimental conditions, and method inherent differences in 
resolution and sensitivity. The resolution and sensitivity of analytical ultracentrifugation 
is much lower than for LILBID and the samples investigated are more concentrated than 
those  investigated  by  LILBID.  Due  to  the  low  resolution  of  the  analytical 
ultracentrifugation  methods,  the  differentiation  and  quantitation  of  different 
oligomerisation  states  was  not  possible.  Here,  it  is  proposed  that  Hsmr,  like  EmrE 
(chapter  9),  is  in  a  concentration  dependent  equilibrium  between  monomer  and 
oligomer.  The  transient  oligomerisation  of  Hsmr  in  detergent  solutions  can  be 
manipulated  by  the  choice  of  detergent  and  probably  salt  concentration.  Functional 
investigations  suggest  that  SMR  proteins  are  only  functional  as  oligomers,  which 
indicates that Hsmr is an obligate multimer.  
Hsmr  oligomerisation  is  not  self-limiting.  From  this,  it  can  be  inferred  that  the 
oligomerisation surface is heterologous. Unfortunately, the obtained data is not able to 
answer the question of the Hsmr oligomerisation state in vivo as this would require 
assessment directly in the native Halobacterium salinarium plasma membrane.  Chapter 6 - Hsmr activity assays 
 
  75 
Chapter 6 - Hsmr activity assays 
 
6. 1 Introduction 
Activity assays have always played a dominant role in elucidating structure-function 
relationships. The knowledge of a protein’s functional mechanism lies at the heart to 
understanding  proteins  and  the  functions  of  living  cells/organisms.  Activity  assays 
enable assessment of the success of purification methods and are necessary to verify 
that structural information of proteins is gained from natively folded proteins. In the 
case of membrane transport proteins, two types of activity assays can be distinguished. 
The first type of activity assay measures the ability of the detergent solubilised protein 
to bind its native substrates with a Kd similar to that observed in vivo. The second type 
of activity assay measures vectorial transport of substrates from one compartment to 
another, thus requiring the protein to be reconstituted in a membrane. 
 
6. 2. Binding assays 
Binding assays enable the substrate binding event to be studied separately from the rest 
of the catalytic cycle. This allows qualitative data regarding the substrate range and 
quantitative  data  such  as  substrate  dissociation  constants  and  protein:substrate 
stoichiometry to be obtained [248]. Binding studies can be performed with crude protein 
preparations or purified protein. For initial investigations, often crude preparations are 
used. But to obtain meaningful and reproducible data regarding one protein, a purified 
preparation is required. The most sensitive binding assays use photochemical reactions 
or radioactivity to generate a signal [249].  
 
6. 2. 1 Radioactive TPP
+ binding assay 
For EmrE a radioactive TPP
+ binding assay is widely used [27]. The basic idea of this 
assay is to selectively measure the specific binding of [
3H]TPP
+ to a known quantity of 
pure  detergent  solubilised  protein  immobilised  on  Ni-NTA  beads.  See  Material  and 
Methods section 2. 2. 7. 1 for a detailed description of the assay procedure. 
Pure EmrE, solubilised in a DDM containing buffer at alkaline pH, exhibits strong and 
specific TPP
+ binding. EmrE Kds of 10 nM – 25  M have been reported [27] [37]. For 
Hsmr,  TPP
+  binding  assays  were  performed  previously  only  on  crude  membrane 
preparations. The reported salt concentration dependent Kd of 40 - 200 nM is therefore 
merely  an  extrapolation  [28].  Here,  radioactive  TPP
+  binding  to  pure  Hsmr  is 
investigated for the first time. A representative experiment is shown in figure 37.  
 
 
Figure 37. Purified Hsmr specifically binds TPP
+. Purified Hsmr (2  g) in 2 M NaCl, 15 mM 
Tris, pH 8.5 and 1 % DDM was bound to Ni-NTA beads and then incubated with 25 nM 
radioactive [
3H]TPP
+. Identical binding reactions were performed with beads that had not been 
bound with Hsmr. Each TPP
+ reaction was performed in the presence and the absence of 25  M 
non-radioactive [
1H] TPP
+. Chapter 6 - Hsmr activity assays 
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In this study, 1  g purified Hsmr was shown to bind 0.25 pmol TPP
+ once non-specific 
binding  is  accounted  for  using  the  control  measurements.  This  value  can  only  be 
compared to ~ 10  g total membrane protein containing Hsmr binding 0.5 pmol TPP
+ 
[28]  and  1   g  purified  EmrE  binding  0.75  pmol  TPP
+  [27].  This  suggests  that  the 
produced and purified Hsmr is functional. However, the assay was only possible in the 
presence of 1 % DDM and at pH 8.5. Lower detergent concentrations and pH values 
published [28] proved to be printing errors [250]. Detergent concentrations far above 
the  cmc  are  known  to  induce  protein  aggregation  and  should  generally  be  avoided 
[222].  The  necessity  to  provide  such  large  excess  of  DDM  highlights  the  already 
discussed instability of Hsmr in DDM, see Chapter 4.6. Therefore, alternatives to a 
radioactive binding assay were sought. 
 
6. 2. 2 Binding study using intrinsic tryptophan fluorescence  
A fluorescence assay based on tryptophan quenching to measure the affinity of SMR 
proteins for TPP
+ has been published previously with EmrE [251]. The technique relies 
on the fact that tryptophans are intrinsic fluorophores. The precise emission wavelength 
of fluorescence and fluorescence intensity of tryptophans is highly sensitive to the local 
environment. In particular changes in hydrophobicity and cation/π interactions are able 
to influence the fluorescence properties of tryptophan. Recently, it was shown for EmrE 
that changes in fluorescence intensity at 338 nm report mainly the occupancy of the 
binding site [252]. Further it could be seen that the binding pocket remains hydrophobic 
under all conditions as no Stoke shift is observed [252]. Cation/ π interactions between 
the conserved residue Trp63 and positively charged substrates such as TPP
+ have been 
proposed and implicated in substrate binding and transport [253]. Indeed, quenching of 
tryptophan fluorescence by TPP
+ by 22 % was observed for EmrE [251]. This further 
supports  the  evidence  that  Trp63  is  directly  involved  in  substrate  binding  and/or 
transport and does not merely fulfil a structural role.  
Here,  Hsmr  substrate  interactions,  TPP
+  and  benzalkonium,  were  investigated  using 
tryptophan quenching to obtain the substrate Kd. Data were fit using a binding function, 
see  equation  12  for  details,  that  takes  into  account  the  approximately  equimolar 
concentrations of protein and substrate as well as non-specific binding. This binding 
function has been previously used to fit Smr tryptophan quenching by TPP
+ [169].   
 
 
Figure 38. Hsmr tryptophan fluorescence changes upon TPP
+ binding. Binding of TPP
+ in 
the mM range to 4  M Hsmr in 1 % DDM and standard high salt buffer leads to quenching of 
tryptophan fluorescence at 330 nm, but does not shift the fluorescence maximum. The relative 
fluorescence intensity  change  ( F/F0)  upon addition  of TPP
+  is  plotted, and the  solid  lines 
represent the best fit of the binding function to the data [169]. Kd = 6.2 mM, fraction of non-
specific binding = 0.0,  Fmax = 0.945, R
2 = 0.995.  F = difference in fluorescence intensity 
between Hsmr without and with added substrate, F0 = fluorescence intensity of Hsmr in the 
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Figure 39. Hsmr tryptophan fluorescence changes upon benzalkonium binding. Binding of 
benzalkonium in the  M range to 4  M Hsmr in 0.1 % DDM and standard high salt buffer leads 
to  quenching  of  tryptophan  fluorescence  at  330  nm,  but  does  not  shift  the  fluorescence 
maximum. The relative fluorescence intensity change ( F/F0) upon addition of TPP
+ is plotted, 
and the solid lines represent the best fit of the binding function to the data [169]. Kd = 39.7  M, 
fractional non-specific binding = 0.0,  Fmax = 0.70, R
2 = 0.983.  F = difference in fluorescence 
intensity between Hsmr without and with added substrate, F0 = fluorescence intensity of Hsmr 
in the absence of substrate 
 
Fluorescence of the single tryptophan in Hsmr (Trp63) is quenched with TPP
+ by as 
much as 94.5 % ( Fmax = 0.945), see figure 38, and with benzalkonium by as much as 
70 % ( Fmax = 0.70), see figure 39. Quenching of the Hsmr tryptophan fluorescence 
upon TPP
+ and benzalkonium addition is specific, as can be seen from the low fraction 
of non-specific binding, see figure 38 and figure 39. This suggests that the conserved, 
essential  and  only  tryptophan  residue  Trp63  of  Hsmr  interacts  directly  with  the 
substrates TPP
+ and benzalkonium.  
 
The Kd observed here using tryptophan quenching  with TPP
+ (Kd = 6.2 mM) is two 
orders  of  magnitudes  higher  than  the  Kd  of  Hsmr:TPP
+,  anticipated  by  Professor 
Schuldiner’s laboratory (Kd = 20 - 400 nM) [28] or the measured EmrE:TPP
+ Kd (Kd = 
20 nM) [27]. During radioactive Hsmr assays, TPP
+ binding was only observed in the 
presence of 1 % DDM and high salt concentrations. These investigations suggested that 
Hsmr, at high salt and detergent concentrations, behaves similarly to EmrE. For soluble 
EmrE, TPP
+ binding could, among a dozen tested detergents, only be detected in the 
presence of DDM [27]. Therefore, buffer conditions identical to the radioactive assay 
were used here for the tryptophan quenching assay with TPP
+. However, high detergent 
concentrations may be detrimental to protein structure and generally time dependent 
Hsmr aggregation has been observed in the presence of DDM. 
 
More successful were attempts to quench Trp63 fluorescence with benzalkonium. The 
Kd lies at the high end of expected substrate Kd’s (Kd = 39.7  M) and was measured in 
the presence of high salt buffer with only 0.1 % DDM. However, it is worth noting that 
reproducibility was also hampered by visible protein aggregation. 
 
Although substrate induced specific tryptophan quenching of Trp63 could be observed 
for Hsmr with this assay, the poor reproducibility arising from Hsmr instability in DDM 
led to the renouncement of this assay. 
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6. 3 Transport assays 
6. 3. 1 Ethidium bromide assay 
Already  the  second  SMR  protein  publication  utilised  an  ethidium  bromide  based 
transport assay to judge protein activity [194]. Here, Smr reconstituted into liposomes 
was added to a solution with ethidium bromide, for which buffers were chosen to test all 
combinations of  pH and  ψ gradients. The observed ethidium bromide fluorescence 
intensity increases in the presence of  the protein Smr and with  pH and  ψ was used 
as proof of vectorial ethidium transport [194]. 
A  more  elegant  set-up  to  generate  both   pH  and   ψ  uses  the  proton  pump 
Bacteriorhodopsin  [171].  Figure  40  is  a  schematic  diagram  of  the  assay  set-up 
developed in our laboratory and used for this study [254].  
 
 
Figure 40. Schematic diagram of assay set-up to monitor transport of ethidium bromide 
by SMR proteins. A) SMR proteins and bR are co-reconstituted into liposomes and ethidium 
bromide is added to the buffer. Irradiation at 545 nm excites ethidium bromide and activates bR. 
During the illumination, bR pumps protons across the membrane, and the fluorescent molecule 
ethidium bromide emits light at 610 nm. The change of fluorescence intensity,  F, with time is 
measured. After an equilibration period in the dark the experiment can be repeated. B) During 
the assay, the ethidium bromide concentration is constant and the experiment starts with an 
equilibrium distribution of ethidium bromide. The fluorescence intensity of ethidium bromide is 
dependent on the polarity of its environment. Ffree is the ethidium bromide fluorescence intensity 
in  the  assay  buffer  and  is  the  background  fluorescence  F0.  During  active  transport,  some 
ethidium bromide is bound to the SMR protein and an intermediate with increased fluorescence 
intensity Fbound is formed. The overall fluorescence intensity during active transport is therefore 
F1. The differences in fluorescence intensity  F = F1 - F0 are measured in this assay.  F arises 
from changes in F1 during the assay which depends on changes in the populations of 
Fbound and Ffree. As  pH and  ψ build up, the amount of ethidium bromide which is present in 
the high fluorescence state F1 increases. A plateau  Fmax is reached when the maximal  pH + 
 ψ gradient is established and the maximal supported ethidium bromide transport is observed 
[254].  Chapter 6 - Hsmr activity assays 
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This assay set-up is ideally suited to investigate the activity of Hsmr as both Hsmr and 
bR  are  halophilic  proteins.  Co-reconstitutions  were  attempted  at  different  salt 
concentrations into E. coli total lipid liposomes. However, E. coli lipid membranes are 
known to be susceptible to proton leakage at high salt concentrations. The highest salt 
concentration which supported a  pH gradient which enables transport activity to be 
detected was 1 M NaCl. More robust results were obtained with 300 mM NaCl. It can 
be expected that at only 300 mM NaCl Hsmr does not exhibit its full activity but here a 
balance  between  ideal  conditions  for  the  protein  and  liposome  leakage  needs  to  be 
struck.  Under  these  low  salt  concentrations  (300  mM  NaCl),  a  measurable  and 
reproducible ethidium transport by Hsmr could be observed, see figure 41. The black 
solid curve is a representative trace for active ethidium bromide transport by Hsmr. The 
grey dashed trace was collected in the presence of the uncoupler CCCP which abolishes 
 pH  and   ψ  and  no  fluorescence  increase  is  observed  during  the  course  of  the 
experiment.  
 
 
Figure 41. Ethidium bromide transport assay with Hsmr at 300 mM NaCl. The black solid 
trace is a typical profile of the fluorescence intensity increase observed with Hsmr mediated 
ethidium  bromide  transport.  The  grey  dashed  trace  is  a  typical  profile  of  the  constant 
fluorescence intensity observed when Hsmr mediated ethidium bromide transport is impeded, 
here by the uncoupler CCCP mediated collapse of  pH and  ψ. 
 
Substrate binding assays suggested that TPP
+ is an Hsmr substrate, see figure 37 and 
figure  38.  To  investigate  this  further,  the  ethidium  bromide  transport  assay  was 
conducted  in  the  presence  of  varying  amounts  of  TPP
+.  Competition  between  the 
substrates for Hsmr leads to a reduction of the ethidium bromide fluorescence. A dose-
response curve, see Materials and Methods equation 13, could be fitted to the data, see 
figure 42, and an IC50 of approximately 4 µM was determined.  
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Figure 42. The dose-response plot for TPP
+, an inhibitor of ethidium bromide transport by 
Hsmr. 1 µM Hsmr co-reconstituted with bR in the presence of 13.6 µM ethidium bromide. 
Competition experiments with TPP
+ (IC50 = 4 µM) are shown here.  
 
The IC50 value is the inhibitor concentration at which the substrate transport is reduced 
by  50  %  [255],  and  is  substrate  concentration  dependent.  A  Ki  is  the  substrate 
concentration  independent  Kd  of  an  inhibitor  and  therefore  suitable  for  comparison 
between  experiments  conducted  by  different  laboratories  [255].  Assuming  that:  the 
reaction  obeys  Michaelis-Menten  kinetics,  binding  is  reversible  and  the  inhibition 
competitive, the reaction mechanism is known and the substrate Km is available; the 
IC50 can be converted into a Ki [255]. 
Under  certain  conditions,  the  IC50  and  Ki  can  even  be  identical.  These  include  the 
simple case of one substrate reaction obeying simple Michaelis-Menten kinetics with a 
reversible inhibitor at concentrations above the substrate Km.  
 
Unsuccessful attempts were made to use the coupled Hsmr/bR assay to determine the 
rate  of  ethidium  bromide  transport.  Measurements  of  transport  rate  would  further 
characterise  Hsmr  by  enabling  the  assessment  of  the  type  of  kinetics  found  and 
providing Km and Vmax values. If simple Michaelis-Menten kinetics apply, experiments 
in the presence of inhibitors can lead to the determination of the mode of inhibition. 
Unfortunately, none of this was possible here as the initial rate of ethidium bromide 
transport, measured as initial increase in ethidium bromide fluorescence, depends on 
two proteins. Firstly the initial transport rate is governed by the transporter Hsmr but 
secondly it depends on the concomitant build-up of  pH +  ψ by bR.   
For  Hsmr,  the  type  of  inhibition  of  ethidium  bromide  transport  by  TPP
+  is  yet 
undetermined, furthermore, the type of kinetic has not been determined previously and 
the  Km  is  unknown.  However,  it  can  be  reasonably  anticipated  that  TPP
+  is  a 
competitive inhibitor with respect to etbr. Attempts to determine the Michaelis Menten 
constant Km from the rate of ethidium bromide transport failed. The ethidium bromide 
transport  rate  is  determined  by  three  inseparable  components  namely,   pH  +   ψ 
generation  by  bR  and  ethidium  bromide  transport  by  Hsmr.  Their  undecipherable 
intermingling makes the determination of Km with this assay impossible. It is therefore 
impossible convert the IC50 to a Ki. However, a Ki of 4 µM for TPP
+ binding to Hsmr 
would  be  in  the  expected  range.  TPP
+  Ki’s  reported  for  TBsmr  are  4.3  µM  when 
competing  against  methylviologen  and  10  µM  when  competing  against  ethidium 
bromide [146, 254].  Chapter 6 - Hsmr activity assays 
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In conclusion, Hsmr can transport ethidium bromide actively in the presence of a bR 
generated   pH  +   ψ  gradient.  TPP
+  can  efficiently  inhibit  this  transport  at  low 
concentrations with an IC50 of 4 µM. Further characterisations of transport kinetics and 
types of inhibition are hampered by the coupling of  pH +  ψ generation and ethidium 
bromide fluorescence.  
 
6. 3. 2 TPP
+ transport assay measured with a TPP
+ electrode 
The first transport assay on purified SMR proteins utilised a TPP
+ electrode to measure 
the rate of MTPP
+ transport [194]. This is an advancement of the common use of TPP
+ 
sensitive electrodes to measure TPP
+ concentrations as indicator of membrane integrity 
[256-258]. The TPP
+ transport assay as used by Grinius and Goldberg is schematically 
depicted in figure x. A  pH and  ψ dependent transport of MTTP
+ was observed for 
Smr. Weak transport activity was also observed in the presence of just  pH. Both  pH 
and  ψ were formed by  using different buffers as  assay buffer and proteoliposome 
reconstitution buffer. More precisely, the assay buffer has a pH of 9.5 and contained 
150 mM KCl, while the proteoliposomes were filled with buffer at pH 7.0 and 0 mM 
KCl.  A  strong   pH  and   ψ  gradient  is  thus  set  up  which  can  be  dissipated  either 
specifically by substrate/proton antiport or unspecifically by uncouplers and proton and 
ion leakage.  
 
 
Figure  43.  Schematic  representation  of  TPP
+  transport  assay.  A)  The  TPP
+  sensitive 
electrode and reference electrode enable the measurement of potential changes, V, due to TPP
+ 
concentration changes. The read-out values are in the range of mV. B) The expected voltage 
profile of active TPP
+ transport is shown.   
 
A  similar  experimental  set-up  was  envisaged  for  Hsmr.  The  TPP
+  assay  should  be 
ideally  conducted  at  high  salt  concentrations  to  observe  maximal  Hsmr  transport 
efficiency.  Alternatively,  Hsmr  could  be  investigated  at  more  convenient  low  salt 
concentrations and accordingly less than maximal transport activity should be observed. 
Both approaches were used here.  Chapter 6 - Hsmr activity assays 
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Figure 44. TPP
+ electrode measurements. A) Typical TPP
+ titration curve in standard buffer. 
At each arrow, TPP
+ at a final concentration of 3 µM is added and a sharp potential increase 
measured. B) Titration curve in the presence of standard buffer + 2 M NaCl and including 3 µM 
TPP
+. Additions of 2.15 µM TPP
+ final concentration at the arrows only show a slow and weak 
potential increase. Without calibration the mV values are arbitrary units and can only be used 
for comparison within one experiment. 
 
In  figure  44  a  calibration  curve  of  (A)  Hsmr  in  the  presence  of  standard  low  salt 
concentration buffer  is compared with a calibration curve (B) in the presence of 2 M 
NaCl. The addition of TPP
+ to low salt buffer causes a sharp and large rise in potential. 
In the presence of high salt concentrations, the potential reading of the TPP
+ selective 
electrode  is  neither  as  fast  responding  as  observed  for  low  salt  concentrations  nor 
changes  as  strongly  as  for  low  salt  concentrations.  The  TPP
+  sensitive  electrode  is 
actually a Ca
2+ selective electrode and the TPP
+/Ca
2+ selectivity ratio is 100 [259]. A 
selectivity  ratio  for  TPP
+/Na
+  was  not  measured  here  but  the  supplier  guarantees  a 
selectivity ratio of 10000 for Ca
2+/Na
+ [260]. The presence of 2 M NaCl thus can be 
anticipated to interfere with the electrodes ability to measure small differences in TPP
+ 
concentrations. Indeed, this hypothesis was supported by the experiment seen in figure 
44B  and  means  that  TPP
+  transport  cannot  be  measured  with  the  TPP
+  selective 
electrode in the presence of high salt concentrations.  Chapter 6 - Hsmr activity assays 
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Figure  45.  TPP
+  transport  by  TBsmr  and  Hsmr.  A  TPP
+  assay  with  standard  buffer 
investigated sequentially the transport activity of TBsmr, Hsmr and empty liposomes. TBsmr 
was used as a positive control. TBsmr addition at the first indicator gives rise to a fast drop and 
large potential drop and slow potential rise. Addition of Hsmr at the second indicator causes a 
less pronounced and slower potential drop which is not recovered. At indicator three protein-
free liposomes, used as negative control, are added and a slow potential drop is detected which 
is not recovered. Potential changes are measured in mV but are not calibrated and thus not 
comparable between experiments and should be treated as arbitrary units. 
 
In figure 45, a typical low salt TPP
+ transport assay is depicted. The first addition are, as 
positive  control,  proteoliposomes  with  TBsmr  and  give  rise  to  the  expected  TPP
+ 
transport curve. The expected transport curve shows an initial drop in potential due to 
dilution  and  transport  of  TPP
+  into  the  liposome,  momentarily  depleting  the  TPP
+ 
concentration in the outside buffer. This is followed by an increase in potential as the 
TPP
+ concentration returns almost to its steady-state value. This is possible as the TPP
+ 
concentration equalises between inside and outside the liposome. TPP
+ is a lipophilic 
substance and can traverse the membrane. This process is no longer counteracted by the 
active transport of TPP
+ by SMR proteins, as the proton gradient is depleted by active 
transport  and  proton  leakage.  From  the  TBsmr/TPP
+  transport  measurement  and  its 
expected, typical curve it can be concluded that the TPP
+ electrode measurement set-up 
used here is functional.  
The second addition contains proteoliposomes with Hsmr. The potential drop observed 
is smaller and the expected slow potential increase arising from equilibration of TPP
+ 
by diffusion is not observed. This suggests that the drop in TPP
+ generated potential 
arises from dilution effects only. Endorsement of this hypothesis arises from the third 
addition  encompassing  protein-free  liposomes  as  the  negative  control.  As  expected 
liposomes afford only a dilution dependent drop of potential but no potential restoration 
is observed. 
During  these  experiments  Hsmr  was  treated  identically  to  TBsmr.  The  inactivity  of 
Hsmr is likely to arise from non-native salt conditions which lead to Hsmr inactivation.  Chapter 6 - Hsmr activity assays 
 
  84 
Unfortunately, it must be concluded that the TPP
+ sensitive electrode cannot be used to 
measure  Hsmr  mediated  TPP
+  transport  due  to  experimental  limitations  and  protein 
specific requirements. 
 
6. 4 Conclusion 
Several Hsmr activity assays were evaluated and improved here. From the radioactive 
TPP
+  binding  assay  and  the  tryptophan  fluorescence  quenching  assay  it  can  be 
concluded that Hsmr in soluble form is unstable but retains residual but varying binding 
activity in the presence of high salt concentrations and DDM. The transport assays, 
using  a  TPP
+  electrode  and  ethidium  bromide  fluorescence,  showed  that  Hsmr 
reconstituted  in  E.  coli  total  lipid  liposomes  exhibits  transport  activity  at  low  salt 
concentrations.  An  electrophysiological  transport  assay  using  solid  supported 
membranes  was  abandoned  as  not  feasible  due  to  the  hydrophobic  nature  of  the 
substrates  leading  to  interactions  with  the  tubings.  The  most  useful  assay  for  Hsmr 
activity  is  thus  the  ethidium  bromide  transport  assay  because  it  directly  measures 
transport function, can be conducted at low salt concentrations and is very reproducible. 
The ethidium bromide fluorescence transport assay is the assay of choice for future 
activity measurements on Hsmr or other SMR proteins. Chapter 7 – Solution state NMR on Hsmr 
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Chapter 7 - Solution state NMR on Hsmr 
 
7. 1 Introduction 
Several  attempts  have  been  made  at  elucidating  the  structure  of  SMR  proteins  by 
solution state NMR. Initially, EmrE was investigated in a chloroform/methanol/water 
mixture. Only approximately 60 % of the expected residues were observed, and only the 
secondary  structure  could  be  determined  [261].  Later  attempts  to  use  overlapping 
peptides of EmrE solubilised by SDS to obtain a full-length structure [62], an approach 
pioneered for Bacteriorhodopsin [262], failed due to the insolubility of one fragment. 
More successful were investigations of Smr. Solubilised in LPPG, the complete Smr 
backbone and 97 % of all Cβ nuclei were assigned [263]. Measurements of Smr in 
bicelles resulted in an almost complete backbone residue assignment [169], but neither 
experiment has resulted in a Smr structure.  
During Hsmr purification inevitably detergents were used and several investigations of 
Hsmr in membrane mimicks, namely detergents, were performed. It was thus of interest 
if Hsmr retains a folded state in any of these detergents. Ultimately, of course a solution 
state structure of Hsmr would be desirable to enable the investigation of the structural 
features of halophilicity.  
 
7. 2 Results and Discussion 
Structure determination by solution state NMR is a process involving many sequential 
steps, starting with the initial screen of detergent, buffer and temperature conditions. For 
membrane proteins detergents are the key component. A successful detergent must yield 
a  suitable  spectral  quality  and  support  protein  functionality.  The  best  possible 
compromise  between  these  two  criteria  is  sought.  Several  groups  have  screened  an 
extensive number of detergents, with vastly different properties regarding ionic state 
and  chain  length,  for  their  ability  to  yield  high  quality  NMR  spectra  of  membrane 
proteins.  Sets  of  proteins  investigated  were  alpha  helical  membrane  proteins  [264], 
Thermotoga maritime membrane proteins [265] and a range of proteins with different 
numbers  of  transmembrane  helices  [112].  The  outcome  suggests  that  the  optimal 
detergent for solution state NMR of a protein needs to be determined empirically. The 
suitability  of  conditions  is  generally  assessed  by  1D 
1H  and  2D 
1H-
15N  HSQC 
experiments. For Hsmr, this screen was simplified by the use of information from long 
term protein stability tests in chapter 4. This information obtained from SEC narrows in 
this case the detergent choices that need to be evaluated by NMR to DPC and SDS.  
 
7. 2. 1 Hsmr in DPC 
The aromatic and amide regions of a 1D 
1H spectrum of Hsmr in DPC is shown in 
figure 46. These regions are used for quality assessment [265].  
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Figure 46. 1D 
1H spectrum of Hsmr in DPC with KxHxPO4 buffer. Uniformly 
15N labelled 
Hsmr at 840 µM in 300 mM NaCl, 300 mM imidazole, 15 mM KxHxPO4, pH 7.0, 0.1 % DPC, 
10 % D2O, 1 mM 3-(trimethylsilyl)propionic acid (TMSP) was measured at 298 K at 600 MHz. 
The spectrum was processed with 2 Hz exponential linebroadening. The black bar above the 
spectrum indicates the aromatic region. The asterisks highlight the 
1H resonances of imidazole, 
values were obtained from the BMRB entry bmse000096. 
 
Many sharp peaks were observed in the 
1H spectrum in the range of 6.5 to 8.5 ppm. The 
line-width of these protein peaks is similar to each other. The resolution in the aromatic 
region, highlighted by a bar in figure 46, is moderate compared to published spectra of 
other proteins [265]. Most disappointingly, no peaks were detected downfield from 8.5 
ppm. In particular, the lack of peaks in the high ppm range is worrying as they are 
indicative of a folded protein [265]. Here, the large peaks marked with asterisks arise 
from the presence of imidazole. In subsequent preparations, imidazole was removed by 
dialysis leading to improved spectra but prolonged sample preparation time. 
For an initial assessment of the spectral quality attainable by a given protein often also 
2D 
1H-
15N HSQCs are used [112, 264-266]. The % of expected resonances that can be 
observed can thus be assessed. HSQC experiments are chosen because they require only 
a simple, inexpensive uniform 
15N labelling scheme and these routine experiments are 
fast. Accordingly, to obtain more conclusive evidence regarding the suitability of this 
Hsmr preparation for NMR, a 2D 
1H-
15N HSQC was collected. 
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Figure 47. 
1H-
15N HSQC spectrum of Hsmr in DPC with KxHxPO4 buffer. Uniformly 
15N 
labelled Hsmr at 840 µM in 300 mM NaCl, 300 mM imidazole, 15 mM KxHxPO4, pH 7.0 , 0.1 
% DPC, 10 % D2O, 1 mM TMSP was measured at 298 K at 600 MHz 
1H frequency and 61 
MHz 
15N frequency with a HSQC. The spectrum was acquired with 2048 points in the direct 
dimension and 512 points in the indirect dimension. A total of 44 transients were collected per 
slice. The spectrum was processed with quadratic sine modulation in both dimensions. Positive 
contour levels are displayed in maroon while negative contour levels are shown in turquoise. 
The spectrum was cropped to include all observed resonances.  
 
Hsmr with myc-his tag has 139 amino acids and thus 139 backbone 
1H-
15N peaks are 
expected. The imidazole peaks should be located outside the spectral range (163.851 
ppm  and  290.715  ppm 
15N  dimension,  bmst000093)  and  should  not  disturb  the  2D 
spectrum. Clearly, far less than 139 peaks are visible. The lack of peaks suggests that 
the  PDC,  which  is  in  the  case  of  membrane  proteins  the  relevant  unit,  has  a  slow 
rotational  correlation  time.  The  resulting  fast  T2  relaxation  leads  to  excessive 
broadening of the signals and possibly even their disappearance. The observed peaks are 
of erratic size, probably arising from several unresolved peaks. The spread of chemical 
shifts observed is very limited, with only one peak in the 1H dimension at >8.5 ppm. 
Although  solely  alpha  helical  proteins  generally  suffer  from  poor  chemical  shift 
dispersion, a folded protein should exhibit a few resonances downfield of 8.5 ppm in the 
1H dimension. The 11 glycine residues and one tryptophan residues of Hsmr-myc-his 
are located exclusively in the Hsmr amino acid sequence, see figure 48.  
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Figure  48.  Schematic  topology  diagram  of  Hsmr  with  myc-his  tag.  The  grey  cylinders 
indicate the predicted TM helices and the black bar indicates the end of the protein sequence 
and start of the myc-his tag. Prediction of TM regions used HMMTOP [267]. The protein 
sequence is shown using the one letter code. Glycine residues in pink, tryptophan in yellow, 
asparagines in green and glutamine in orange. 
 
The  observed  peaks  therefore  likely  stem  from  the  tag  as  the  characteristic  glycine 
(minimal observed chemical shift 88.30 ppm/3.01 ppm, maximal observed chemical 
shift  135.80  ppm/12.22  ppm  and  average  chemical  shift  109.72  ppm/8.34  ppm  for 
15N/
1H  nuclei  respectively  [268])  and  tryptophan  side-chain  (minimal  observed 
chemical  shift  101.75  ppm/4.49  ppm,  maximal  observed  chemical  shift  134.89 
ppm/11.67  ppm,  average  observed  chemical  shift  121.76  ppm/8.29  ppm  for 
15N/
1H 
respectively  [268])  peaks  are  absent.  The  tag  is  known  to  protrude  from  the  PDC 
micelle  as  purification  using  IMAC  is  possible.  The  tag  is  thus  expected  to  have 
motions in addition to the PDC motions leading to shorter rotational correlation times. 
This  assessment  is  supported  by  the  fact  that  the  sidechains  of  asparagines  and 
glutamine (Asn: 112.82 ppm 15N, 7.14 ppm and 7.34 ppm 
1H; Gln: 111.85 
15N, 7.02 
ppm and 7.22 ppm 
1H [268]), which are also expected to have motions in addition to the 
PDC motions, can be observed.  
It can thus be concluded that Hsmr in DPC has a too long rotational correlation time and 
T2  relaxation  broadens  the  lines.  This  makes  Hsmr  in  DPC  unsuitable  for  NMR 
experiments. Chapter 7 – Solution state NMR on Hsmr 
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7. 2. 2 Hsmr in SDS 
Hsmr  in  SDS  is  extremely  stable  (see  chapter  4)  and  could  thus  be  subjected  to  a 
temperature  scan.  Two  1D 
1H  spectra  are  shown  in  figure  49,  exemplifying  the 
resolution gain associated with even modest temperature increases.  
 
 
 
Figure 49. 1D 
1H spectra of Hsmr in Tris buffer with SDS at two different temperatures. 
Uniformly 
15N labelled Hsmr at 480 µM in 300 mM NaCl, 15 mM Tris, pH 8.0, 0.41 % SDS, 10 
%  D2O,  1  mM  TMSP  was  measured  at  900  MHz.  The  spectra  were  processed  with  2  Hz 
exponential line-broadening. The lowest temperature with maximal resolution was determined 
by comparison of 1D 
1H spectra. The spectrum in black was acquired at 303 K, while the 
spectrum in red was acquired at 310 K. The black bar above the spectra indicates the aromatic 
region.  
 
The  measurement  at  310  K  has  a  better  resolution  both  in the  aromatic  region  and 
around 8 ppm. 310 K was chosen as the temperature for further measurements. Hsmr in 
the presence of Tris and SDS exhibited again low spectral resolution in the aromatic 
region,  see  figure  49.  A  broad  peak  is  detected  downfield  of  8.5  ppm  in  the 
1H 
dimension, an improvement compared to the 1D spectrum of Hsmr in DPC. For a more 
thorough assessment again a 2D 
1H-
15N HSQC was carried out. 
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Figure 50. 
1H-
15N HSQC spectrum of Hsmr in SDS with Tris buffer. Uniformly 
15N labelled 
Hsmr at 480 µM in 300 mM NaCl, 15 mM Tris, pH 8.0 , 0.41 % SDS, 10 % D2O, 1 mM TMSP 
was measured at 310 K at 900 MHz 
1H frequency and 91 MHz 
15N frequency with a HSQC. 
The spectrum  was  acquired  with  2048  points  in the  direct  dimension and  96  points  in the 
indirect  dimension.  A  total  of  128  transients  were  collected  per  slice.  The  spectrum  was 
processed  with  quadratic  sine  modulation  in  both  dimensions.  Positive  contour  levels  are 
displayed in maroon while negative contour levels are shown in turquoise. The spectrum was 
cropped to include all observed resonances.  
 
The 
1H-
15N HSQC of Hsmr in Tris buffer with SDS, figure 50, again shows low spectral 
resolution,  inhomogeneous  peak  shape  and  line-width,  too  few  peaks  and  a  lack  of 
peaks beyond 8.5 ppm in the 
1H dimension. However, the spectrum is an improvement 
over Hsmr in DPC in several aspects. Characteristic glycine peaks (109.75 ppm 
15N, 
8.34 ppm 
1H [268]) can be detected although the intensity and number of resonances are 
not representative of 11 amino acids. Overall, this spectrum suggests that most peaks 
detected  arise  still  from  the  myc-his  tag,  but  some  magnetization  arises  from  Hsmr 
itself. The likeliest cause of the low % of expected peaks detected is again the PDC size.  
 
Further  improvements  of  sample  conditions  were  made  with  respect  to  detergent 
concentration and pH. A detergent concentration of 1.5 % SDS theoretically ensures 
that every PDC contains only the minimal protein complex, likely a dimer.  From the 
NMR spectroscopy point of view this is an improvement, but detergent concentrations 
high above the cmc can lead to protein aggregation and were thus avoided initially. To 
rule  out  the  possibility  that  the  relatively  high  but  physiological  pH  of  previous 
measurements (pH 8.0) causes a loss of many Hsmr resonances, HEPES at pH 6.8 was 
chosen here. A 2D 
1H-
15N HSQC was obtained of this optimised sample, see figure 51. 
 Chapter 7 – Solution state NMR on Hsmr 
 
  91 
 
Figure 51. 
1H-
15N HSQC spectrum of Hsmr in SDS with HEPES buffer. Uniformly 
15N 
labelled Hsmr at 480 µM in 300 mM NaCl, 15 mM HEPES, pH 6.8 , 1.5 % SDS, 10 % D2O, 1 
mM TMSP was measured at 310 K at 900 MHz 
1H frequency and 91 MHz 
15N frequency with a 
HSQC. The spectrum was acquired with 2048 points in the direct dimension and 72 points in 
the indirect dimension. A total of 40 transients were collected per slice. The spectrum was 
processed  with  quadratic  sine  modulation  in  both  dimensions.  Positive  contour  levels  are 
displayed in magenta while negative contour levels are shown in green. The spectrum was 
cropped to include all observed resonances.  
 
Overall, Hsmr in HEPES and 1.5 % SDS gives rise to a spectrum similar to Hsmr in 
Tris and 0.41 % SDS. Again a few glycine resonances and no tryptophan resonances 
were found. This suggests that again the majority of peaks obtained arise from the tag. 
Lowering the pH does not enhance the number of visible 
1H-
15N resonances and thus 
excludes the high pH of previous experiments as the cause of the small number of 
observed  resonances.  Hsmr in HEPES and 1.5 % SDS exhibits resonances of more 
uniform size and increased resolution when compared to figure 50. This suggests that 
the increase of the SDS concentration indeed leads to a smaller PDC.  However, the 
improvements in spectral quality are not sufficient. Hsmr in SDS micelles is therefore 
not amenable to structural characterisation by solution state NMR due to the low quality 
spectra obtained at two different pH values and SDS concentrations. The most likely 
causes of the poor spectral quality are the large PDC size and possibly unfolded Hsmr.  
 
7. 3 Conclusion 
The detergent DDM was shown in chapter 6 to support the substrate binding activity of 
Hsmr but the lack of long-term stability in this detergent, see chapter 4, rules out NMR 
investigations in this detergent. Other promising detergents were pre-selected for Hsmr 
long-term stability in chapter 4. The successful detergents DPC and SDS showed a large Chapter 7 – Solution state NMR on Hsmr 
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PDC with Hsmr of approximately 132 kDa. A complex of this size is outside the realms 
of solution state NMR. However, investigations with Smr in LPPG suggested that SMR 
proteins can be highly mobile in detergent micelles and can tumble independently of the 
micelle, thus dramatically reducing the effective molecular weight [112]. The lack of 
sufficient numbers of resonances and spectral resolution as seen here suggests however 
that Hsmr is not tumbling inside the detergent micelle and the total PDC is too large for 
solution state NMR. The limited number of long-term structure supporting detergents 
further  advocates  a  fast  transition  from  heterologous  membranes  into  artificial 
membranes.    The  structural  investigation  of  Hsmr  by  solution  state  NMR  was 
abandoned due to the lack of detergents which could support long-term protein stability 
in solution and give rise to NMR spectra with a quantitative number of peaks and high 
resolution. Chapter 8 – Solid state NMR 
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Chapter 8 - Solid state NMR  
 
8. 1 Introduction 
Solid state NMR offers a wide range of possibilities for the investigation of membrane 
proteins and their interactions with lipids and ligands. During the work carried out for 
this thesis, three different solid state NMR approaches were chosen to study multidrug 
transporter of the SMR family. First, the membrane interaction of TPP
+, a ubiquitous 
multidrug  transporter  substrate,  has  been  studied  by 
1H  MAS  NMR.  Next,  the 
perspective to investigate structure and dynamics of uniformly 
13C labelled Hsmr using 
13C-
13C correlation spectroscopy has been evaluated. Finally, the global dynamics of 
Hsmr within lipid bilayers has been probed by static 
2H NMR.  
 
8. 2 
1H MAS NMR Studies on Substrate-Lipid Interactions 
8. 2. 1 Membrane localisation of Hsmr substrates 
One of the open questions related to multidrug efflux pumps is how they recognize and 
translocate  many  different,  structurally  diverse  drugs.  Although  structurally  distinct 
from each other, most of them are lipophilic which raises the question whether the 
membrane  could  act  as  a  selectivity  filter  sorting  these  drugs  with  respect  to  their 
membrane localisation. This would enable them to enter the protein via the membrane. 
The  access  route  of  lipophilic  substrates  into  multidrug  transporters  has  been 
investigated thoroughly in particular for p-glycoprotein, an ABC transporter [269, 270]. 
For ABC transporters, three substrate uptake and efflux mechanism models have been 
discussed: the classical pump, hydrophobic vacuum cleaner [20] and flippase model 
[21]. 
So far, for secondary transporters, the classical pump mechanism is assumed. Direct 
evidence for the hydrophobic vacuum cleaner model was only obtained for LmrP [271] 
and the flippase mechanism has not been observable at all, for secondary multidrug 
transporters. Indirect evidence for substrate entry from the lipid bilayer was seen in the 
x-ray  crystallography  structure  of  AcrB  [18].  The  difficulties  associated  with 
investigating membrane proteins and the need to compare drugs with respect to their 
membrane  activity  has  led  to  approaches  which  allow  determining  the  substrate 
localisation. The localisation of the lipophilic substrates of multidrug transporter has 
been widely discussed and investigated previously [272]. 
 
8. 2. 2 NOESY spectroscopy of small molecules in lipid membranes 
Nuclear overhauser spectroscopy was first developed as 1D technique for solution state 
NMR, later the potential as a 2D technique was realised in 1980 [186]. The NOE is a 
dipolar  magnetization  transfer  between  nuclei.  This  cross-relaxation  shows  a  strong 
distance dependence (r
-6)[109]. First NOESY spectra of hydrated lipid membranes using 
solid state MAS NMR were recorded at the end of the 1980s [273, 274] but the full 
potential of this technique was only realised by Gawrisch and co-workers [275]. The 
thorough testing of different quantitative data analysis methods and the ability to rule 
out extensive intramolecular spin diffusion as source of lipid cross peaks paved the way 
for the general applications of this technique [187]. The membrane location of many 
diverse  small  molecules  [275-277]  has  thus  been  investigated  using  NOESY  MAS 
NMR.  The  molecules  were  located  in  four  membrane  regions,  namely;  head  group, 
glycerol backbone, upper acyl chain and end of the acyl chains. Here, the location of the 
Hsmr and EmrE substrates ethidium bromide and TPP
+ in hydrated unilamellar DMPC 
vesicles is investigated. 
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8. 2. 3 
1H NOESY MAS spectroscopy of ethidium bromide 
Observation  of  measurable  lipid  substrate  cross  peaks  using  this  technique  ideally 
requires a mol ratio in the range of  1:4.5 [272]. The high concentration of substrate 
molecules in the lipid membrane may force a certain membrane localisation [276] or 
lead to substrate aggregation. For ethidium bromide, no experimental conditions (buffer, 
pH, temperature) and concentration range could be found that yielded strong diagonal 
peaks  and  measurable  cross  peaks.  This  probably  is  caused  by  ethidium  bromide 
stacking [278]. The self-association into dimers has been observed below 8 mM, but 
higher  aggregates  are  found  above  this  threshold  [278].  For  NOESY  MAS,  fast 
anisotropic molecular tumbling is required which is significantly reduced in case of 
molecular  multimers  within  the  membrane.  All  conditions  feasible  for  NOESY 
spectroscopy used here exceed these concentrations. Therefore, the membrane location 
of  ethidium  bromide  in  DMPC  membranes  could  not  be  determined  by  NOESY 
spectroscopy. 
 
8. 2. 4 NOESY spectroscopy of TPP
+ 
For  mixtures  of  TPP
+/DMPC  membranes,  NOESY  spectra  of  high  quality  could  be 
obtained. A total of 12 spectra with mixing times ranging from 10 ms to 1 s were 
acquired. A representative NOESY spectrum can be seen in figure 52. The spectrum 
was acquired with a mixing time of 400 ms. 
 
 
Figure  52. 
1H  NOESY  spectrum  of  DMPC  with  TPP
+.  A  typical  NOESY  spectrum  of 
unilamellar [279] DMPC vesicles in the Lα phase [280] with TPP
+ at a 1:4.5 TPP
+:lipid mol 
ratio.. The diagonal peaks were named L1-L10 for lipids, HDO for water and S1-S3 for the 
substrate TPP
+ from top right to bottom left. The NOESY experiment was conducted at 310 K 
with MAS at 8000 Hz and a mixing time of 400 ms. The spectrum was acquired using States-
TPPI and 
1H was measured at 400.13 MHz. The spectrum was acquired with 4096 points in the 
direct dimension and 256 points in the indirect dimension. A total of 8 transients were collected 
per  slice.  The  spectrum  was  processed  with  squared  sine  modulation  in  both  dimensions. 
Positive contour levels are displayed in red while negative contour levels are shown in green. 
 
The diagonal peaks in the NOESY spectrum were arbitrarily labelled from the top right 
corner with L1-L10 for lipid peaks, S1-S3 for substrate peaks and HDO for the water Chapter 8 – Solid state NMR 
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peak. The spectrum is very well resolved and lipid-lipid cross peaks are abundant. To 
see the lipid-substrate cross peaks of much lower intensity, figure 53 shows only the 
lipid-substrate region of the spectrum in figure 52.  
 
 
Figure 53. Lipid-substrate cross-peak region of 
1H NOESY spectrum of DMPC with TPP
+. 
The lipid-substrate cross-peak region of, figure 52, a TPP
+:DMPC (1:4.5 mol ratio) NOESY 
spectrum  with  400  ms  mixing  time  is  enlarged  here.  Locations  of  possible cross-peaks  are 
automatically labelled using the diagonal peak assignment shown in figure 54. The NOESY 
experiment was conducted at 310 K with MAS at 8000 Hz and a mixing time of 400 ms. The 
spectrum was acquired using States-TPPI and 
1H was measured at 400.13 MHz. The spectrum 
was acquired with 4096 points in the direct dimension and 256 points in the indirect dimension. 
A total of 8 transients were collected per slice. The spectrum was processed with quadratic sine 
modulation in both dimensions. Positive contour levels are displayed in red while negative 
contour levels are shown in green. 
 
It can be clearly seen that of the three substrate nuclei S1, S2 and S3 only S2 has 
measurable cross peaks with all lipid nuclei and S3 has barely measurable cross peaks 
with two lipid nuclei (L2 and L5). The assignment of the arbitrary lipid nuclei names to 
the DMPC molecule was obtained from literature values [187] and is depicted in figure 
54.  Similarily,  the  assignment  of  the  substrate  nuclei  was  derived  from  a  previous 
investigation of TPP
+ in egg phosphocholine membranes [276]. Also see figure 54 for 
the assignment. 
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Figure  54.  Schematic  drawing  of  DMPC  and  TPP
+  labelled  with  chemical  name  and 
spectrum nomenclature at each position. The 
1H peaks for DMPC and TPP
+ are labelled 
arbitrarily in the spectrum: CH3 = L1, CH2 = L2, C3 = L3, C2 =L4, G1 = L9, G2 = L10, G3 = 
L7, α = L8, β =L6 and γ = L5 for DMPC and S3 = ortho, S2 = meta, S1 = para for TPP
+. 
 
In the enlarged lipid-substrate cross-peaks region it can clearly be seen that only for the 
S2 nuclei (meta position on the benzene ring) measurable cross-peak with all lipids can 
be detected. For the substrate nucleus S1 (para position on the benzene ring), no cross 
peaks with lipids could be detected. Finally, for S3 (ortho position on the benzene ring), 
barely measurable cross peaks could be detected with lipid nuclei L2 (acyl chain CH2 
groups) and L5 (phosphocholine head group CH3 groups, γ). In the following analysis, 
only the S2 nucleus is utilised because cross peak volumes at the signal to noise ratio 
result in erratic results. 
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All lipid-lipid and S2-lipid cross peak volumes were analysed using the full matrix 
approach  [187]  which  calculates  the  cross  relaxation  rates  between  all  peaks 
simultaneously (see material and methods for details). Lipid molecules in the Lα phase, 
as used here, undergo axial rotations, lateral diffusion, vertical motion and trans-gauche 
isomerisations on the µs to ps time scale [275]. Similarly, small molecules like TPP
+ 
can be expected to undergo motions in the lipid membrane. The cross peak volumes 
used here are used to calculate cross relaxation rates to determine location probabilities, 
and represent a time averaged and lipid molecule averaged localisation. 
Figure 55 shows the NOESY cross peak volume build up curves  from 12 different 
mixing times measured for TPP
+ in DMPC vesicles. 
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Figure 55. Overview of diagonal and cross-peak volumes at all measured mixing times, 
fitted  using  the  full  matrix  approach.  Horizontal  axes  of  individual  graphs  represent  the 
mixing time from 0 to 1 s. The vertical axes represent the diagonal and cross-peak volumes 
scaled individually from 0 to 1 for each graph. The filled red circles show measured peak 
volumes while the dotted blue line represents the best fit to the data points using the full matrix 
analysis. Graphs of diagonal peaks are have a grey background, while lipid-substrate cross-peak 
graphs have a yellow background.  Chapter 8 – Solid state NMR 
 
  99 
The boxes show individual cross peak or diagonal peak volumes as a function of mixing 
time and the best fitting cross relaxation rate as determined by the full matrix analysis is 
also  shown.  Boxes  with  grey  background  belong  to  diagonal  peaks.  With  yellow 
background are the boxes showing lipid-S2 cross peak volumes. The cross relaxation 
rate indicates the relative location probability of a nucleus. The distribution of the meta 
protons of TPP
+ in a DMPC membrane are shown as distribution probabilities in figure 
56.  
 
 
Figure  56.  Bar  plot  indicating  the  location  probability  of  the  TPP
+  nucleus  S2  (meta 
position) along the DMPC chain. The lipid nuclei are arranged in the order found in the lipid, 
left most the CH3 group of the acyl chain and right most the choline head group γ protons. L1 = 
CH3, L2 = CH2, L3 = C3, L4 = C2, L9 = G1, L10 = G2, L7 = G3, L8 = α, L6 = β and L5 = γ. 
The highest location probability is found in the glycerol backbone.  
 
The smooth distribution profile suggests that the majority of TPP
+ meta protons resides 
at the top of the acyl chain (L3, L4) and in the glycerol backbone (L9, L10, L7). A more 
hydrophobic  localisation  of  TPP
+  in  the  membrane  was  expected  due  to  its  high 
predicted octanol-water partition coefficient logPow = 5.11 [281]. 
 
8. 2. 5 Conclusions 
Here, the location probability of TPP
+ in unilamellar DMPC vesicles in the Lα (liquid 
crystalline) phase was determined using MAS-NOESY spectroscopy and the full matrix 
analysis of cross-peak volumes. Taking the benzene ring meta substituent protons as 
indicators suggests that TPP
+ is located mainly at the top of the acyl chain and in the 
glycerol backbone of DMPC. This is in accordance with previously analysed multidrug 
transporter substrates [272]. Independent studies on TPP
+ and tetraphenyl boron (TPB
+) 
in egg phosphatidylcholine suggested a concentration dependent localisation of TPP
+. 
At  high  TPP
+  concentrations,  the  main  location  of  TPP
+  was  near  the  choline  head 
group, while at low TPP
+ concentrations the preferred localisation was in the acyl chain  Chapter 8 – Solid state NMR 
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[276]. A possible concentration dependent relocalisation of TPP
+ in DMPC membranes 
was not investigated here. 
The efficient removal of lipophilic TPP
+ from a bacterial cell would be aided by access 
to the multidrug transporter binding sites from the glycerol backbone region of the lipid 
membrane.  The  flippase  and  hydrophobic  vacuum  cleaner  models  of  multidrug 
transporter would thus seem evolutionary more favourable for lipophilic substrates than 
the classical pump mechanism. 
 
8. 3 
13C MAS NMR on U-
13C Hsmr 
While drug-lipid interaction studies by 
1H MAS NMR allow an important insight, more 
direct  experiments  using  labelled  transporter  proteins  are  needed  to  elucidate  the 
structural basis of multidrug efflux. In the following, the potential of solid state NMR 
on U-
13C labelled Hsmr in lipid bilayers has been evaluated.   
  
8. 3. 1 Introduction to 
13C MAS NMR on membrane proteins 
In contrast to solution state NMR, there is not yet an established suite of experiments 
for  the  membrane  protein  structure  determination  by  solid  state  NMR.  The  few 
structural investigations of membrane proteins that have been attempted by solid state 
NMR have relied heavily on 2D symmetric homonuclear correlation experiments such 
as  PDSD,  RFDR  and  DARR,  although  recently  the  use  of  a  few  heteronuclear 
experiments has been shown on model proteins such as ubiquitin [119], thioredoxin 
[282], GB1 [283] and phospholamban [122]. 
2D  homonuclear  experiments  allow  the  measurement  of 
13C-
13C  through  space 
correlations and thereby theoretically enable the assignment of all carbon resonances of 
one amino acid residue as well as long distance restraints in one experiment. These 
experiment types all rely on dipolar coupling to transfer the magnetization in a distance 
dependent manner between nuclei. The heavy reliance on homonuclear 
13C spectra in 
solid state NMR arises from difficulties associated with the measurement of 
1H signals, 
and low efficient magnetization transfers between 
13C and 
15N nuclei. 
Briefly, the acquisition of 
1H spectra in the solid state is hampered by the extremely 
large and strong homonuclear 
1H dipolar coupling network which severely limits the 
spectral resolution at the available MAS speeds (routinely up to 15 kHz) and decoupling 
power  (approximately  100  kHz).  Heteronuclear  experiments,  such  as 
13C  - 
15N 
correlations, however, are challenged by the low magnetic susceptibility of both nuclei 
and the long magnetization transfer times causing excessive signal loss by relaxation. 
Today the most promising experiments, at least for the initial investigation, to judge the 
feasibility  of  structure  determination  by  solid  state  NMR  are  therefore 
13C-
13C 
correlation experiments. Several studies have already investigated the effectiveness for 
various 
13C-
13C  dipolar  recoupling  experiments  [284].  Here,  the  solid  state  NMR 
suitability  of  Hsmr  regarding  residue  specific  assignment  was  investigated  using 
homonuclear 
13C-
13C correlation spectra and two different isotope labelling schemes.  
 
8. 3. 2 
13C MAS NMR on Hsmr 
The initial solid state NMR assessment of Hsmr used an in vivo uniformly 
13C labelled 
protein which was reconstituted at 1:100 protein:lipid mol ratio in E. coli total lipids. As 
shown  in  chapter  4,  these  conditions  afford  the  most  uniform  and  dense  protein 
incorporation as judged by sucrose density gradient centrifugation and freeze fracture 
analysis.  Also,  these  conditions  were  shown  in  chapter  6  to  yield  active  protein  as 
judged using an bR coupled ethidium bromide transport assay [254]. Latter experiments 
used a uniformly 
13C labelled Hsmr, selectively unlabelled at the abundant alanine and 
valine residues [285]. In theory, for complete residue specific resonance assignment, a Chapter 8 – Solid state NMR 
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single uniformly labelled protein sample is required. However, if spectral crowding due 
to poor signal dispersion, large number of resonances, large abundance of a specific 
residue type and line-broadening are present, it may be necessary to resort to the use of 
several partially labelled samples. Many such approaches have been documented for 
solid  state  NMR  investigations.  These  include  specific  unlabelling  [285],  pattern 
labelling [286, 287], amino acid specific labelling [158] and amino acid group labelling 
[288]  .  For  investigations  of  the  suitability  of  Hsmr  for  structural  studies,  specific 
unlabelling of the highly abundant amino acids alanine and valine, together comprising 
nearly 40 % of all Hsmr amino acids, were chosen. This approach can be expected to 
have a large effect on spectral quality while being inexpensive.  
 
The first 2D experiment used was a PDSD spectrum, a homonuclear 
13C-
13C correlation 
experiment (see materials and methods). The sample was measured in the frozen state, 
to enable cross polarisation from protons to be used for signal enhancement and to 
ensure long-term protein stability. 
A spinning speed of 10000 Hz was chosen to remove most of the 
13C chemical shift 
anisotropy, and ensure long-term stable sample spinning. The 
1H-
13C dipolar couplings 
was  decoupled  during  the 
13C  evolution  periods  to  remove  line-broadening  effects. 
Mixing took place without decoupling, i.e. in the presence of 
1H-
13C dipole couplings. 
The resulting 
13C linebroadening and spectral overlap enabled 
13C-
13C spin diffusion. 
Measurements were carried out for several mixing times. Here, a short mixing period 
(20 ms) is chosen to spatially limit spin diffusion. It has been previously shown that at 
such  short  mixing  times  magnetization  is  transferred  only  between  one  bond 
neighbours, thus providing strictly intraresidue  cross peaks [123]. This is confirmed 
here (see figure 57 for an overlay of two different mixing times). The effect on spectral 
crowding  of  uniformly 
13C  labelled  Hsmr  or  uniformly 
13C  labelled  and  selectively 
unlabelled alanine and valine Hsmr are shown for the CαCβ region in figure 58A) and 
58B) respectively. 
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Figure  57.  2D 
13C-
13C  PDSD  experiments  on  selectively  unlabelled  Hsmr 
reconstituted into E. coli total lipids. A PDSD spectrum with a mixing time of 20 ms is shown 
in black while the PDSD experiment with a spin diffusion step of 200 ms is shown in red. The 
sample  was  uniformly 
13C  labelled,  with  the  exception  of  and  Ala  and  Val.  Hsmr  was 
reconstituted into E. coli total lipids at a protein:lipid mol ratio of 1:100. Spinning side bands 
occurring are indicated by arrows. Two or more bond correlations are indicated by boxes. 
The PDSD experiment on Hsmr was measured at 235 K and a spinning rate of 10000 Hz. The 
spectra were acquired using TPPI and 
1H was measured at 400.13 MHz and 
13C was measured 
at 100.62 MHz. The spectrum was acquired with 2098 points in the direct dimension and 256 
points in the indirect dimension. A total of 128 transients were collected per slice. The spectrum 
was processed with exponential line broadening of 50 Hz in the direct dimension and quadratic 
sine modulation in the indirect dimension.  
 
At first glance the PDSD spectra in figure 57 reveal an intense diagonal, which arises 
from  the  short  magnetization  transfer  time  of  20  ms  (black  spectrum)  and  natural 
abundance 
13C  signals  from  the  lipids  (both  spectra).  Although 
13C  has  a  natural 
abundance of only 0.1 %, the lipids are present at a 100 fold mol excess compared to the 
protein. The intense diagonal may in general limit the ability to detect low intensity 
cross peaks due to limitations of the dynamic range during acquisition. In particular, the 
intense diagonal may limit the detection of cross peaks close to the diagonal.  
Also immediately evident are the two strong lines running parallel to the diagonal. In 
figure 57, the spinning sideband are indicated by arrows. If the spinning speed cannot 
be chosen such that the chemical shift anisotropy is completely removed, it is chosen in Chapter 8 – Solid state NMR 
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such a way as to avoid interference between cross peaks and the spinning sidebands of 
the diagonal, as is seen here. 
The overlay of spectra acquired with respective 20 ms and 200 ms mixing times allows 
the progress of spin diffusion to be assessed. Indeed, the black spectrum (20 ms) shows 
mainly  one  bond  correlations,  namely  CαC’,  CβCα,  CβCγ  and  CaromaticCaromatic 
cross peaks. The red spectrum (200 ms) shows more cross peaks, now also including 
two or more bond correlations namely C’Caromatic, CaromaticC α, CaromaticCβ, C’Cβ 
and C’Cγ, highlighted in the spectrum by boxes. A decrease of the diagonal intensity is 
clearly visible and arises from the longer pulse sequence and concomitantly increased 
relaxation. 
 
For resonance assignment, individual peaks must be discernible for ‘assignment walks’ 
between residues to be carried out. The CαCβCγ region of uniformly and selectively 
unlabelled Hsmr are enlarged in figure 58 to enable resonance assignment and the effect 
of selective alanine and valine unlabelling to be detected. 
 
 
 
Figure 58. PDSD Cαβ region of uniformly 
13C labelled Hsmr and selectively unlabelled 
Hsmr.  A)  uniformly 
13C  labelled  Hsmr  and  B)  uniformly 
13C  labelled  Hsmr  selectively 
unlabelled with alanine and valine. The PDSDs were acquired with 20 ms mixing time. The 
PDSD experiment on uniformly labelled Hsmr was measured at 190 K at a 9500 Hz MAS spin 
rate. The spectrum was acquired with 1398 points in the direct dimension and 128 points in the 
indirect dimension. The PDSD experiment on selectively unlabelled Hsmr was measured at 235 
K and 10000 Hz MAS rate. The spectrum was acquired with 2098 points in the direct dimension 
and 256 points in the indirect dimension. Both spectra were measured with 
1H at 400.13 MHz 
and 
13C at 100.62 MHz using TPPI and a total of 128 transients per slice. The spectra were 
processed with exponential line broadening of 50 Hz in the direct dimension and a squared sine 
modulation in the indirect dimension. Only positive contour levels are shown. 
 
As can be clearly seen in figure 58A) and 58B), a few narrow resonances, a few broad 
resonances and large areas of unresolved magnetization are observable. The number of 
discrete resonances is increased in the spectrum of selectively unlabelled Hsmr, and the 
area covered by unresolved magnetization is reduced. These changes occur in a region 
of  typical  alanine  and  valine  chemical  shifts  and  this  resolution  increase  is  thus 
attributed to the isotope dilution by specific unlabelling. However, it must be noted that 
in neither sample the resolution was sufficient to observe the expected 139 Cα (fully 
labelled sample) or 91 Cα (selectively unlabelled sample) diagonal peaks or 128 CαCβ Chapter 8 – Solid state NMR 
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(fully  labelled  sample)  or  80  CαCβ  (selectively  unlabelled  sample)  cross  peaks. 
Additionally, it must be noted that the individual peaks observed could not be assigned 
to  spin  groups  and  amino  acids  types.  An  INADEQUATE  type  experiment  could 
alleviate problems with assigning spin groups and amino acid types. Figure 59 shows a 
theoretical DQSQ spectrum for three amino acids.    
 
 
Figure 59. Theoretical spectrum of three amino acids in a 2D DQSQ spectrum. The DQSQ 
correlation pattern of glutamate (black), tryptophan (yellow) and serine (green) is shown here. 
The pattern is diagnostic of the amino acid type but crowding is also observed, particularly in 
the C’ and Cα region. The average chemical shifts for the amino acids, as reported in the 
BMRB, were used here.   
 
Figure 60 shows an INADEQUATE type DQSQ experiment of Hsmr. Although more 
individual resonances can be resolved, not a single spin  group could be completely 
assigned. Here, again it is observable that Hsmr samples have a large line-width and 
poor  chemical  shift  spread,  making  Hsmr  a  poor  candidate  for  structural 
characterisation by solid state NMR. Recently published 
13C-
13C PDSD spectra of EmrE 
in  2D  DMPC  crystals  by  solid  state  NMR  also  report  problems  with  unresolved 
resonances [136]. 
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Figure 60. 2D 
13C-
13C DQSQ experiment on selectively unlabelled Hsmr reconstituted into 
E. coli total lipids. Part of an assignment walk was possible for the acidic amino acids and their 
uncharged derivatives (Asp, Glu, Asn and Gln) due to their characteristic Cγ and Cδ shifts 
respectively. The aromatic region is highlighted with a box. An arrow indicates the 1 bond 
correlations likely arising from Asp, Asn (CβCδ) and Glu, Gln (CγCδ). The DQSQ experiment 
on Hsmr was measured at 220 K and 10000 Hz MAS rate. Double quantum (DQ) coherence 
was generated using a SR22 sequence. The sample was uniformly 
13C labelled and Ala, Val 
12C 
unlabelled. Hsmr reconstituted into E. coli total lipids at a protein:lipid mol ratio of 1:100. The 
spectra were acquired in phase sensitive mode (States-TPPI) and 1H was measured at 600.12 
MHz and 
13C was measured at 150.91 MHz. The spectrum was acquired with 1796 points in the 
direct  dimension  and  240  points  in  the  indirect  dimension.  A  total  of  512  transients  were 
collected per slice. The spectrum was processed with exponential line broadening of 50 Hz in 
the direct dimension and a squared sine modulation in the indirect dimension. Only positive 
contour levels are shown. 
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8. 3. 3 Conclusion 
Hsmr was investigated using two different 
13C labelling schemes and using several 
13C - 
13C  correlation  experiments.  The  resulting  PDSD  and  DQSQ  spectra  show  poor 
resolution due to broad line width, a limited chemical shift spread and high amino acid 
type redundancy. A limited chemical shift spread is typical for alpha helical membrane 
proteins,  but  the  large  line-width  indicates  structural  heterogeneity  of  the  sample. 
Sucrose  gradient  centrifugation  and  freeze  fracture  electron  microscopy  indicate  a 
macroscopically  homogenous  sample.  Theoretically,  Hsmr  could  be  in  exchange 
between distinct conformational states such as binding or release conformations leading 
to sample heterogeneity. However, Hsmr in the absence of substrate and a pH gradient 
can be expected to have its conformational space limited to the binding position. More 
likely, freeze trapping of thermal motions on the ms range are the cause of microscopic 
sample heterogeneity [132, 289]. This is commonly observed with solid state NMR of 
biological materials and the protein is considered natively folded for unaligned and non-
crystalline proteins with linewidth between 1 and 4 ppm [124, 290]. 
In order to obtain a more global view, static 
2H NMR has been used to probe Hsmr 
mobility within the lipid bilayer.  
 
8. 4 
2H NMR on Ala-d3-Hsmr 
8. 4. 1 Molecular dynamics from static 
2H solid state NMR 
Solid  state  NMR  is  well  suited  to  studies  of  molecular  motion  as  a  large  range  of 
motional  regimes  can  be  investigated  through  the  analysis  of  their  effects  onto 
anisotropic  spin  interactions.    Relaxation  studies  as  well  as  lineshape  analysis  of 
chemical  shift  anisotropy  (CSA),  dipolar  and  quadrupole  couplings  allow  a  wide 
frequency range to be charaterised.  
Mostly, however, the study of protein dynamics by solid state NMR has historically 
relied on 
2H quadrupole NMR. Spin lattice relaxtion times are sensitive to motions in 
the order of the inverse Larmor frequency (10
-6 s) while the typical quadrupolar Pake 
pattern response to motions of the inverse of the quadrupolar coupling constant (167 
kHz für static C-D; 10
-3 s). Processes accessible by 
2H NMR cover a range of 10
-10 to 
10
-4  s.  In  case  of  membrane  proteins,  this  can  involve  sidechain  flexibility,  helix 
wobbling,  internal  fluctuations  and  rotational  diffusion.  Seminal  work  on  protein 
dynamics using 
2H NMR was conducted collagen [291, 292], bacteriorhodopsin [293] 
[294] and pancreatic phospholipase A2 [295] in the 1980s. 
2H is a spin 1 quadrupolar 
nucleus and can be incorporated into biomolecules as a replacement for 
1H. Deuterium 
offers  the  advantage  of  low  natural  abundance  (0.01  %  [296]),  numerous  possible 
incorporation  sites  and  simple  incorporation  during  sample  preparation.  [297].  The 
quadrupole-coupling  constant  dominates  the  deuterium  powder  pattern  and  a  Pake 
pattern is observed. The expected unscaled linewidth of the Pake pattern lies in the 
hundreds  of  kHz  (167kHz  quadrupole  coupling  for  C-D).  Large  spectral  width  thus 
required  for  these  experiments  means  specifically  tailored  NMR  experimental 
conditions and pulse sequences, generally a standard quadrupole echo experiment (see 
materials  and  methods),  need  to  be  used.[298].  In  contrast  to  the  large  quadrupole-
coupling constant linewidth the chemical shift dispersion of 
2H is small and identical to 
1H  [299].  Accordingly,  the  site  specific  resolution  of  samples  labelled  at  multiple 
positions is poor. Therefore, static experiments are preferred over 
2H MAS. 
 
8. 4. 2 Dynamics of Hsmr reconstituted in E. coli lipids by 
2H NMR  
Investigations into the 3D structure of Hsmr by solid state NMR have indicated the 
presence of motions occurring in the proteins structure. Chapter 8 – Solid state NMR 
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Here, the global motional regime of Hsmr incorporated into E. coli total lipid liposomes 
is  directly  investigated  using  static 
2H  NMR.  During  static  experiments  the  full 
anisotropy of all NMR interactions is observed. Deviations of the observed lineshape 
from the theoretical powder pattern can thus be directly, without simulations, attributed 
to protein dynamics. Hsmr global protein dynamics were investigated using deuterated 
alanine, chosen due to its abundance (19 alanine residues) and distribution in three of 
the  four  proposed  Hsmr  transmembrane  helices,  (see  figure  61).  Due  to  the  poor 
chemical shift dispersion of deuterons and the fact that the spectrum is dominated by the 
quadrupole-coupling  constant,  only  global  alanine  dynamics  can  be  investigated. 
Alanine-d3  is  ideally  suited  for  the  investigation  of  backbone  mobility  as  it  offers 
increased sensitivity due to three reporting deuterons and the fast rotation around the 
Cαβ  bond  ensures  that  at  ambient  temperatures  the  quadrupole-coupling  constant  is 
reduced to 51.7 kHz [292]. Deviations from this quadrupole-coupling constant report 
directly on protein backbone mobility and the methyl group environment. See figure 62 
for the alanine-d3 chemical structure.  
 
 
 
Figure 61. Topology diagram of Hsmr with myc-his tag and highlighted alanine residues. 
Alanines are highlighted in blue and the proposed transmembrane regions are depicted as grey 
boxes [267]. Two alanine residues are located in the myc-his tag and one alanine in the C-
terminus. 
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Figure 62. Chemical structure of alanine-d3. 
 
Here, Hsmr mobility in the exchange mode, i.e. with substrate but without pmf, was 
assessed at 283 K and 230 K reconstituted into total E. coli lipids in the absence and 
presence  of  100  fold  excess  of  the  substrate  ethidium  bromide.  The  native  Hsmr 
environment is the plasma membrane of H. salinarium, and is most closely mimicked 
by E. coli lipids. These two temperatures were chosen to measure Hsmr mobility in 
gel/Lβ phase membranes (283 K) and largely immobilised by freezing (230 K) [300]. At 
283 K, E. coli lipids are below the liquid-crystalline phase transition temperature (20-25 
°C) [301], but the membrane still exhibits extensive motions [300] [302]. These low 
temperatures were beneficial for the longevity of the fragile protein Hsmr. 
Samples measured at 230 K should have negligible backbone mobility and merely side 
chain  bond  rotations,  around  the  CαCβ  bond  of  alanine  are  observed.  This  low 
temperature was chosen as a control measurement to provide the lineshape of immobile 
protein. Among the known Hsmr substrates, ethidium bromide was selected for this 
investigation, as transport activity assays in this study (chapter 6) directly showed its 
active  transport.  The  membrane  integrity  was  preserved  in  the  presence  of  excess 
ethidium bromide, see figure 63.  
 
 
Figure 63. Freeze fracture analysis of Hsmr in E. coli total lipids with ethidium bromide. 
Hsmr reconstituted at 1:100 protein/lipid mol ratio in E. coli lipids and spiked with ethidium 
bromide, 100 fold mole excess during incubation, was subjected to freeze fracture analysis after 
several days of NMR measurements at 283 K and 230 K.  Chapter 8 – Solid state NMR 
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Hsmr NMR spectra without and with the substrate ethidium bromide, figure 64A)C) and 
64B)D),  are  essentially  identical  at  230  K.  It  can  be  seen  that  the 
2H  spectrum  is 
dominated  by  the  quadrupolar  interactions.  The  observed  lineshape  arises  from  the 
superposition  of  the  quadrupole-coupling  constants  of  19  alanine-d3  molecules 
incorporated into non-equivalent sites.  
 
 
Figure  64.  Static 
2H  spectra  of  alanine-d3  labelled  Hsmr.  Hsmr  reconstituted  at  1:100 
protein/lipid  mol  ratio  in  E.  coli  lipids  was  measured  static  with  a  quadrupole  echo  pulse 
sequence (see materials and methods) at 230 K A), B) and at 283 K C), D). Hsmr without 
substrate  is  shown  in  A)  and  C)  while  Hsmr  after  incubation  with  an  excess  of  ethidium 
bromide is shown in B) and D). The same sample was used for all four measurements and 
incubation with etbr led to a reduction in sample quantity. The spectra were acquired using 
2H 
92 MHz with 4892 points. A total of ~ 400,000 transients were collected per spectrum. The 
spectra were processed with exponential line broadening of 2500 Hz.  
 
The apparent quadrupole coupling constant χ at 230 K can be calculated and is 49.0 kHz 
for Hsmr without substrate and 45.6 kHz for Hsmr in the presence of ethidium bromide. 
The  quadrupole  coupling  constant  is  only  apparent  as  it  is  a  superposition  of  19 
individual quadrupole couplings. The apparent effective quadrupole coupling constants 
are very similar and compare favourably with the literature value of 49 kHz [303]. Hsmr 
without and with substrate at 230 K is thus largely immobile and methyl group rotation 
is impeded in the folded protein as judged by 
2H NMR lineshape analysis. Reducing 
methyl group rotation by temperature requires temperatures smaller than 120 K [297]. 
 
In contrast, Hsmr in E. coli total lipid membranes at 283 K is expected to be more 
mobile, to undergo increased thermal fluctuations and possibly conformational changes. 
Indeed, the 
2H NMR spectra of Hsmr without substrate (figure 64C)) and Hsmr with 
substrate (figure 64D)) are dramatically different from the frozen Hsmr spectra (figure 
64A) and figure 64B)). At 283K, the observed static 
2H NMR spectra are composed of 
at  least  two  components.  At  least  one  cumulative  broad  Pake  pattern  shaped 
contribution is superimposed on one cumulative narrow contribution. Calculation of the Chapter 8 – Solid state NMR 
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apparent quadrupole-coupling constant for the broad component is hampered by the 
absence of the expected “horns”. Taking the outmost shoulder as horn, the apparent 
quadrupolar-coupling constant is 48.5 kHz for Hsmr without substrate and 42.5 kHz for 
Hsmr  with  substrate.  Both  quadrupole-coupling  constants  are  very  similar  to  the 
apparent  quadrupolar-coupling  constant  observed  for  frozen  Hsmr.  However,  the 
absence  of  the  “horns”  provides  evidence  that  the  broad  component  is  indeed  a 
superposition of several distinct quadrupolar-coupling constants. If for Hsmr without 
substrate it is assumed that only two components contribute to the spectrum then it can 
be concluded that one component undergoes slow motions on the 
2H time scale (10
-3 to 
10
-6 s) yielding a powder pattern-like component. By contrast the second component 
then can be concluded to undergo fast motions on the 
2H time scale (10
-3 to 10
-6 s) 
yielding a nearly isotropic lineshape. The narrow component can be expected to have 
contributions from residual natural abundance D2O as observed previously [292]. The 
contribution should be very small, as D2O depleted H2O was used during the sample 
preparation, and even the natural abundance of D2O is low with just 0.01 % [296]. A 
90° pulse experiments with the spinning speed set equal to the sweep width to remove 
all anisotropic interactions [298], see figure 65, reveals two signals. The sharp D2O 
peak  has  a  small  integral  compared  to  the  broad  alanine  peak  and  concomitantly 
produces only a minor contribution to the narrow component in figures 64. It can thus 
be derived that at 283 K the majority of alanine residues is largely immobile while 
several Hsmr alanine residues are remarkably mobile. These mobile alanine residues are 
likely tag and loop residues.  
 
-1000 1000 0 Hz 
Figure 65. 
2H spectra of alanine-d3 labelled Hsmr at 8000 Hz MAS. Hsmr reconstituted at 
1:100 protein/lipid mol ratio in E. coli lipids was measured at 283 K and 8000 Hz MAS. The 
spectrum was acquired using 
2H 92 MHz with 1596 points. A total of 100,000 transients were 
collected per spectrum. The spectra were processed with an exponential line broadening of 1 
Hz. The narrow peak (left hand side) arises from D2O, while the right broad peak is due to 
alanine-d3. 
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For Hsmr with substrate, figure 64D), a significant decrease in signal intensity of the 
narrow components to the total signal is observed. Correspondingly, the signal intensity 
of  the  powder  pattern  components  increased  with  respect  to  the  total  signal.  The 
addition of the substrate ethidium bromide to Hsmr in exchange mode could be the 
cause of reduced transmembrane mobility or accumulation of ethidium bromide in the 
membrane could affect the protein mobility.  
The  overall  large  mobility  of  Hsmr  transmembrane  segments  embedded  in  an 
anisotropic  lipid  membrane  is  surprising.  Unexpectedly,  large  protein  mobility  of 
transmembrane  regions  however  has  also  been  reported  for  other  transport  proteins 
including  LmrA  and  LacY  [304,  305].  No  attempt  was  made  to  quantify  these 
components, because transmembrane dynamics have previously been proven to exhibit 
a loss of signal intensity due to intermediate rate motions [306]. A direct correlation of 
integrals and spin numbers is thus not possible. Equally importantly, to obtain integrals 
of  the  fast  and  slow  components  the  complex  experimental  spectrum  needs  to  be 
deconvoluted. A total of 19 separate alanine contributions and D2O give rise to the 
observed lineshape and fitting so many parameters with no additional information is not 
sensible. 
Discussions  about  possible  mechanisms  enabling  the  broad  substrate  specificity  of 
multidrug  transporter  include  protein  flexibility  as  a  contributing  factor  [307,  308]. 
Most investigations into substrate recognition however have been performed on soluble 
transcription  factors  of  multidrug  transporters  [9,  10,  12,  13].  The  large  dynamics 
observed here, of the transmembrane region of a protein embedded in a lipid membrane, 
support the notion that protein mobility plays a role in substrate recognition for Hsmr. 
This is further supported here by the limitation of protein conformational flexibility 
upon  substrate  binding.  The  complementary  limited  substrate  mobility  in  the  bound 
state was detected with the fluorescence based ethidium bromide transport assay [254]. 
 
8. 4. 3 Conclusion 
Hsmr  incorporated  into  an  E.  coli  total  lipid  membrane  showed  differential  global 
mobility, as judged by a global lineshape analysis of 19 alanine residues, as a function 
of temperature and presence of substrate. Hsmr in E. coli total lipid membrane frozen at 
230 K yielded a single Pake pattern with a quadrupole splitting typical for proteins. At 
the higher temperature (280 K), Hsmr was present in a gel phase E. coli total lipid 
membrane  and  lineshape  analysis  revealed  alanine  residues  in  different  motional 
regimes and as well as contributions from residual D2O. Hsmr incorporated into a gel 
phase membrane showed several remarkably mobile alanine residues. Their mobility 
was reduced upon substrate addition supporting the notion that protein flexibility is one 
mechanism of multidrug transporter to enable recognition of highly diverse substrates.    
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Chapter 9 - Investigations of EmrE and its key residue for 
substrate transport E14 – in the membrane embedded dimer 
EmrE is asymmetric  
 
9. 1 Introduction 
Here, E. coli EmrE, a member of the SMR protein SMP subclass and its structural 
model,  is  investigated  [25].  EmrE  transports  a  diverse  array  of  aromatic,  positively 
charged substrates, including ethidium bromide, in exchange for protons [39]. Like all 
SMP proteins, EmrE has the highly conserved key residue E14 in its proposed first TM 
helix [27, 154]. It has been shown that E14 is an essential residue and directly involved 
in drug and proton binding [65] [64, 309]. It can reasonably be assumed, that the E14s 
of both protomers in a dimer form a shared binding pocket [19, 44, 47]. See figure 66 
for a schematic representation of helices 1 forming an ethidium bromide binding pocket. 
Whether EmrE forms a symmetric or an asymmetric dimer should be reflected in the 
chemical shifts of residues such as E14, which are likely to be found at the dimerisation 
interface. This provided the motivation for the direct, non-invasive investigations of 
E14 in EmrE. Here, E14 in EmrE was 
13C labelled using a cell free expression system 
and investigated reconstituted in E. coli total lipids by solid state NMR.  
 
 
Figure 66. Schematic model of the TM helices 1 of dimeric EmrE with ethidium bromide. 
The sidechain of residue E14 is depicted as stick model and the nuclei are labelled according to 
the IUPAC convention. The inherent asymmetry of ethidium bromide suggests that its binding 
pocket should also be asymmetric. 
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9. 2 Results 
9. 2. 1 Sample preparation 
In order to investigate the electronic structure of E14 in EmrE, a selectively labelled 
sample was required. For this, in vitro transcription and translation has to be employed, 
as selective glutamate labelling in vivo is difficult due to isotope scrambling [310]. In 
addition,  a  single  glutamate  mutation  is  necessary  to  avoid  spectral  overlap,  and  to 
obtain  unambiguous  data.  Cell  free  protein  expression  has  been  carried  out  both  as 
precipitate  followed  by  solubilisation  in  DDM  and  also  directly  in  the  presence  of 
DDM. The resultant 
13C E14 EmrE E25A was reconstituted into native E. coli lipids. 
Sample  purity,  labelling  efficiency,  activity  and  sample  homogeneity  were  carefully 
examined.  
 
9. 2. 1. 1 Protein purity 
Protein purity was analysed by MALDI-TOF mass spectrometry and SDS PAGE. A 
typical spectrum is shown in figure 67 and the measurements are summarised in table 
25.  
 
 
Figure  67.  Representative  MALDI-TOF  mass  spectrum  of  purified 
13C/
15N  glutamate 
labelled EmrE E25A. Triplicate measurements give a mass of 12,785.34 ± 2.68 Da for EmrE 
E25A 
13C/
15N glutamate labelled, formylated and with attached sodium. The mass measured 
here agrees well with the expected mass for EmrE E25A 
13C/
15N glutamate labelled formylated 
and with attached sodium
 (12780.1 Da). Peaks of the reference compounds used for internal 
two-point calibration are labelled Std1 and Std2. No other signals were detected. These data 
show that EmrE E25A is pure and confirm conventional SDS PAGE analysis (see inset picture, 
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  theoretical Mr  theoretical Mr 
+ formylation (28 Da)  
+ Na
+ (23 Da) 
m/z 
measurement 1  12729.1  12780.1  12782.31 
measurement 2  12729.1  12780.1  12787.42 
measurement 3  12729.1  12780.1  12786.29 
       
average (sdv)  12729.1  12780.1  12785.34  ± 2.68 
Table 25. Average EmrE E25A masses from three independent MALDI-TOF experiments 
using  internal  calibration.  Listed  are  measured  values  (m/z)  corresponding  to  the  singly 
charged 
13C,
15N  glutamate  labelled  EmrE  E25A  formylated  and  with  attached  sodium  ion. 
Additionally, the theoretical average masses (Mr) of 
13C,
15N glutamate labelled EmrE E25A and 
of 
13C,
15N glutamate labelled EmrE E25A formylated with attached sodium were calculated. 
The presence of formylation is verified by MS after tryptic digestion, see figure 69. 
 
The  peak  at  12,785.34  ±  2.68  Da  agrees  well  with  the  mass  expected  for 
13C/
15N 
glutamate  labelled  EmrE  E25A  formylated  and  with  attached  sodium
  (12780.1  Da). 
Formylation was confirmed by MS after tryptic digestion, see figure 69. The absence of 
other  signals  and  the  result  of  SDS  PAGE  show  EmrE  E25A  is  pure.  Mass 
spectrometry, in addition to SDS PAGE, is a very sensitive tool to assess contamination 
with soluble proteins. Membrane proteins other than EmrE are not present in the cell 
free expression system.  
 
9. 2. 1. 2 Scrambling and labelling efficiency 
The absence of 
13C glutamate scrambling in the in vitro expression system was verified 
by  performing  a  complete  translation  and  transcription  experiment  without  DNA 
template. A 
13C-NMR analysis of the whole reaction mixture did not show any signs of 
glutamate to glutamine conversion, see figure 68.  
 
 
Figure 68.  Scrambling  control. 
13C J-coupled  1D NMR  spectrum  of  cell  free  reaction. A 
complete  cell  free  translation  and  transcription  experiment  was  performed  under  standard 
conditions with uniformly labelled 
13C glutamate but omitting a DNA template [12]. Here, the 
carbonyl section of the reaction mixture is shown. Typical glutamate Cδ chemical shifts and the 
expected J-coupling pattern were observed [311]. By contrast, no Cδ chemical shifts and J-
coupling  pattern  were  detected  for  glutamine,  a  metabolic  pathway  neighbour  [312].  The 
spectrum was collected at 300 MHz 
1H Larmor frequency with 8 k transients. 
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However, the labelling  efficiency of  glutamate  depends on dilution effects. Dilution 
effects describe the conversion of unlabelled amino acids into the amino acid which was 
supplied  in  an  isotope  labelled  form.  This  dilution  effect  could  be  assessed  using 
MALDI-TOF spectrometry of tryptic EmrE E25A digests. In figure 69 spectra of tryptic 
digests of EmrE E25A before and after dialysis can be seen. Prolonged sample handling 
leads  to  the  increased  occurrence  of  a  specific  N-terminal  degraded  EmrE  E25A 
fragment. Only the N-terminal tryptic digestion fragments are detected for EmrE E25A 
as the remaining fragments are extremely hydrophobic.  
 
 
Figure  69.  MALDI-TOF  spectra  of  tryptic  digests  of 
13C/
15N  labelled  EmrE  E25A.  A) 
EmrE E25A dialysed (24 h at 4°C) prior to tryptic digestion; B) EmrE E25A not dialysed before 
tryptic digestion. Only the N-terminal tryptic digestion fragment is detected for EmrE E25A. 
During  dialysis  the  abundance  of  a  specific  N-terminal  degradation  product  increases.  The 
insets show enlargements of the formylated peaks and enable quantitation of the labelled peaks 
(a difference of 6 Da is expected between 
12C/
14N glutamate and 
13C/
15N glutamate) as well as 
sodium attachments (addition of 23 Da) and methionine oxidations (Mox) to be seen. Spectra are 
corrected by subtraction of buffer peaks and triangles indicate signals above the noise level. 
Peaks close to 1000 m/z are known matrix peaks and are ignored.  
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The inset shows that the EmrE E25A N-terminal fragment is mainly correctly 
13C/
15N 
labelled  at  E14,  but  fragments  with  a  mass  corresponding  to 
12C/
14N  E14  are  also 
present. The labelling efficiency can be calculated and is 64 % ± 1 %. The expected 
technique inherent error is 20 %. The low labelling efficiency was unexpected. MS 
analysis  of  uniformly 
13C/
15N  labelled  amino  acid  glutamic  acid  confirmed  the 
manufacturer’s claim of 98 % labelling efficiency. The discrepancy of amino acid and 
protein labelling efficiency must arise from glutamic acid contamination of the cell free 
extract  or  dilution.  However,  if  MALDI-TOF  is  used  to  assess  protein  labelling 
efficiencies  such  low  values  are  typically  encountered  [313].  The  low  labelling 
efficiency of course is the main cause of low NMR signal intensity.  
 
Formylation was confirmed by MS and MS/MS after tryptic digestion, see figure 69 and 
figure 70. The assignment of the tryptic fragments and the formylation by MS were 
verified by MS/MS mass spectrometry. Figure 70 shows the MS/MS spectrum obtained 
when  the  formylated  N-terminal  EmrE  E25A  fragment  from  tryptic  digestion  was 
selected as precursor ion. The major ions in this type of spectrum are the y and b ions. A 
nearly complete ion pattern of the N-terminal fragment was observed. All b ions clearly 
show the mass shift of  28 Da due to the formylation of the  N-terminal methionine 
residue. If the spectrum is enlarged, see insets for the high molecular weight y ions, the 
peak doublets separated by 6 Da can be clearly seen. The doublets arise due to the 
selection of the formylated N-terminal fragment of EmrE E25A with both labelled and 
unlabelled  glutamate  as  precursor  ion.  This  confirms  the  presence  of  formylation, 
fragment assignment in figure 69 and calculated labelling efficiency.    
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Figure 70. MS/MS of an EmrE E25A tryptic digest. Part A and B show the same spectrum 
but  in  A)  the  ions  of  the 
12C/
14N  glutamate  unlabelled  N-terminal  tryptic  fragment  are 
highlighted while in B) the ions of the 
13C/
15N glutamate labelled N-terminal tryptic fragment 
are  highlighted.  The  precursor  ions  of 
13C/
15N  glutamate  labelled  and 
12C/
14N  glutamate 
unlabelled N-terminal EmrE E25A fragment are selected together and the pattern of double 
peaks is seen for all ions of the y and b series. The insets show an enlargement of the high mass 
y ions and the double peaks separated by 6 Da can be seen. Chapter 9 – Investigations of EmrE and its key residue for substrate transport E14  - in 
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9. 2. 1. 3 Reconstitution and sample homogeneity 
Purified protein solubilised in DDM was directly reconstituted into E. coli total lipids at 
a 1:100 mol ratio. E. coli lipids were selected to ensure a native membrane environment. 
Reconstitution was consistently successful, as monitored by freeze fracture microscopy. 
Even after many days of NMR experiments, samples were very homogeneous without 
any aggregates as shown in figure 71.  
 
 
Figure 71. Representative freeze fracture electron micrograph of EmrE E25A in E. coli 
total lipids. After ten days of MAS NMR experiments, the sample (EmrE E25A incubated with 
etbr) was subjected to freeze fracture analysis. EmrE E25A, visible as particles in the fracture 
face, was incorporated evenly into similarly sized E. coli total lipid liposomes. The sample was 
very homogeneous and no protein aggregation was detected. 
 
The interpretation of the NMR data relies on the knowledge of the observed EmrE 
E25A oligomeric species. For wild type EmrE the majority of studies indicate a dimeric 
organisation in solution and crystals [19, 35, 36, 40, 56]. Here the novel MS technique 
LILBID,  already  used  to  investigate  Hsmr  in  chapter  5,  was  used  to  assess  the 
oligomeric species of wild type EmrE under the conditions used in this study. As can be 
seen in figure 72 EmrE is present as dimer and monomer in solution. A decrease of 
EmrE concentration by one order of magnitude increases the monomeric population. 
This contrasts with older observations of the Schuldiner lab which suggest that heat 
treatment  (80  °C  for  10  min)  is  necessary  to  separate  dimers  [314].  However,  it  is 
supported by a more recent publication from the Schuldiner lab suggesting that EmrE in 
solution is mainly present as a dimer [56]. The observations made here suggest that the 
ratio of monomeric and dimeric EmrE species depend on the EmrE concentration in 
solution. This is in accordance with the results for Hsmr, see chapter 5, and has been 
previously described for other proteins [245] [246] [247]. Overall it can be concluded 
that the solution oligomeric state of EmrE in my hands is similar to previously reported 
solution  oligomeric  states  for  EmrE.  This  lends  support  to  the  extrapolation  of 
membrane oligomeric state determinations in other studies to the system investigated 
here.  
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Figure 72. LILBID of EmrE in DDM at different concentrations. EmrE in < 0.1 % DDM, 
10 mM Tris, pH 8.0, 2.5 mM DTT at A) 6.7x10
-5 M and B) 6.7x10
-6 M is measured under 
ultrasoft LILBID conditions. At both concentrations monomers and dimers are detected but in 
different ratios.  
 
9. 2. 1. 4 Transport activity of EmrE E25A 
The activity of cell free produced EmrE E25A and wild type EmrE prepared in vivo was 
verified with a previously described ethidium bromide transport assay [254]. The assay 
methodology is described in the Materials and Methods chapter 2 and the experiments 
are discussed in detail for Hsmr in chapter 6.  
Briefly, in the course of the assay, bR driven  H
+ pumping and etbr fluorescence is 
initiated by light excitation at 545 nm. EmrE then uses the generated pH gradient as 
energy source for an antiport of etbr. The transport can be detected by an increase of  
etbr total fluorescence intensity due to binding to a transport cycle intermediate [254]. 
The time traces in figure 73 show an increase of total fluorescence for EmrE produced 
in vivo and EmrE E25A produced cell free both as precipitate and in the presence of 
detergent. Traces are almost identical and transport activity ceases when adding CCCP 
which uncouples both  pH and  ψ [194] ,  nigericin which uncouples  pH [39], or 
TPP
+  a  competitive  non-fluorescent  substrate  [27].  These  data  verified  that  active 
protein was produced using in vitro translation/transcription and that both expression 
modes, as precipitate or in the presence of detergent, are possible. As a consequence of 
these results, all NMR experiments described below were carried out on EmrE E25A 
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Figure 73.  Etbr transport activity of in vitro expressed EmrE E25A in E. coli total lipid 
liposomes.  EmrE  E25A  expressed  as  precipitate (A),  EmrE  E25A expressed soluble  in  the 
presence of detergents (C) and wild type EmrE expressed in vivo (E) all show transport activity 
in the presence of a pH gradient as judged by the increase in etbr fluorescence intensity (see 
text). Time traces B, D and F are negative controls generated by adding to samples A, C and E 
the uncoupler CCCP which collapses the proton motif force (B), the ionophore nigericin which 
collapses the pH gradient (D) or the competitive but non-fluorescent substrate TPP
+ (E). The 
experiments show that EmrE E25A produced in vitro as precipitate is active. 
 
9. 2. 2 1D NMR 
DQF 
13C MAS NMR spectra of 
13C glutamate labelled EmrE E25A in E. coli lipids are 
shown  in  figure  74a)  and  74b).  Filtering  was  necessary  to  remove  the 
13C  natural 
abundance  contributions  (1.1%),  from  lipids  and  unlabelled  residues,  which  overlap 
with the resonances of E14. However DQF does not affect the signal of the naturally 
occurring 0.01 % spin pairs. Their spectral contribution has been probed with E. coli 
lipids, figure 74c), which show a clear signal in the DQF spectrum at the CH2 position. 
This result is not surprising considering the large number of lipids per protein with 24-
28 CH2 groups per lipid.   
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Figure 74. 1D 
13C MAS NMR spectra of EmrE E25A, in E. coli total lipids and Cα line 
shape  fitting.  (a)  The  single  glutamate  mutant  EmrE  E25A  was  selectively 
13C  glutamate 
labelled and reconstituted into E. coli total lipid liposomes at a 1:100 protein:lipid mol ratio. 
13C 
double quantum filtering (25k acquisitions) was used and a symmetric peak doublet is observed 
for the Cα signal around 55 ppm. (b) After the addition of etbr the Cα peak doublet is retained 
but becomes asymmetric (70k acquisitions). (c) DQF efficiently removes the background signal 
of  the  1.1%  naturally  occurring 
13C  nuclei,  but  does  not  affect  the  signal  of  the  naturally 
occurring 0.01% spin pairs. Their spectral contribution has been probed with E. coli lipids 
which show a clear signal in the DQF spectrum at the CH2 position. (d) A line shape analysis of 
the Cα resonances of E14 in EmrE E25A shows two peaks. (e) Upon addition of etbr, Glu I and 
Glu II are shifted and additional populations are observed. Protein spectra (a, b, d, e) were 
acquired at 150.9 MHz and the lipid spectrum (c) at 100.62 MHz 
13C Larmor frequency. 
13C 
spectra at 150.90 MHz a) and b) and at 100.62 MHz c) were recorded on 600 MHz Bruker 
Avance  and  400  MHz  Bruker  Avance  spectrometers  respectively  using  4  mm  MAS  DVT 
probeheads.  Sample  measurements  were  performed  at  200 K  with a MAS  spinning  rate  of 
10,000 ±5 Hz. DQF spectra were collected with the SR22
9
4 pulse sequence [190]. Marked with 
an asterisk is a spectrometer artefact occurring at 168 ppm at 150.90 MHz. Exponential 150 Hz 
line broadening was used. For chemical shift anisotropy line shape fitting in Topspin 2.0 the 
Solids Lineshape Analysis tool was used with mixed Gaussian/Lorentzian line shapes.  
 
The spectrum shown in figure 74a reveals a symmetric Cα doublet (labelled Glu I and 
Glu II) which becomes asymmetric upon addition of etbr (see figure 74b). A line shape 
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are of similar integral intensity with a line width of 3 ppm (Glu I) and 4 ppm (Glu II). A 
further line shape analysis upon addition of etbr, figure 74e), shows that Glu I and Glu 
II are shifted, become more narrow (1.8 and 2.8 ppm) and additional populations are 
observed. Here, a minimum of four peaks is required for an adequate description of the 
whole line shape. The minor populations contribute 28 % to the total magnetization. 
The Cα splitting was stable during long measurements and reproducible, as verified 
with two independent sample preparations (see figure 75).  
 
 
Figure 75. Reproducibility of the Cα splittings. Two independent preparations of EmrE E25A 
and time stability are assessed here. The reproducibility of the unusual peak multiplicity was 
verified using two independently produced EmrE E25A samples (46 k and 25 k scans) (a) and 
the time stability was assessed using EmrE E25A+etbr before and after 2D spectroscopy (70 k 
and 24 k scans) (b) preparations showed the same 
13C lineshape. Spectra were acquired at a 
13C 
frequency of 150.90 MHz on a Bruker Avance 600 spectrometer. Sample measurements were 
performed at 200 K with MAS spinning rate of 10,000 ±5 Hz. DQF spectra were also collected 
with the SR22
9
4 pulse sequence [190]. Exponential 150 Hz line broadening was used.  
 
The spectral contributions of natural abundance spin pairs (0.01 %), which will not be 
suppressed by double quantum filtering, was assessed by acquiring a 
13C DQF spectrum 
of neat E. coli lipids (figure 74c). Despite the very low abundance of naturally occurring 
spin  pairs,  a  CH2  signal  can  clearly  be  seen.  This  observation  is  not  surprising 
considering that 100 lipids with ~28 methylene groups contribute approximately 30 % 
of the magnetization to the EmrE E25A glutamate side chain signal.  
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9. 2. 3 2D DQSQ spectra 
In order to unambiguously assign C’, Cα, Cβ, Cγ and Cδ resonances, and to check 
whether  all  resonances  are  doubled,  two  dimensional 
13C  DQSQ  experiments  were 
carried out. These correlation spectra contain chemical shift information for all nuclei in 
the direct dimension and depict bond connectivities in the indirect dimension [315]. 2D 
spectra  without  substrate  (figure  76a)  and  with  etbr  (figure  76b)  indicate  at  first 
inspection  multiple  peaks,  with  distinct  chemical  shifts,  for  each  nucleus.  
INADEQUATE type assignment walks starting from both major Cα peaks shown in 
figure76a and figure 76b confirm peak doublets for all E14 carbons. An unambiguous 
assignment  in  this  type  of  spectra  is  aided  by  the  fact  that  the  sum  of  two  peak 
frequencies  in  the  direct  dimension  is  equal  to  their  frequencies  in  the  indirect 
dimension. As already indicated in figure 74, the set of resonances connected to the less 
shielded Cα is designated Glu I (blue lines in figure 76) and the other Glu II (red lines in 
figure  76).  Chemical  shifts  for  both  Glu  I  and  Glu  II  with  and  without  etbr  are 
summarised in table 26. 
 
Figure  76.  2D 
13C  DQSQ  correlation  spectra  of  EmrE  E25A  and  EmrE  E25A+etbr. 
Assignment of all C’, Cα, Cβ, Cγ, Cδ resonances has been aided by the fact that strongly dipole 
coupled one-bond neighbours produce a signal in the indirect dimension at the sum of their 
individual  chemical  shifts.  The  spectrum  shows  at  least  two  peaks  for  each  resonance. 
Assignment walks for both E14 populations Glu I (blue) and Glu II (red) are indicated in both 
spectra. Residual 
13C natural abundance of lipid CH2 groups (see figure 74c) is highlighted. A 
black arrow indicates the shift of Cδ Glu II upon substrate addition.  Chemical shifts are given 
in table 26. (a) EmrE E25A has been measured with 4k scans per increment and (b) EmrE 
E25A+etbr was acquired with 5k scans per increment.  
13C spectra at 150.90 MHz were recorded on 600 MHz Bruker Avance spectrometers 
using 4 mm MAS DVT probeheads. The measurements were performed at 200 K with a 
MAS  spinning  rate  of  10,000  ±5  Hz.  The  DQSQ  correlation  spectra  were  of  the 
INADEQUATE  type  [316,  317]  by  using  the  SR22
9
4  pulse  sequence  previously 
described [318] and TPPI acquisition [319]. 400  s DQ excitation and reconversion 
time was used. 
1H decoupling during the DQ excitation and reconversion was achieved 
using  continuous  wave  irradiation  at  ~100  kHz  and  during  t1  and  t2  evolution 
composite decoupling with SPINAL 64 [320] at 83.3 kHz was used. Experiments were 
recorded with 45,000 Hz sweepwidth in the direct dimension and 90,000 Hz in the 
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The spectra were recorded with 128 or 96 increments in the indirect dimension and 
2720 points in the direct dimension. 
(a)              
13C chemical shifts of E14 of  EmrE E25A (ppm) 
  C’  Cα  Cβ  Cγ  Cδ 
Glu I  177.3  56.8  27.8  33.5  180.1 
Glu II  172.4  53.1  25.4  30.9  177.2 
 
(b)           
13C chemical shifts of E14 of  EmrE E25A with etbr (ppm) 
  C’  Cα  Cβ  Cγ  Cδ 
Glu I  174.6  58.7  27.3  32.6  178.9 
Glu II  170.9  52.9  23.5  28.1  176.3 
Table 26. 
13C chemical shifts of E14 in EmrE E25A with and without etbr. Chemical shift 
values for both observed E14 populations were derived from the 2D DQSQ spectra.  
 
9. 2. 4 Line shape analysis 
Multiple distinct molecular environments are suggested by the need for at least two 
distinct sets of chemical shifts to describe the 
13C spectra of E14. To obtain a more 
quantitative  picture,  a  line  shape  analysis  was  carried  out  for  the  Cα  peaks  which 
showed the most pronounced splitting. The symmetric Cα doublet of EmrE E25A can 
be adequately described by two resonances of similar integral intensity with respective 
line widths of 3.0 (Glu I) and 4.0 ppm (Glu II) (figure 74d). The different chemical 
shifts  of  these  two  resonances  are  indicative  of  two  inequivalent  EmrE  E25A 
populations. The line width indicates a limited amount of heterogeneity.   
 
 
Figure 77. 
13C chemical shift shift analysis. Changes in EmrE E25A chemical shifts after 
substrate addition were investigated. The displacement of chemical shifts was calculated as 
follows:  13Cδ  (Cδ  EmrE  E25A+etbr)  –  13Cδ  (Cδ  EmrE  E25A)  =  13C δ  (chemical  shift 
displacement).  Negative  values  indicate  a  decrease  of  chemical  shift  values  after  substrate 
addition, whereas positive values indicate an increase of chemical shift values after substrate 
addition. Both major E14 populations are displayed (Glu I in blue and Glu II in red). 
 
In contrast, at least four peaks are required to describe the asymmetric Cα line shape 
which is observed in the presence of etbr (figure 74e). The two main peaks Glu I and 
Glu  II  are  of  equal  integral  intensity.  The  two  additional  peaks  contribute  28  % 
magnetization to the spectrum. The addition of etbr therefore causes E14 to be present 
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reduced to 1.8 (Glu I) and 2.8 ppm (Glu II) compared to EmrE E25A without substrate, 
suggesting  a  decrease  in  structural  heterogeneity  concomitant  with  an  increase  of 
populations. 
 
9. 3 Discussion 
9. 3. 1 General 
In this study, the proposed active site structure of the functional homodimeric EmrE 
with and without the substrate etbr was investigated. For this investigation, the single 
glutamate  mutant  EmrE  E25A  was  selectively  isotope  labelled  at  the  remaining 
conserved E14. This enabled unambiguous chemical shift assignment and simplified 
data interpretation. The capability of E. coli based cell free transcription and translation 
systems to express wild type EmrE in a functional form with and without detergent was 
previously shown [36, 197]. Furthermore, it has been reported that amino acid selective 
isotope labelling without dilution or scrambling is possible [49].  
Several  control  experiments  verified  that  cell  free  expressed  EmrE  E25A  is  indeed 
functional and correctly labelled. Preparations as precipitate as well as in the presence 
of detergent produce functional protein. The precipitation method was preferred here as 
the protein yield was higher. 
The protein was reconstituted into E. coli lipids under conditions that allow the protein 
to be functional in the exchange mode. This active protein conformation was trapped by 
freezing  with  liquid  nitrogen.  Non-invasive  solid  state  NMR  revealed  significantly 
different  chemical  shifts  between  both  E14s  with  and  without  addition  of  ethidium 
bromide. This indicates an asymmetric homodimer for EmrE with and without substrate 
bound.  
In this study the key to understanding the chemical environment of glutamate lies in the 
chemical shifts.  
 
9. 3. 2 Inequivalence of E14s in homodimeric EmrE is genuine 
These data clearly show two distinct and similarly abundant populations of E14 (Glu I 
and Glu II).  A number of controls were carried out to exclude the possibility that the 
observed  E14  populations  were  caused  by  sample  preparation  problems  such  as 
impurities, incorrect 
13C labelling, aggregation or sample disintegration. 
EmrE E25A preparations contain no protein contamination as judged by MALDI-TOF 
mass spectrometry and SDS PAGE (figure 67). No isotope scrambling took place as 
verified by analytical NMR analysis (figure 68) and as judged by the spectral pattern 
characteristic for glutamic acid (figure 76). Dilution of glutamate was observed (figure 
69), leading to only 64 % NMR spectroscopically observable EmrE E25A molecules 
and  concomitantly  long  NMR  acquisition  times.  Aggregation  could  be  excluded  by 
freeze  fracture  microscopy  which  was  performed  after  NMR  measurements  and 
detected no signs of protein aggregation (figure 71). Finally, sample deterioration, due 
to  e.g.  radiofrequency  irradiation,  can  be  excluded  because  the  spectra  of  frozen 
samples did not change with time (figure 75a)). Results were reproducible as judged by 
additional, independent sample preparations (figure 75b)). 
 
9. 3. 3 The E14s of different protomers in the homodimeric EmrE binding pocket 
are asymmetric 
Possible reasons for the genuine inequivalence of E14 could be (a) freeze trapping of 
general conformational  flexibility (b) freeze trapping of conformations  which are in 
dynamic  exchange  (c)  a  protonation/deprotonation  equilibrium  or  (d)  a  structurally 
asymmetric dimer. Chapter 9 – Investigations of EmrE and its key residue for substrate transport E14  - in 
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(a) Freeze trapping of thermal motions causes increased line widths. At least two sets of 
chemical  shifts  are  found  for  all  glutamate  nuclei  with  chemical  shift  differences 
between +1.9 ppm (Glu I Cα versus Glu I Cα+etbr) and -2.8 ppm (Glu II Cγ versus Glu 
II Cγ+etbr) (see Fig. 6). Peak doubling has been observed previously by solid state 
NMR and structural significance could be assigned in cases with large chemical shift 
changes (>1.5 ppm) whereas smaller differences were suggested to arise from motions 
in the ms range [132, 289]. H/D exchange infrared spectroscopy is commonly used to 
judge relative membrane protein mobility. The amides of EmrE reconstituted in both 
DMPC and E. coli total lipids (as in this study) showed only negligible exchange, while 
for example the lactose transporter LacY exchanges  95 % of all amide protons within 
24 hours [305, 321]. This suggests that EmrE is remarkably immobile in the absence of 
substrate, similar to the K
+ channel Slik and bacteriorhodopsin [305]. Extensive work 
on the soluble multidrug-binding protein QacR suggests a rigid drug-binding pocket 
with distinct and overlapping mini-pockets for different drugs. It is anticipated that a 
similar mechanism for multidrug binding is employed by EmrE and other multidrug 
transporters [13]. This suggests restricted mobility of the empty EmrE E25A binding 
pocket.  Similarly,  theoretical  considerations  suggest  that  empty  EmrE  should  be 
immobile and only the presence of etbr and H
+ should enable conformational changes 
[322]. Taking all of this into consideration, the broad line widths likely reflect structural 
heterogeneity  caused  by  small,  thermal  fluctuations  about  an  equilibrium  structure. 
Thermal fluctuations could not account for peak multiplicities. Large line widths are 
commonly encountered in solid state NMR of biological materials and are considered 
native for unaligned and non-crystalline proteins between 1 and 4 ppm [124, 290]. 
(b) Theoretically EmrE E25A could be in exchange between distinct conformational 
states such as binding or release conformations. However, this is unlikely in the absence 
of  substrate  and  energetic  coupling  to   pH  or   ψ  gradients  to  drive  the  protein 
conformational changes normally associated with substrate transport. EmrE E25A in the 
absence of substrate and a pH gradient can thus be expected to have its conformational 
space limited to the binding position and thus cannot itself lead to peak multiplicity. 
Furthermore,  if  EmrE  E25A  would  be  in  dynamic  exchange  between  binding  and 
release  conformation,  H/D  exchange  rates  similar  to  LacY  would  be  expected. 
However, FTIR spectroscopy detects a slow H/D exchange rate for EmrE and suggests 
EmrE to be rigid when reconstituted in a lipid environment [323]. 
(c) Cδ, Cγ and Cβ shifts are sensitive to protonation state and long-range electrostatic 
interactions.  All  observed  Cδ  chemical  shifts  are  found  in  the  typical  range  for 
protonated  and  deprotonated  glutamate  Cδ  [324].  A  possible  explanation  for  the 
observation of two distinct glutamate Cδ chemical shifts could be differences in the 
protonation states of E14 near its pKa. Both wild type EmrE and the single glutamate 
mutant  E25C/D84C  have  a  reported  pKa  of  7.5  [64]  and  accordingly  in  this  study 
approximately  50  %  of  the  glutamates  are  expected  to  be  protonated  at  pH  8.0. 
However,  the  Cα  and  C’  chemical  shifts  are  only  weakly  affected  by  side  chain 
protonation/deprotonation  or  long-range  electrostatic  interactions  at  the  side  chain 
nuclei Cδ, Cγ, Cβ [325] [326]. More specifically, using model peptides glutamate C’ 
and Cα were shown to maximally shift 1 ppm while Cδ shifts up to 4 ppm upon side 
chain  protonation/deprotonation  [326].  Therefore,  a  protonation/deprotonation 
equilibrium can be excluded to explain the observed backbone peak multiplicity.  
(d) Equally sized glutamate populations could be explained if EmrE would form an 
asymmetric dimer. In an asymmetric dimer both (φ/ψ) torsion angles and therefore the 
secondary structures are different leading to variations in the C’ and Cα chemical shift 
values,  as  detected  here.  In  addition,  the  side  chain  nuclei  Cβ,  Cγ  and  Cδ  are  less 
affected  by  the  protein  secondary  structure  but  monitor  hydrogen-bonding,  χ  angle, Chapter 9 – Investigations of EmrE and its key residue for substrate transport E14  - in 
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protonation/deprotonation,  long  range  electrostatic  interactions  and  other  effects  on 
their electronic environment. Therefore, both distinct sets of E14 Cβ, Cγ and Cδ shifts 
indicate  that  the  side  chains  within  the  homodimer  are  found  in  different  chemical 
environments. They are inequivalent. 
Based on this evidence it can be concluded that the peak splitting is genuine and caused 
by the asymmetry of functional EmrE E25A dimers in E. coli lipid liposomes at pH 8.0. 
This conclusion is also supported by the similar intensities of both Glu I and Glu II. 
 
9. 3. 4 Interpretation of E14 line shape and chemical shifts 
The  symmetric  line  shape  of  EmrE  E25A  Cα could  be  fitted  best  by  two  peaks  of 
similar integral intensity (figure 74). The line widths are most likely caused by residual 
structural heterogeneity trapped by sample freezing, as discussed above. The chemical 
shifts belonging to these two E14 populations show significant differences (table 26).  
The chemical shifts of both backbone carbons differ by 4.9 ppm for C’ and 3.7 ppm for 
Cα. The chemical shifts of these backbone atoms are mainly influenced by the backbone 
secondary  structure  and  neighbouring  residues.  In  the  EmrE  homodimer,  both  E14s 
have the same preceding and proceeding amino acid, so the differences must be caused 
by slightly different backbone conformations.  
Three liquid state NMR studies on SMR proteins (EmrE and Smr) have been reported 
before  [61,  263,  327].  All  studies  used  non-native  membrane  mimicking  conditions 
such as chloroform/methanol for monomeric EmrE [61], LPPG micelles for dimeric 
Smr [263] or biPC bicelles for dimeric Smr [169]. Interestingly, no asymmetry was 
observed and the reported 
13C chemical shifts of E14 deviate from our measurements up 
to 8.4 ppm (figure x). This underlines the importance of a native lipid environment and 
supports  arguments  that  the  dimer  only  assumes  an  asymmetric  conformation  in  its 
active state within the membrane [40, 289, 290, 328]. 
 
 
Figure 78. 
13C chemical shifts of EmrE E25A in liposomes compared to Smr and EmrE 
chemical shifts in solution. Chemical shifts of reconstituted EmrE E25A (this study) were 
compared  to  Smr  and  EmrE  chemical  shifts  obtained  by  liquid-state  NMR  on  solubilised 
samples. Solution state NMR 
13C chemical shifts of dimeric Smr in LPPG micelles (BMRB 
code: 6796), dimeric Smr in biPC bicelles [169] and monomeric EmrE in a solvent system 
(BMRB code: 4136) were adjusted to comply with our referencing compound tetramethylsilane. 
All available chemical shifts were used.  
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9. 3. 5 Interpretation of E14 line shape and chemical shifts upon substrate addition 
Upon substrate addition, the Cα line shape becomes asymmetric and was reproduced 
best by fitting under the assumption of four peaks. The line widths of both main peaks 
Glu I and Glu II was considerably reduced, which is most likely  caused by reduced 
thermal motions in the presence of the substrate etbr. After addition of the substrate 
etbr,  the  transporter  should  be  in  equilibrium  exchange  conformations.  These 
conformations include an open state of EmrE E25A, an exchange intermediate and one 
release position. Therefore, additional peaks would be expected as seen in figure 74. 
Not all of these resonances are populated equally, possibly due to the different residence 
times for each state and an unsaturated binding pocket. However, the etbr concentration 
was chosen to theoretically provide greater than 99 % occupancy at the binding site.  
It is not possible to unequivocally assign both E14 populations Glu I and Glu II found in 
EmrE E25A to both main populations found in the presence of substrate. Assuming that 
the more shielded Glu I population is the same in both situations, changes in chemical 
shifts can be discussed. Only with this assignment, realistic chemical shift changes are 
obtained.    
The differences between E14 chemical shifts without and with etbr are summarized in 
figure  77.    Changes  of  up  to  -2.8  ppm  are  observed.  Upon  substrate  binding  both 
glutamate Cδ chemical shifts change towards values indicative of protonation or long-
range electrostatic interactions. The Cβ and Cγ chemical shifts concertedly shift upfield 
supporting  the  notion  that  the  chemical  environment  of  both  E14s  within  the 
asymmetric  homodimer  changes.  This  suggests  that  both  glutamates  coordinate  etbr 
giving rise to two different etbr/glutamate interactions and therefore different chemical 
shifts.  
 
9. 3. 6 An asymmetric binding pocket of EmrE in the context of known EmrE data 
Asymmetry has been reported for SMR proteins before. A subgroup of EmrE-like SMR 
proteins (YdgE/F[193, 329], yvdR/S, ykkC/D [193], EbrA/EbrB [54, 55, 330]) has been 
found  to  act  as  heterooligomers  with  a  defined  topology  for  each  molecule.  Such 
heterooligomers are obviously asymmetric at the glutamate residue and for EbrA/B it 
could be shown that the two glutamates are functionally inequivalent [55]. Additionally, 
EmrE can be manipulated to force it into a unique and defined topology.  A dimer 
produced  this  way  to  yield  one  Cin  and  one  Cout  protomer  showed  functional 
inequivalence of the E14s [33].  
Independently,  EPR  spectroscopy  on  EmrE  in  solution  revealed  a  heterogeneous 
conformational state at E14, an asymmetric dimer was seen in the EM structure
 [44, 
331] and an antiparallel dimer was observed by x-ray crystallography [19]. Figure 79 
shows this x-ray crystallography model of EmrE with TPP
+. 
It can be postulated that the monomers take up a unique fold as seen by liquid state 
NMR and CD spectroscopy but upon dimerisation each protomer assumes a different 
conformation. Such induced asymmetry has been previously described for HIV1 reverse 
transcriptase, hot dog thioesterase PaaI and for the trimeric multidrug transporter AcrB 
[18,  332,  333].  Further,  a  true  dual  topology,  MCR-2  accessory  protein,  has  been 
recently described in eukarotes [334]. The here observed asymmetry at the EmrE E25A 
binding  pocket  however  is  consistent  with  both  the  parallel  and  the  antiparallel 
arrangement of protomers in a dimer. H
+ release studies [65], carbodiimide reactivity 
[335] and fluorescence spectroscopy [252] enable only the global accessibility of the 
two E14 residues in a dimer to be investigated. These techniques, unlike the solid state 
NMR experiments used here, do not afford site-specific resolution or directly monitor 
structural parameter.  Chapter 9 – Investigations of EmrE and its key residue for substrate transport E14  - in 
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Figure 79. EmrE backbone structure by x-ray crystallography from 3D crystals modelled 
into the EM electron density of the EmrE 2D crystals. This EmrE model is asymmetric and 
displays dual topology of EmrE. The modelling work was provided as supplementary data by 
Chen et al. [19]. 
 
9. 4 Conclusion 
These  data  show  directly  that  both  E14  in  the  EmrE  dimer  are  in  a  structurally 
inequivalent environment and coordinate substrate binding. This structural asymmetry 
could be consistent with both an antiparallel and parallel dimer topology.  
Here cell free expression was used for the first time to supply a membrane transport 
protein for the investigation by solid state NMR. The cell free expression methodology 
proved its applicability for solid state NMR.  
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